0001571049-16-019689.txt : 20161109 0001571049-16-019689.hdr.sgml : 20161109 20161109161206 ACCESSION NUMBER: 0001571049-16-019689 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161109 DATE AS OF CHANGE: 20161109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 161984352 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 10-Q 1 t1602621-10q.htm FORM 10-Q t1602621-10q - none - 4.5334533s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2016
OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ____
Commission File Number: 001-36410
Phibro Animal Health Corporation
(Exact name of registrant as specified in its charter)
Delaware
13-1840497
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21
Teaneck, New Jersey
(Address of Principal Executive Offices)
07666-6712
(Zip Code)
(201) 329-7300
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)  Yes ☒ No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of  “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No ☒
As of November 2, 2016, there were 18,519,757 shares of the registrant’s Class A common stock, par value $0.0001 per share, and 20,887,811 shares of the registrant’s Class B common stock, par value $0.0001 per share, outstanding.

PHIBRO ANIMAL HEALTH CORPORATION
TABLE OF CONTENTS
Page
PART I—FINANCIAL INFORMATION
Item 1.
Financial Statements (unaudited)
3
4
5
6
7
18
28
28
PART II—OTHER INFORMATION
29
29
29
29
29
29
29
30
2

P ART I—FINANCIAL INFORMATION
Item 1.   Financial Statements
PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months
For the Periods Ended September 30
2016
2015
(unaudited)
(in thousands, except per
share amounts)
Net sales
$ 187,987 $ 187,120
Cost of goods sold
126,988 127,913
Gross profit
60,999 59,207
Selling, general and administrative expenses
39,186 37,349
Operating income
21,813 21,858
Interest expense, net
3,907 3,819
Foreign currency (gains) losses, net
334 (5,453)
Income before income taxes
17,572 23,492
Provision for income taxes
5,395 4,739
Net income
$ 12,177 $ 18,753
Net income per share
basic
$ 0.31 $ 0.48
diluted
$ 0.31 $ 0.47
Weighted average common shares outstanding
basic
39,408 39,092
diluted
39,906 40,012
Dividends per share
$ 0.10 $ 0.10
The accompanying notes are an integral part of these consolidated financial statements
3

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Three Months
For the Periods Ended September 30
2016
2015
(unaudited)
(in thousands)
Net income
$ 12,177 $ 18,753
Change in fair value of derivative instruments
34 (4,903)
Foreign currency translation adjustment
(893) (21,729)
Unrecognized net pension gains (losses)
7,169 384
(Provision) benefit for income taxes
(2,750) 3,686
Other comprehensive income (loss)
3,560 (22,562)
Comprehensive income (loss)
$ 15,737 $ (3,809)
The accompanying notes are an integral part of these consolidated financial statements
4

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
As of
September 30,
2016
June 30,
2016
(unaudited)
(in thousands, except share
and per share amounts)
ASSETS
Cash and cash equivalents
$ 37,415 $ 33,605
Accounts receivable, net
119,607 123,790
Inventories, net
162,644 167,691
Other current assets
20,102 17,745
Total current assets
339,768 342,831
Property, plant and equipment, net
127,336 127,323
Intangibles, net
58,572 60,095
Goodwill
21,121 21,121
Other assets
51,287 56,465
Total assets
$ 598,084 $ 607,835
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt
$ 2,903 $ 2,907
Accounts payable
54,274 60,167
Accrued expenses and other current liabilities
44,159 45,703
Total current liabilities
101,336 108,777
Revolving credit facility
62,000 69,000
Long-term debt
277,698 278,265
Other liabilities
54,774 61,313
Total liabilities
495,808 517,355
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 18,519,757 shares issued and outstanding at September 30, 2016, and June 30, 2016; 30,000,000 Class B shares authorized, 20,887,811 shares issued and outstanding at September 30, 2016, and June 30, 2016
4 4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no
shares issued and outstanding
Paid-in capital
118,299 118,299
Retained earnings
42,198 33,962
Accumulated other comprehensive income (loss)
(58,225) (61,785)
Total stockholders’ equity
102,276 90,480
Total liabilities and stockholders’ equity
$ 598,084 $ 607,835
The accompanying notes are an integral part of these consolidated financial statements
5

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months
For the Periods Ended September 30
2016
2015
(unaudited)
(in thousands)
OPERATING ACTIVITIES
Net income
$ 12,177 $ 18,753
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization
6,318 5,429
Amortization of debt issuance costs and debt discount
253 242
Acquisition-related accrued compensation
420 420
Acquisition-related accrued interest
393 345
Deferred income taxes
1,706 38
Foreign currency (gains) losses, net
97 (5,434)
Other
87 53
Changes in operating assets and liabilities:
Accounts receivable, net
3,906 (5,597)
Inventories, net
4,544 (5,469)
Other current assets
(2,430) (1,570)
Other assets
346 (444)
Accounts payable
(5,004) (3,010)
Accrued expenses and other liabilities
(1,357) (6,150)
Net cash provided (used) by operating activities
21,456 (2,394)
INVESTING ACTIVITIES
Capital expenditures
(5,911) (8,094)
Other, net
25 246
Net cash provided (used) by investing activities
(5,886) (7,848)
FINANCING ACTIVITIES
Revolving credit facility borrowings
34,000 55,500
Revolving credit facility repayments
(41,000) (38,000)
Payments of long-term debt, capital leases and other
(729) (734)
Proceeds from common shares issued
693
Dividends paid
(3,941) (3,910)
Net cash provided (used) by financing activities
(11,670) 13,549
Effect of exchange rate changes on cash
(90) (706)
Net increase (decrease) in cash and cash equivalents
3,810 2,601
Cash and cash equivalents at beginning of period
33,605 29,216
Cash and cash equivalents at end of period
$ 37,415 $ 31,817
The accompanying notes are an integral part of these consolidated financial statements
6

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
1.
Description of Business
Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (collectively, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.
The unaudited consolidated financial information for the three months ended September 30, 2016 and 2015, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 (the “Annual Report”), filed with the Securities and Exchange Commission on August 29, 2016 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of financial position, results of operations and cash flows for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2016, was derived from the audited consolidated financial statements, which include the accounts of Phibro and its consolidated subsidiaries, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.
The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity. Intercompany balances and transactions have been eliminated in the consolidated financial statements.
2.
Summary of Significant Accounting Policies and New Accounting Standards
Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2016, there have been no material changes to any of the significant accounting policies contained therein, except for the application of Accounting Standards Update (“ASU”) 2015-03, Interest—Imputation of Interest (Subtopic 835-30), during the three months ended September 30, 2016. Prior periods have been adjusted to reflect the retrospective application of this guidance. For further discussion, see “—New Accounting Standards.”
Revisions of Previously Issued Financial Statements
During the fourth quarter of fiscal 2016, the Company determined that amortization expense related to product-related intangible assets should be recorded in cost of goods sold rather than in selling, general and administrative expense within the consolidated statement of operations. The Company has revised its financial statements for the three months ended September 30, 2015, to correct the classification of amortization expense to increase cost of goods sold and reduce gross profit and selling, general and administrative expenses by $953. These revisions had no impact on the Company’s previously reported net income (loss) or cash flows. The Company evaluated the impact of the revisions on prior periods, assessing materiality quantitatively and qualitatively, and concluded the errors were not material to any previously issued financial statements.
Net Income per Share and Weighted Average Shares
Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.
7

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares equivalents resulting from the assumed exercise of stock options. For the three months ended September 30, 2016 and 2015, all common share equivalents were included in the calculation of diluted net income per share.
Three Months
For the Periods Ended September 30
2016
2015
Net income
$ 12,177 $ 18,753
Weighted average number of shares – basic
39,408 39,092
Dilutive effect of stock options
498 920
Weighted average number of shares – diluted
39,906 40,012
Net income per share
basic
$ 0.31 $ 0.48
diluted
$ 0.31 $ 0.47
Dividends
We declared and paid quarterly cash dividends of  $0.10 per share, totaling $3,941, during the three months ended September 30, 2016, to holders of our Class A common stock and Class B common stock.
New Accounting Standards
Financial Accounting Standards Board (“FASB”) ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2016-02, Leases (Topic 842), supersedes the current lease accounting guidance and requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December 15, 2018. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-12, Plan Accounting (Topics 960, 962 and 965), modifies certain disclosure requirements and asset valuation measurements. We applied the provisions of this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
ASU 2015-11, Inventory (Topic 330), requires entities to measure inventory at the lower of cost and net realizable value (“NRV”). NRV is defined as “the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-05, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) provides guidance regarding the treatment of cloud computing arrangements and if an arrangement includes a software license. We adopted this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
8

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30), requires debt issuance costs to be presented as a reduction of the related liability. These costs were previously included in other assets. Debt issuance costs associated with line-of-credit arrangements may continue to be recognized in other assets. We adopted this guidance during the three months ended September 30, 2016, and applied the guidance retrospectively. Debt issuance costs of  $2,406 and $2,538 as of September 30, 2016, and June 30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.
ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), requires management to assess an entity’s ability to continue as a going concern within one year after the issuance date of the financial statements, and to provide related footnote disclosures in certain circumstances. Management will need to consider relevant conditions that are known and reasonably knowable at the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. Under the new standard, the definition of substantial doubt incorporates a likelihood threshold of  ”probable” similar to the current use of that term in GAAP for loss contingencies. ASU 2014-15 will be effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.
ASU 2014-09, Revenue from Contracts with Customers (Topic 606), establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2015-14, Deferral of the Effective Date, amended ASU 2014-09, resulting in a one-year deferral of the effective date. ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing; and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients also amended ASU 2014-09. The amendments are effective concurrent with the effective date for ASU 2014-09 for annual periods beginning after December 15, 2017, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
3.
Statements of Operations—Additional Information
Three Months
For the Periods Ended September 30
2016
2015
Interest expense, net
Term B loan
$ 2,905 $ 2,935
Revolving credit facility
955 260
Acquisition-related accrued interest
393 345
Amortization of debt issuance costs and debt discount
253 242
Other
81 86
Interest expense
4,587 3,868
Interest (income)
(680) (49)
$ 3,907 $ 3,819
Depreciation and amortization
Depreciation of property, plant and equipment
$ 4,731 $ 4,111
Amortization of intangible assets
1,528 1,259
Amortization of other assets
59 59
$ 6,318 $ 5,429
9

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
4.
Balance Sheets—Additional Information
As of
September 30,
2016
June 30,
2016
Inventories
Raw materials
$ 56,789 $ 51,369
Work-in-process
8,900 8,074
Finished goods
96,955 108,248
$ 162,644 $ 167,691
Goodwill balances did not change during the three months ended September 30, 2016.
We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,040 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.
As of
September 30,
2016
June 30,
2016
Accrued expenses and other current liabilities
Employee related
$ 19,043 $ 21,712
Commissions and rebates
4,143 3,722
Insurance related
1,717 1,780
Professional fees
3,546 3,573
Income and other taxes
2,203 1,910
Deferred consideration on acquisitions
1,250 1,250
Other
12,257 11,756
$  44,159 $  45,703
As of
September 30,
2016
June 30,
2016
Accumulated other comprehensive income (loss)
Derivative instruments
$ 2,689 $ 2,655
Foreign currency translation adjustment
(42,797) (41,904)
Unrecognized net pension gains (losses)
(23,808) (30,977)
(Provision) benefit for income taxes on derivative instruments
(1,561) (1,548)
(Provision) benefit for incomes taxes on long-term intercompany investments
8,166 8,166
(Provision) benefit for income taxes on pension gains (losses)
(914) 1,823
$ (58,225) $ (61,785)
5.
Debt
Revolving Credit Facility and Term B Loan
We have a revolving credit facility (the “Revolver”), where we can borrow up to $200,000, subject to the terms of the agreement, and a term B loan (the “Term B Loan,” and together with the Revolver, the “Credit Facilities”). The Revolver has applicable margins equal to 2.50% or 2.75%, in the case of LIBOR loans and 1.50% or 1.75%, in the case of base rate loans; the margins are based on the First Lien Net Leverage Ratio. The Term B Loan has applicable margins equal to 3.00% with regards to LIBOR loans and 2.00% regarding base rate loans. The LIBOR rate on the Term B Loan is subject to a floor of 1.00%.
10

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
The Revolver requires, among other things, the maintenance of a maximum consolidated first lien net debt to consolidated EBITDA leverage ratio, calculated on a trailing four quarter basis, and contains an acceleration clause should an event of default (as defined in the agreement governing the Credit Facilities) occur. As of September 30, 2016, we were in compliance with the covenants of the Credit Facilities.
As of September 30, 2016, we had $62,000 in borrowings under the Revolver and had outstanding letters of credit of  $14,242 leaving $123,758 available for borrowings and letters of credit under the Revolver. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The tenors of these letters of credit are all one year or less.
The weighted-average interest rates for the Revolver and Term B Loan were 3.26% and 4.00%, respectively, for the three months ended September 30, 2016.
Long-Term Debt
As of
September 30,
2016
June 30,
2016
Term B loan due April 2021
$ 283,475 $ 284,200
Capitalized lease obligations
3 7
283,478 284,207
Unamortized debt issuance costs and debt discount
(2,877) (3,035)
Less: current maturities
(2,903) (2,907)
$ 277,698 $ 278,265
During the three months ended September 30, 2016, we applied the provisions of ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30). Debt issuance costs of  $2,406 and $2,538 as of September 30, 2016, and June 30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.
6.
Related Party Transactions
Certain relatives of Jack C. Bendheim provided services to us as employees or consultants and received aggregate compensation and benefits of  $603 and $699 during the three months ended September 30, 2016 and 2015, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.
7.
Employee Benefit Plans
The Company maintains a noncontributory defined benefit pension plan for all domestic nonunion employees employed on or prior to December 31, 2013, who meet certain requirements of age, length of service and hours worked per year. Plan benefits are based upon years of service and average compensation, as defined.
In July 2016, we amended our domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of  $6,822 in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities. We also modified the 401(k) retirement savings plan, effective October 1, 2016, to include, for all domestic employees, a non-elective Company contribution of 3% of compensation and an additional discretionary contribution of up to 4% of compensation, depending on the employee’s age and years of service.
Separately, we recently offered a lump sum settlement option to certain pension plan participants. During the three months ending December 31, 2016, we will recognize a partial settlement of the pension plan and a charge to the consolidated statement of operations. The settlement expense is expected to be approximately $1,700.
11

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Net periodic pension expense was:
Three Months
For the Periods Ended September 30
2016
2015
Service cost – benefits earned during the period
$ 561 $ 719
Interest cost on benefit obligation
543 689
Expected return on plan assets
(863) (742)
Amortization of net actuarial loss and prior service costs
347 384
Net periodic pension expense
$ 588 $ 1,050
8.
Commitments and Contingencies
Environmental
Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the time period during which such costs are likely to be incurred are difficult to predict.
While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.
The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based upon our experience to date, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.
The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of a facility in Santa Fe Springs, California, operated by our subsidiary Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified
12

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that groundwater contamination at its site is due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, a nearby property owner has filed a complaint in the Superior Court of the State of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for alleged contamination of groundwater underneath its property, and a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling has filed a complaint under CERCLA, RCRA and the common law public nuisance doctrine in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.
Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be $6,990 and $7,024 at September 30, 2016, and June 30, 2016, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries is liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.
Claims and Litigation
PAHC and its subsidiaries are party to a number of claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.
9.
Derivatives
We monitor our exposure to foreign currency exchange rates and use derivatives to manage certain of these risks. These derivatives generally have an expiration/maturity of two years or less and are intended to hedge cash flows related to the purchase of inventory. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). We record the portion of the changes in the value of the derivative, related to a hedged asset or liability (the effective portion), in accumulated other comprehensive income (loss). As the hedged item is sold, we recognize the gain or loss recorded in accumulated other comprehensive income (loss) to the consolidated statements of operations on the same line where the hedged item is charged when released/sold. We immediately recognize in the consolidated statements of operations in the same line as the hedged item, the portion of the changes in fair value of derivatives used as cash flow hedges that is not offset by changes in the expected cash flows related to a recognized asset or liability (the ineffective portion).
13

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
We routinely assess whether the derivatives used to hedge transactions are effective. If we determine that a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.
We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “—Fair Value Measurements.”
The following table details the Company’s outstanding derivatives that are designated and effective as cash flow hedges as of September 30, 2016:
Instrument
Hedge
Notional
Amount at
September 30,
2016
Fair value as of
September 30,
2016
June 30,
2016
Options
Brazilian Real calls​
R$97,500
$ 2,815 $ 3,027
Options
Brazilian Real puts​
R$97,500
$ (126) $ (372)
The fair values at September 30, 2016, are unrealized and will fluctuate based on future exchange rates until the derivative contracts mature. Other comprehensive income (loss) for the three months ended September 30, 2016, included $34 of net unrecognized gains. Accumulated other comprehensive income (loss) at September 30, 2016, included $2,689 of net unrecognized gains on derivative instruments; we estimate that $167 of those gains will be recognized in earnings within the next twelve months. At June 30, 2016, realized losses of  $1,528, related to matured contracts were recorded as a component of inventory. We recognized $1,135 of these losses in cost of goods sold during the three months ended September 30, 2016, and anticipate we will recognize the remaining $393 of these losses in costs of goods sold during the three months ending December 31, 2016. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold. We hedge forecasted transactions for periods not exceeding twenty-four months.
10.
Fair Value Measurements
Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Financial assets and liabilities are measured at fair value using the three-level valuation hierarchy for disclosure of fair value measurements. The determination of the applicable level within the hierarchy of a particular asset or liability depends on the inputs used in the valuation as of the measurement date, notably the extent to which the inputs are market-based (observable) or internally derived (unobservable). Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs are inputs based on a company’s own assumptions about market participant assumptions developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of inputs as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—
Significant observable inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly through corroboration with observable market data.
Level 3—
Unobservable inputs for which there is little or no market data available, and that are significant to the overall fair value measurement, are employed that require the reporting entity to develop its own assumptions.
In assessing the fair value of financial instruments at September 30, 2016, and June 30, 2016, we used a variety of methods and assumptions that were based on estimates of market conditions and risks existing at the time.
14

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
Current Assets and Liabilities
We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.
Letters of Credit
We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The carrying values of these letters of credit are considered to be representative of their fair values because of the nature of the instruments. The tenors of these letters of credit are all one year or less.
Long Term Debt
We record the Term B Loan and the Revolver at book value in our consolidated financial statements. We believe the carrying value of the Term B Loan is approximately equal to the fair value, which is based on quoted broker prices that are Level 2 inputs. We believe the carrying value of the Revolver is approximately equal to the fair value due to the variable nature of the instrument.
Deferred Consideration on Acquisitions
We estimated the fair value of the deferred consideration on acquisitions using the income approach, based on the Company’s current sales forecast related to the acquired business.
Derivatives
We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.
As of
September 30, 2016
June 30, 2016
Level 1
Level 2
Level 3
Level 1
Level 2
Level 3
Derivatives asset
$  — $ 2,689 $  — $  — $ 2,655 $  —
Deferred consideration on acquisitions
$  — $  — $ (7,068) $  — $  — $ (6,745)
The table below provides a summary of the changes in the fair value of Level 3 liabilities:
Balance, June 30, 2016
$ (6,745)
Acquisition-related accrued interest
(393)
Payment
70
Balance, September 30, 2016
$ (7,068)
11.
Business Segments
The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace mineral products for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.
We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and such costs are referred to as Corporate. We do not allocate such items to the principal segments because they are not used to evaluate their operating results or financial position.
15

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.
The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.
Three Months
For the Periods Ended September 30
2016
2015
Net sales
MFAs and other
$ 83,419 $ 85,521
Nutritional Specialties
26,304 22,370
Vaccines
14,778 12,243
Animal Health
124,501 120,134
Mineral Nutrition
51,592 54,469
Performance Products
11,894 12,517
Total segments
$ 187,987 $ 187,120
Depreciation and amortization
Animal Health
$ 4,898 $ 3,876
Mineral Nutrition
542 608
Performance Products
218 194
Total segments
$ 5,658 $ 4,678
Adjusted EBITDA
Animal Health
$ 32,619 $ 31,476
Mineral Nutrition
3,988 3,160
Performance Products
742 86
Total segments
$ 37,349 $ 34,722
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes
$ 17,572 $ 23,492
Interest expense, net
3,907 3,819
Depreciation and amortization – Total segments
5,658 4,678
Depreciation and amortization – Corporate
660 751
Corporate costs
7,524 7,015
Acquisition-related accrued compensation
420 420
Acquisition-related transaction costs
1,274
Foreign currency (gains) losses, net
334 (5,453)
Adjusted EBITDA – Total segments
$ 37,349 $ 34,722
16

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
As of
September 30,
2016
June 30,
2016
Identifiable assets
Animal Health
$ 435,512 $ 444,751
Mineral Nutrition
59,687 57,939
Performance Products
20,988 21,557
Total segments
516,187 524,247
Corporate
81,897 83,588
Total
$ 598,084 $ 607,835
The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of  $4,040 and $4,076 as of September 30, 2016, and June 30, 2016, respectively. The Performance Products segment includes an investment in an equity method investee of  $428 and $504 as of September 30, 2016, and June 30, 2016, respectively. Corporate assets include cash and cash equivalents, debt issuance costs related to the Revolver, income tax related assets and certain other assets.
17

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided to assist readers in understanding our performance and summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. This MD&A should be read in conjunction with our consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Our future results could differ materially from our historical performance or our future expectations as a result of various factors, such as those discussed in “Forward-Looking Statements” and “Risk Factors.”
Overview of our business
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. We also are a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.
Trends and uncertainties
Our business depends heavily on a healthy and growing livestock industry. Some in the public perceive risks to human health related to the consumption of food derived from animals that utilize certain of our products, including certain of our medicated feed additives products. In particular, there is increased focus, primarily in the United States, on the use of medically important antibacterials, as defined by the FDA. Medically important antibacterials include classes that are prescribed in animal and human health and are listed in the Appendix of the FDA-CVM Guidance for Industry (GFI) #152. Our products that contain virginiamycin, oxytetracycline or neomycin have previously been classified by the FDA as medically important antibacterials. This may lead to a decline in the demand for and production of food products derived from animals that utilize our products and, in turn, demand for our products. Livestock producers may experience decreased demand for their products or reputational harm as a result of evolving consumer views of nutrition and health-related concerns, animal rights, and other concerns. Any reputational harm to the livestock industry may also extend to companies in related industries, including us. In addition, campaigns by interest groups, activists and others with respect to perceived risks associated with the use of our products in animals, including position statements by livestock producers and their customers based on non-use of certain medicated products in livestock production, whether or not scientifically-supported, could affect public perceptions and reduce the use of our products. Those adverse consumer views related to the use of one or more of our products in animals could have a material adverse effect on our financial condition and results of operations.
Our sales in the United States of products classified by the FDA as medically important antibacterials were approximately $33 million for the twelve months ended September 30, 2016.
Our business is subject to product registration and authorization regulations. Changes in these regulations could have a material impact on our business. In April 2016, the FDA began initial steps to withdraw approval of Mecadox (carbadox), due to concerns that certain residues from the product may persist in tissues for longer than previously determined. This initial action by the FDA does not prohibit the sale or use of Mecadox in the United States. Mecadox has been approved and sold in the United States for more than 40 years and is a widely used treatment for controlling bacterial diseases including Salmonella and swine dysentery. Mecadox is not used in human medicine and the class of drug is not considered a medically important antimicrobial. The approved Mecadox label requires a 42-day withdrawal period pre-harvesting, and to date we have not seen any hazardous residues of carbadox being detected from pig meat treated in accordance with the approved label. We have complete confidence in the safety of Mecadox. In response to FDA inquiries several years ago, we began rigorous new studies of the continued safety of the product when used in accordance with the label. Our studies were completed in July 2016, and we submitted our data, analyses and information to the FDA that we believe support the continued safe use of Mecadox. As of September 30, 2016, we await the response of the FDA as the timing of their response to our submission is not subject to a predetermined deadline. Should we be unable to successfully defend the
18

safety of the product, the loss of Mecadox sales would have a negative impact to the results of our operations.
Our sales of Mecadox in the United States were approximately $14 million for the twelve months ended September 30, 2016, a decrease of  $1 million compared with the twelve months ended June 30, 2016, as a result of normal variation in customer order patterns.
Analysis of the consolidated statements of operations
Summary Results of Operations
Three Months
For the Periods Ended September 30
2016
2015
Change
(in thousands, except per share amounts and percentages)
Net sales
$ 187,987 $ 187,120 $ 867
0%
Gross profit
60,999 59,207 1,792
3%
Selling, general and administrative expenses
39,186 37,349 1,837
5%
Operating income
21,813 21,858 (45)
(0)%
Interest expense, net
3,907 3,819 88
2%
Foreign currency (gains) losses, net
334 (5,453) 5,787
*
Income before income taxes
17,572 23,492 (5,920)
(25)%
Provision for income taxes
5,395 4,739 656
14%
Net income
$ 12,177 $ 18,753 $ (6,576)
(35)%
Net income per share
basic
$ 0.31 $ 0.48 $ (0.17)
diluted
$ 0.31 $ 0.47 $ (0.16)
Weighted average number of shares outstanding
basic
39,408 39,092
diluted
39,906 40,012
Ratio to net sales
Gross profit
32.4% 31.6%
Selling, general and administrative expenses
20.8% 20.0%
Operating income
11.6% 11.7%
Income before income taxes
9.3% 12.6%
Net income
6.5% 10.0%
Effective tax rate
30.7% 20.2%
Certain amounts and percentages may reflect rounding adjustments.
*
Calculation not meaningful
19

Net sales, Adjusted EBITDA and reconciliation of GAAP net income to Adjusted EBITDA
We report net sales and Adjusted EBITDA by segment to understand the operating performance of each segment. This enables us to monitor changes in net sales, costs and other actionable operating metrics at the segment level. See “—General description of non-GAAP financial measures” for descriptions of EBITDA and Adjusted EBITDA.
Segment net sales and Adjusted EBITDA:
Three Months
For the Periods Ended September 30
2016
2015
Change
(in thousands, except percentages)
Net sales
MFAs and other
$ 83,419 $ 85,521 $ (2,102)
(2)%
Nutritional specialties
26,304 22,370 3,934
18%
Vaccines
14,778 12,243 2,535
21%
Animal Health
124,501 120,134 4,367
4%
Mineral Nutrition
51,592 54,469 (2,877)
(5)%
Performance Products
11,894 12,517 (623)
(5)%
Total
$ 187,987 $ 187,120 $ 867
0%
Adjusted EBITDA
Animal Health
$ 32,619 $ 31,476 $ 1,143
4%
Mineral Nutrition
3,988 3,160 828
26%
Performance Products
742 86 656
763%
Corporate
(7,524) (7,015) (509)
*
Total
$ 29,825 $ 27,707 $ 2,118
8%
Adjusted EBITDA ratio to segment net sales
Animal Health
26.2% 26.2%
Mineral Nutrition
7.7% 5.8%
Performance Products
6.2% 0.7%
Corporate(1)
(4.0)%
(3.7)%
Total(1)
15.9%
14.8%
(1)
Reflects ratio to total net sales
*
Calculation not meaningful
The table below sets forth a reconciliation of net income, as reported under GAAP, to Adjusted EBITDA:
Three Months
For the Periods Ended September 30
2016
2015
Change
(in thousands, except percentages)
Net income
$ 12,177 $ 18,753 $ (6,576)
(35)%
Interest expense, net
3,907 3,819 88
2%
Provision for income taxes
5,395 4,739 656
14%
Depreciation and amortization
6,318 5,429 889
16%
EBITDA
27,797 32,740 (4,943)
(15)%
Acquisition-related accrued compensation
420 420
0%
Acquisition-related transaction costs
1,274 1,274
*
Foreign currency (gains) losses, net
334 (5,453) 5,787
*
Adjusted EBITDA
$ 29,825 $ 27,707 $ 2,118
8%
20

Amounts and percentages may reflect rounding adjustments.
*
Calculation not meaningful
Comparison of three months ended September 30, 2016 and 2015
Net sales
Net sales of  $188.0 million for the three months ended September 30, 2016, increased $0.9 million, or less than 1%, as compared to the three months ended September 30, 2015. Animal Health grew $4.4 million, while Mineral Nutrition and Performance Products declined $2.9 million and $0.6 million, respectively.
Animal Health
Net sales of $124.5 million for the three months ended September 30, 2016, grew $4.4 million, or 4%. The growth was primarily due to volume increases in the nutritional specialty and vaccine product groups within the segment. Nutritional specialty products grew $3.9 million, or 18%, primarily due to U.S. volume growth of our products for the dairy and poultry industries. Vaccines grew $2.5 million, or 21%, principally from volume growth, including products acquired from MVP Laboratories, Inc. in January 2016. Medicated feed additives (“MFAs”) and other declined $2.1 million, or 2%, primarily due to domestic volume declines resulting from adverse views regarding medically important antibacterials, partially offset by domestic growth in other products. International net sales declined slightly due to economic conditions in Brazil, partially offset by growth in other regions.
Mineral Nutrition
Net sales of $51.6 million decreased $2.9 million, or 5%, for the three months ended September 30, 2016. Stable volumes from demand for trace mineral products were offset by lower average selling prices due to underlying raw material commodity price declines.
Performance Products
Net sales of $11.9 million decreased $0.6 million, or 5%, for the three months ended September 30, 2016, due to lower average selling prices of personal care ingredients and lower volumes of copper-based products and chemical catalyst products. Higher average selling prices of copper-based products partially offset the declines.
Gross profit
Gross profit of $61.0 million for the three months ended September 30, 2016, increased $1.8 million, or 3%, as compared to the three months ended September 30, 2015. Gross profit increased to 32.4% of net sales for the three months ended September 30, 2016, as compared to 31.6% for the three months ended September 30, 2015. Animal Health gross profit increased $0.5 million due to volume growth in nutritional specialty and vaccine products, as well as lower unit costs from improved operating efficiencies. Current year Animal Health gross profit was reduced by $0.3 million of increased acquisition-related intangible amortization and $0.7 million of increased depreciation expense due to recent capital expenditures. Mineral Nutrition gross profit increased $0.7 million due to lower material costs, partially offset by lower average selling prices. Performance Products gross profit increased $0.5 million due to higher volumes of personal care ingredients and higher average selling prices of copper-based products, partially offset by lower average selling prices of personal care ingredients.
Selling, general and administrative expenses
Selling, general and administrative (“SG&A”) expenses of $39.2 million for the three months ended September 30, 2016, increased $1.8 million, or 5%, as compared to the three months ended September 30, 2015.
21

During the three months ended September 30, 2016, we incurred $1.3 million in acquisition-related transaction costs for professional fees and other items in the evaluation and negotiation of an unsuccessful acquisition. Excluding these costs, SG&A used in calculating Adjusted EBITDA increased $0.6 million, or 2%.
Animal Health accounted for $0.4 million of the increase, driven by increased sales force and development costs. Mineral Nutrition SG&A decreased $0.2 million due to one-time costs in the prior year. Corporate expenses accounted for $0.4 million of the increase due to increased compensation and benefit costs.
Interest expense, net
Interest expense, net of $3.9 million for the three months ended September 30, 2016, increased $0.1 million, or 2%, compared to the three months ended September 30, 2015. Interest expense increased $0.7 million due to increased borrowings under our Revolver, compared to the same three-month period last year, and increased acquisition-related accrued interest. Interest income increased $0.6 million from interest on deposits in foreign jurisdictions.
Foreign currency (gains) losses, net
Foreign currency (gains) losses, net for the three months ended September 30, 2016, amounted to net losses of  $0.3 million, as compared to $5.5 million in net gains for the three months ended September 30, 2015. Foreign currency losses in the three months ended September 30, 2016, were primarily due to the movement of Brazil and Israel currencies relative to the U.S. dollar. Foreign currency gains and losses primarily arise from intercompany balances.
Provision for income taxes
The provision for income taxes was $5.4 million and $4.7 million for the three months ending September 30, 2016, and September 30, 2015, respectively. The effective income tax rates for these periods were 30.7% and 20.2%, respectively. The increase of 10.5% during the three months ended September 30, 2016, was primarily due to the benefit of a valuation allowance during the three months ended September 30, 2015, which offset the majority of our domestic income tax provision. In addition, we recognized an income tax benefit related to certain discrete items during the three months ended September 30, 2015. Excluding the benefits of the prior year valuation allowance and discrete items, the effective income tax rate for the three months ended September 30, 2015, was approximately 33%.
Our effective tax rate may be impacted due to the effects of various discrete items, the fluctuation in tax rates in foreign jurisdictions, as well as the amount of income earned in our foreign subsidiaries, some of which may have significant net operating loss carryforwards. As of September 30, 2016, we maintained a full valuation allowance against the deferred tax assets related to our foreign net operating loss carryforwards. We review the realizability of our deferred tax assets and evaluate our valuation allowances on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. We will continue to evaluate the necessity of these foreign valuation allowances in future periods, and to the extent that a positive earnings trend continues, a significant portion of these allowances may be released in future periods.
Net income
Net income of  $12.2 million for the three months ended September 30, 2016, decreased $6.6 million, compared to net income of $18.8 million for the three months ended September 30, 2015. The decrease was a result of the factors described above, including a $5.8 million decline in foreign currency (gains) losses, net and a $0.7 million increase in income tax expense.
Adjusted EBITDA
Adjusted EBITDA of $29.8 million for the three months ended September 30, 2016, increased $2.1 million, or 8%, as compared to the three months ended September 30, 2015. Animal Health Adjusted EBITDA increased $1.1 million, or 4%, due to sales growth and increased gross profit, partially offset by
22

increased SG&A expenses. Mineral Nutrition increased $0.8 million, or 26%, due to improved operating margins from lower material costs, partially offset by lower average selling prices. Performance Products increased $0.7 million, due to higher volumes and lower product costs, partially offset by lower average selling prices. Corporate expenses increased $0.5 million due to increased compensation and benefit costs.
Pension Plan and Retirement Savings Plan Changes
In July 2016, we amended our domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of  $6.8 million in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities. We also modified the 401(k) retirement savings plan, effective October 1, 2016, to include, for all domestic employees, a non-elective Company contribution of 3% of compensation and an additional discretionary contribution of up to 4% of compensation, depending on the employee’s age and years of service.
Separately, we recently offered a lump sum settlement option to certain pension plan participants. During the three months ending December 31, 2016, we will recognize a partial settlement of the pension plan and a charge to the consolidated statement of operations. The settlement expense is expected to be approximately $1.7 million.
Analysis of financial condition, liquidity and capital resources
Net increase (decrease) in cash and cash equivalents was:
Three Months
For the Periods Ended September 30
2016
2015
Change
(in thousands)
Cash provided by/(used in):
Operating activities
$ 21,456 $ (2,394) $ 23,850
Investing activities
(5,886) (7,848) 1,962
Financing activities
(11,670) 13,549 (25,219)
Effect of exchange-rate changes on cash and cash equivalents
(90) (706) 616
Net increase/(decrease) in cash and cash equivalents
$ 3,810 $ 2,601 $ 1,209
Net cash provided (used) by operating activities was comprised of:
Three Months
For the Periods Ended September 30
2016
2015
Change
(in thousands)
EBITDA
$ 27,797 $ 32,740 $ (4,943)
Acquisition-related accrued compensation
420 420
Acquisition-related transaction costs
1,274 1,274
Foreign currency (gains) losses, net
334 (5,453) 5,787
Interest paid
(3,770) (3,269) (501)
Income taxes paid
(3,717) (2,315) (1,402)
Changes in operating assets and liabilities and other items
(882) (24,517) 23,635
Net cash provided (used) by operating activities
$ 21,456 $ (2,394) $ 23,850
Certain amounts and percentages may reflect rounding adjustments.
Operating activities
Net cash provided by operating activities was $21.5 million for the three months ended September 30, 2016, primarily attributable to operating income of  $21.8 million, partially offset by changes
23

in operating assets and liabilities of  $0.9 million. Accounts receivable provided $3.9 million due to timing of sales and collections. Decreased inventories provided $4.5 million of cash due to timing of purchases and production. Accounts payable and accrued expenses used $6.4 million of cash primarily due to timing of purchases, payments for annual incentive compensation and retirement plan funding.
Investing activities
Net cash used in investing activities was $5.9 million for the three months ended September 30, 2016. Capital expenditures were $5.9 million as we continued to invest in our existing asset base and for capacity expansion and productivity improvements.
Financing activities
Net cash used by financing activities was $11.7 million for the three months ended September 30, 2016. Net repayments on our Revolver used $7.0 million. We paid $3.9 million in dividends to holders of our Class A and Class B common stock. We paid $0.7 million in scheduled debt and other requirements.
Liquidity and capital resources
We believe our cash on hand and our financing arrangements, including the availability of borrowings under the Revolver, will be sufficient to support our future cash needs. Our operating plan projects adequate liquidity throughout the year. However, we can provide no assurance that our liquidity and capital resources will be adequate for future funding requirements. We believe we will be able to comply with the terms of the covenants under the Revolver based on our operating plan. In the event of adverse operating results and/or violation of covenants under the facilities, there can be no assurance we would be able to obtain waivers or amendments. Other risks to our meeting future funding requirements include global economic conditions and macroeconomic, business and financial disruptions that could arise. There can be no assurance that the challenging economic environment or an economic downturn would not impact our liquidity or our ability to obtain future financing. In addition, our debt covenants may restrict our ability to invest.
Certain relevant measures of our liquidity and capital resources were:
As of
September 30,
2016
June 30,
2016
Change
(in thousands, except ratios)
Cash and cash equivalents
$ 37,415 $ 33,605 $ 3,810
Working capital
203,920 203,356 564
Ratio of current assets to current liabilities
3.07:1 2.92:1
We define working capital as total current assets (excluding cash and cash equivalents) less total current liabilities (excluding current portion of long-term debt). We calculate the ratio of current assets to current liabilities based on this definition.
At September 30, 2016, our cash and cash equivalents included $37.0 million held by our international subsidiaries. There are no restrictions on cash distributions to PAHC from our international subsidiaries.
At September 30, 2016, we had $62.0 million in outstanding borrowings under the Revolver. We had outstanding letters of credit and other commitments of  $14.2 million, leaving $123.8 million available for borrowings and letters of credit.
We currently intend to pay quarterly dividends of  $0.10 per share, representing $15.8 million annually on our Class A and Class B common stock, subject to approval from the Board of Directors. We declared and paid a cash dividend of  $0.10 per share on Class A common stock and Class B common stock during the three months ended September 30, 2016. On November 7, 2016, our Board of Directors declared a cash dividend of  $0.10 per share on each share of our Class A and Class B common stock outstanding on the record date of November 30, 2016, payable on December 21, 2016.
24

Contractual obligations
As of September 30, 2016, there were no material changes in payments due under contractual obligations from those disclosed in the Annual Report.
Off-balance sheet arrangements
We do not currently use off-balance sheet arrangements for the purpose of credit enhancement, hedging transactions, investment or other financial purposes.
In the ordinary course of business, we may indemnify our counterparties against certain liabilities that may arise. These indemnifications typically pertain to environmental matters. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications generally are subject to certain restrictions and limitations.
General description of non-GAAP financial measures
Adjusted EBITDA
Adjusted EBITDA is an alternative view of performance used by management as our primary operating measure, and we believe that investors’ understanding of our performance is enhanced by disclosing this performance measure. We report Adjusted EBITDA to portray the results of our operations prior to considering certain income statement elements. We have defined EBITDA as net income (loss) plus (i) interest expense, net, (ii) provision for income taxes or less benefit for income taxes, and (iii) depreciation and amortization. We have defined Adjusted EBITDA as EBITDA plus (a) (income) loss from, and disposal of, discontinued operations, (b) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (c) certain items that we consider to be unusual, non-operational or non-recurring. The most directly comparable GAAP measure to EBITDA and Adjusted EBITDA is net income (loss). The Adjusted EBITDA measure is not, and should not be viewed as, a substitute for GAAP reported net income (loss).
The Adjusted EBITDA measure is an important internal measurement for us. We measure our overall performance on this basis in conjunction with other performance metrics. The following are examples of how our Adjusted EBITDA measure is utilized:

senior management receives a monthly analysis of our operating results that is prepared on an Adjusted EBITDA basis;

our annual budgets are prepared on an Adjusted EBITDA basis; and

other goal setting and performance measurements are prepared on an Adjusted EBITDA basis.
Despite the importance of this measure to management in goal setting and performance measurement, Adjusted EBITDA is a non-GAAP financial measure that has no standardized meaning prescribed by GAAP and, therefore, has limits in its usefulness to investors. Because of its non-standardized definition, Adjusted EBITDA, unlike GAAP net income, may not be comparable to the calculation of similar measures of other companies. Adjusted EBITDA is presented to permit investors to more fully understand how management assesses performance.
We also recognize that, as an internal measure of performance, the Adjusted EBITDA measure has limitations, and we do not restrict our performance management process solely to this metric. A limitation of the Adjusted EBITDA measure is that it provides a view of our operations without including all events during a period, such as the depreciation of property, plant and equipment or amortization of purchased intangibles, and does not provide a comparable view of our performance to other companies.
Certain significant items
Adjusted EBITDA is calculated prior to considering certain items. We evaluate such items on an individual basis. Such evaluation considers both the quantitative and the qualitative aspect of their unusual or non-operational nature. Unusual, in this context, may represent items that are not part of our ongoing
25

business; items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis. We consider foreign currency gains and losses to be non-operational because they arise principally from intercompany transactions and are largely non-cash in nature.
New accounting standards
For discussion of new accounting standards, see “Notes to Consolidated Financial Statements— Summary of Significant Accounting Policies and New Accounting Standards.”
Critical Accounting Policies
Critical accounting policies are those that require application of management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of these significant accounting policies require management to make difficult, subjective or complex judgments or estimates. However, management is required to make certain estimates and assumptions during the preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. Significant estimates include depreciation and amortization periods of long-lived and intangible assets, recoverability of long-lived and intangible assets and goodwill, realizability of deferred income tax and value-added tax assets, legal and environmental matters and actuarial assumptions related to our pension plans. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the period they are determined to be necessary. Actual results could differ from those estimates. Our significant accounting policies are described in the notes to the consolidated financial statements included in the Annual Report. Except as described below, as of September 30, 2016, there have been no material changes to any of the critical accounting policies contained therein.
During the three months ended September 30, 2016, we applied Accounting Standards Update (“ASU”) 2015-03, Interest—Imputation of Interest (Subtopic 835-30). All prior periods have been adjusted to reflect the retrospective application of this guidance, which requires that certain debt issuance costs be classified as a reduction of the related liability. Debt issuance costs were previously classified as an asset.
Forward-Looking Statements
This report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “believe,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected earnings, revenues, costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth or initiatives, strategies, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Examples of such risks and uncertainties include:

perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products;

restrictions on the use of antibacterials in food-producing animals may become more prevalent;

a material portion of our sales and gross profits are generated by antibacterials and other related products;
26


competition in each of our markets from a number of large and small companies, some of which have greater financial, research and development, production and other resources than we have;

the impact of current and future laws and regulatory changes;

outbreaks of animal diseases could significantly reduce demand for our products;

our ability to successfully implement several of our strategic initiatives;

the effect of weather conditions and the availability of natural resources;

the continuing trend toward consolidation of certain customer groups as well as the emergence of large buying groups;

our ability to control costs and expenses;

any unforeseen material loss or casualty;

exposure relating to rising costs and reduced customer income;

competition deriving from advances in veterinary medical practices and animal health technologies;

unanticipated safety or efficacy concerns;

our dependence on suppliers having current regulatory approvals;

our raw materials are subject to price fluctuations and their availability can be limited;

natural and man-made disasters, including but not limited to fire, snow and ice storms, flood, hail, hurricanes and earthquakes;

terrorist attacks, particularly attacks on or within markets in which we operate;

our reliance on the continued operation of our manufacturing facilities and application of our intellectual property;

adverse U.S. and international economic market conditions, including currency fluctuations;

the risks of product liability claims, legal proceedings and general litigation expenses;

our dependence on our Israeli and Brazilian operations;

our substantial level of indebtedness and related debt-service obligations;

restrictions imposed by covenants in our debt agreements;

the risk of work stoppages; and

other factors as described in “Risk Factors” in Item 1A. of the Annual Report.
While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, are disclosed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.
We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any
27

forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.
Item 3.   Quantitative and Qualitative Disclosures about Market Risk
In the normal course of operations, we are exposed to market risks arising from adverse changes in interest rates, foreign currency exchange rates and commodity prices. As a result, future earnings, cash flows and fair values of assets and liabilities are subject to uncertainty. We use, from time to time, foreign currency contracts as a means of hedging exposure to foreign currency risks. We also utilize, on a limited basis, certain commodity derivatives, primarily on copper used in manufacturing processes, to hedge the cost of anticipated purchase or supply requirements. We do not utilize derivative instruments for trading or speculative purposes. We do not hedge our exposure to market risks in a manner that completely eliminates the effects of changing market conditions on earnings, cash flows and fair values. We monitor the financial stability and credit standing of our major counterparties.
For financial market risks related to changes in interest rates, foreign currency exchange rates and commodity prices, reference is made to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures about Market Risk” section in the Annual Report and to the notes to the consolidated financial statements included therein. There were no material changes in the Company’s financial market risks from the risks disclosed in the Annual Report.
Item 4.   Controls and Procedures
Evaluation of Disclosure Controls and Procedures
An evaluation was carried out under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)). Based upon that evaluation as of September 30, 2016, our Chief Executive Officer and Chief Financial Officer each concluded that, as of the end of such period, our disclosure controls and procedures were not effective because of material weaknesses in our internal control over financial reporting, as described in Management’s Report on Internal Control Over Financial Reporting in “Item 9A. Controls and Procedures” in the Annual Report on Form 10-K for the year ended June 30, 2016.
Management’s Remediation Plan
Management has begun implementing changes to our internal control over financial reporting to remediate the material weaknesses that existed as of June 30, 2016. Our remediation plan includes (i) designing and implementing additional formal accounting policies and procedures and (ii) restricting access to key financial systems and records to appropriate users to ensure that appropriate segregation of duties is maintained. Recent actions taken to address material weaknesses include the design and implementation of certain formal accounting policies and procedures, as well as restricting certain access to users of key financial systems and records. We will continue to build on the progress we have made in our remediation plan. We cannot determine when our remediation plan will be fully completed, and we cannot provide any assurance that these remediation efforts will be successful or that our internal control over financial reporting will be effective as a result of these efforts.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting during the three months ended September 30, 2016, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
28

PART II—OTHER INFORMATION
Item 1.
Legal Proceedings
Information required by this Item is incorporated herein by reference to “Notes to the Consolidated Financial Statements—Commitments and Contingencies” in Part I, Item 1, of this Quarterly Report on Form 10-Q.
Item 1A.
Risk Factors
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in the “Risk Factors” section in the Annual Report, which could materially affect our business, financial condition or future results.
There were no material changes in the Company’s risk factors from the risks disclosed in the Annual Report.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3.
Defaults Upon Senior Securities
None.
Item 4.
Mine Safety Disclosures
None.
Item 5.
Other Information
None.
Item 6.
Exhibits
Exhibit 31.1 Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
Exhibit 31.2 Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
Exhibit 32.1 Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
Exhibit 32.2 Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
Exhibit 101.INS* XBRL Instance Document
Exhibit 101.SCH* XBRL Taxonomy Extension Schema Document
Exhibit 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
Exhibit 101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
Exhibit 101.LAB* XBRL Taxonomy Extension Label Linkbase Document
Exhibit 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document
*
Furnished with this Quarterly Report. Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933 and are deemed not filed for purposes of section 18 of the Exchange Act.
29

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Phibro Animal Health Corporation
November 9, 2016 By:
/s/ Jack C. Bendheim
Jack C. Bendheim
President and Chief Executive Officer
November 9, 2016 By:
/s/ Richard G. Johnson
Richard G. Johnson
Chief Financial Officer
30

EX-31.1 2 t1602621_ex31-1.htm EXHIBIT 31.1 t1602621-10q_DIV_06-ex31-1 - none - 1.3091309s
EXHIBIT 31.1​
CERTIFICATIONS
I, Jack C. Bendheim, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 9, 2016
/s/ Jack C. Bendheim
Jack C. Bendheim
Chairman, President and Chief Executive Officer

EX-31.2 3 t1602621_ex31-2.htm EXHIBIT 31.2 t1602621-10q_DIV_07-ex31-2 - none - 1.3031303s
EXHIBIT 31.2​
CERTIFICATIONS
I, Richard G. Johnson, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Dated: November 9, 2016
/s/ Richard G. Johnson
Richard G. Johnson
Chief Financial Officer

EX-32.1 4 t1602621_ex32-1.htm EXHIBIT 32.1 t1602621-10q_DIV_08-ex32-1 - none - 1.2721272s
EXHIBIT 32.1​
CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.
Dated: November 9, 2016
/s/ Jack C. Bendheim
Jack C. Bendheim
Chairman, President and Chief Executive Officer

EX-32.2 5 t1602621_ex32-2.htm EXHIBIT 32.2 t1602621-10q_DIV_09-ex32-2 - none - 1.2761276s
EXHIBIT 32.2​
CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.
Dated: November 9, 2016
/s/ Richard G. Johnson
Richard G. Johnson
Chief Financial Officer

EX-101.INS 6 pahc-20160930.xml XBRL INSTANCE FILE 0001069899 2012-09-01 2012-09-30 0001069899 2015-07-01 2015-09-30 0001069899 us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember pahc:CompensationAndBenefitForServicesMember 2015-07-01 2015-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2015-07-01 2015-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2015-07-01 2015-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2015-07-01 2015-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2015-07-01 2015-09-30 0001069899 pahc:TermBLoansMember 2015-07-01 2015-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2015-07-01 2015-09-30 0001069899 pahc:MfasAndOtherMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2015-07-01 2015-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2015-07-01 2015-09-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2015-07-01 2015-09-30 0001069899 us-gaap:OperatingSegmentsMember 2015-07-01 2015-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2015-07-01 2016-06-30 0001069899 2016-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2016-06-30 0001069899 us-gaap:CorporateNonSegmentMember 2016-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2016-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2016-06-30 0001069899 pahc:TermBLoansMember 2016-06-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0001069899 us-gaap:CommonClassAMember 2016-06-30 0001069899 us-gaap:CommonClassBMember 2016-06-30 0001069899 us-gaap:CapitalLeaseObligationsMember 2016-06-30 0001069899 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0001069899 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-06-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2016-06-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember us-gaap:ShortMember 2016-06-30 0001069899 us-gaap:OperatingSegmentsMember 2016-06-30 0001069899 pahc:DomesticNoncontributoryDefinedBenefitPensionPlanMember 2016-07-01 2016-09-30 0001069899 pahc:RetirementSavings401KPlanMember 2016-07-01 2016-09-30 0001069899 2016-07-01 2016-09-30 0001069899 us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember pahc:CompensationAndBenefitForServicesMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2016-07-01 2016-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2016-07-01 2016-09-30 0001069899 pahc:TermBLoansMember 2016-07-01 2016-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2016-07-01 2016-09-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-07-01 2016-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2016-07-01 2016-09-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember us-gaap:OtherComprehensiveIncomeMember 2016-07-01 2016-09-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember 2016-07-01 2016-09-30 0001069899 pahc:MfasAndOtherMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:TermBLoansAndRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-07-01 2016-09-30 0001069899 pahc:TermBLoansAndRevolvingCreditFacilityMember us-gaap:BaseRateMember 2016-07-01 2016-09-30 0001069899 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2016-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2016-09-30 0001069899 pahc:TermBLoansMember 2016-09-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2016-09-30 0001069899 us-gaap:CommonClassAMember 2016-09-30 0001069899 us-gaap:CommonClassBMember 2016-09-30 0001069899 us-gaap:CapitalLeaseObligationsMember 2016-09-30 0001069899 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-09-30 0001069899 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-09-30 0001069899 pahc:TermBLoansAndRevolvingCreditFacilityMember 2016-09-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2016-09-30 0001069899 pahc:OptionsMember us-gaap:CashFlowHedgingMember us-gaap:ShortMember 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember 2016-09-30 0001069899 pahc:TermBLoansMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-09-30 0001069899 pahc:TermBLoansMember us-gaap:BaseRateMember 2016-09-30 0001069899 us-gaap:CommonClassAMember 2016-11-02 0001069899 us-gaap:CommonClassBMember 2016-11-02 0001069899 2015-06-30 0001069899 2015-09-30 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure pahc:PRPs PHIBRO ANIMAL HEALTH CORP 0001069899 pahc --06-30 Accelerated Filer 18519757 20887811 10-Q 2016-09-30 false 2017 Q1 187120000 12517000 120134000 54469000 85521000 22370000 12243000 187987000 11894000 124501000 51592000 83419000 26304000 14778000 127913000 126988000 59207000 60999000 37349000 39186000 21858000 21813000 -3819000 -3907000 5453000 5453000 -334000 -334000 23492000 23492000 17572000 17572000 4739000 5395000 18753000 12177000 0.48 0.31 0.47 0.31 39092 39408 40012 39906 0.10 0.10 -4903000 34000 -21729000 -893000 -384000 -7169000 -3686000 2750000 -22562000 3560000 -3809000 15737000 33605000 37415000 29216000 31817000 123790000 119607000 167691000 162644000 17745000 20102000 342831000 339768000 127323000 127336000 60095000 58572000 21121000 21121000 56465000 51287000 607835000 20988000 83588000 444751000 57939000 524247000 598084000 21557000 81897000 435512000 59687000 516187000 2907000 2903000 60167000 54274000 45703000 44159000 108777000 101336000 69000000 14242000 278265000 277698000 61313000 54774000 517355000 495808000 4000 4000 118299000 118299000 33962000 42198000 -61785000 -58225000 90480000 102276000 607835000 598084000 0.0001 0.0001 0.0001 0.0001 300000000 30000000 300000000 30000000 18519757 20887811 18519757 20887811 18519757 20887811 18519757 20887811 0.0001 0.0001 16000000 16000000 0 0 0 0 5429000 194000 751000 3876000 608000 4678000 6318000 218000 660000 4898000 542000 5658000 242000 253000 420000 420000 420000 420000 345000 2935000 260000 393000 2905000 955000 -393000 38000 1706000 5434000 -97000 -53000 -87000 5597000 -3906000 5469000 -4544000 1570000 2430000 444000 -346000 -3010000 -5004000 -6150000 -1357000 -2394000 21456000 8094000 5911000 -246000 -25000 -7848000 -5886000 55500000 34000000 38000000 41000000 734000 729000 693000 3910000 3941000 13549000 -11670000 -706000 -90000 2601000 3810000 <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 0pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Description of Business</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Phibro Animal Health Corporation (&#8220;Phibro&#8221; or &#8220;PAHC&#8221;) and its subsidiaries (collectively, the &#8220;Company&#8221;) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and similar expressions refer to Phibro and its subsidiaries.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The unaudited consolidated financial information for the three months ended September&#160;30, 2016 and 2015, is presented on the same basis as the financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2016 (the &#8220;Annual Report&#8221;), filed with the Securities and Exchange Commission on August&#160;29, 2016 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of financial position, results of operations and cash flows for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June&#160;30, 2016, was derived from the audited consolidated financial statements, which include the accounts of Phibro and its consolidated subsidiaries, but does not include all disclosures required by accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity. Intercompany balances and transactions have been eliminated in the consolidated financial statements.</div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 0pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">2.&#160;&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies and New Accounting Standards</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September&#160;30, 2016, there have been no material changes to any of the significant accounting policies contained therein, except for the application of Accounting Standards Update (&#8220;ASU&#8221;) 2015-03,&#160;<font style="font-style: italic;">Interest&#8212;Imputation of Interest (Subtopic 835-30)</font>, during the three months ended September&#160;30, 2016. Prior periods have been adjusted to reflect the retrospective application of this guidance. For further discussion, see &#8220;&#8212;New Accounting Standards.&#8221;</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Revisions of Previously Issued Financial Statements</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">During the fourth quarter of fiscal 2016, the Company determined that amortization expense related to product-related intangible assets should be recorded in cost of goods sold rather than in selling, general and administrative expense within the consolidated statement of operations. The Company has revised its financial statements for the three months ended September&#160;30, 2015, to correct the classification of amortization expense to increase cost of goods sold and reduce gross profit and selling, general and administrative expenses by $953. These revisions had no impact on the Company&#8217;s previously reported net income (loss) or cash flows. The Company evaluated the impact of the revisions on prior periods, assessing materiality quantitatively and qualitatively, and concluded the errors were not material to any previously issued financial statements.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Net Income per Share and Weighted Average Shares</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares equivalents resulting from the assumed exercise of stock options. For the three months ended September&#160;30, 2016 and 2015, all common share equivalents were included in the calculation of diluted net income per share.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 121px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net income</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">12,177</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">18,753</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.25pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,408</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,092</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Dilutive effect of stock options</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">498</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">920</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">39,906</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">40,012</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;">Net income per share</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.48</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.47</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 21.19pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Dividends</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We declared and paid quarterly cash dividends of&#8201; $0.10 per share, totaling $3,941, during the three months ended September&#160;30, 2016, to holders of our Class A common stock and Class B common stock.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">New Accounting Standards</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Financial Accounting Standards Board (&#8220;FASB&#8221;) ASU 2016-15,&#160;<font style="font-style: italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font>, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December&#160;15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2016-02,&#160;<font style="font-style: italic;">Leases (Topic 842)</font>, supersedes the current lease accounting guidance and requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December&#160;15, 2018. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-12,&#160;<font style="font-style: italic;">Plan Accounting (Topics 960, 962 and 965)</font>, modifies certain disclosure requirements and asset valuation measurements. We applied the provisions of this guidance during the three months ended September&#160;30, 2016, and it had no material impact on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-11,&#160;<font style="font-style: italic;">Inventory (Topic 330)</font>, requires entities to measure inventory at the lower of cost and net realizable value (&#8220;NRV&#8221;). NRV is defined as &#8220;the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#8221; The guidance is effective for annual periods beginning after December&#160;15, 2016, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-05,&#160;<font style="font-style: italic;">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40)</font>&#160;provides guidance regarding the treatment of cloud computing arrangements and if an arrangement includes a software license. We adopted this guidance during the three months ended September&#160;30, 2016, and it had no material impact on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-03,&#160;<font style="font-style: italic;">Interest&#8212;Imputation of Interest (Subtopic 835-30)</font>, requires debt issuance costs to be presented as a reduction of the related liability.&#160;These costs were previously included in other assets. Debt issuance costs associated with line-of-credit arrangements may continue to be recognized in other assets. We adopted this guidance during the three months ended September&#160;30, 2016, and applied the guidance retrospectively. Debt issuance costs of&#8201; $2,406 and $2,538 as of September&#160;30, 2016, and June&#160;30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2014-15,&#160;<font style="widows: 2; text-transform: none; font-style: italic; text-indent: 53px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40)</font>, requires management to assess an entity&#8217;s ability to continue as a going concern within one year after the issuance date of the financial statements, and to provide related footnote disclosures in certain circumstances. Management will need to consider relevant conditions that are known and reasonably knowable at the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. Under the new standard, the definition of substantial doubt incorporates a likelihood threshold of&#8201;&#8201;&#8221;probable&#8221; similar to the current use of that term in GAAP for loss contingencies. ASU 2014-15 will be effective for annual periods ending after December&#160;15, 2016, and for annual periods and interim periods thereafter. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2014-09,&#160;<font style="font-style: italic;">Revenue from Contracts with Customers (Topic 606)</font>, establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2015-14,&#160;<font style="font-style: italic;">Deferral of the Effective Date</font>, amended ASU 2014-09, resulting in a one-year deferral of the effective date. ASU 2016-08,&#160;<font style="font-style: italic;">Principal versus Agent Considerations</font>; ASU 2016-10,&#160;<font style="font-style: italic;">Identifying Performance Obligations and Licensing</font>; and ASU 2016-12,&#160;<font style="font-style: italic;">Narrow-Scope Improvements and Practical Expedients</font>&#160;also amended ASU 2014-09<font style="font-style: italic;">.&#160;</font>The amendments are effective concurrent with the effective date for ASU 2014-09 for annual periods beginning after December&#160;15, 2017, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> </div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">3.&#160;&#160;&#160;&#160;&#160;Statements of Operations&#8212;Additional Information</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 220px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;">Interest expense, net</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Term B loan</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,905</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,935</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Revolving credit facility</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">955</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">260</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">393</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">345</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of debt issuance costs and debt discount</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">253</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">242</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Other</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">81</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">86</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Interest expense</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">4,587</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,868</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest (income)</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(680<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(49<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,907</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,819</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Depreciation of property, plant and equipment</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,731</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,111</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of intangible assets</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,528</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,259</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of other assets</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">6,318</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">5,429</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">4.&#160;&#160;&#160;&#160;&#160;Balance Sheets&#8212;Additional Information</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 88px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Inventories</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="6">&#160;</td> <td colspan="6">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Raw materials</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">56,789</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">51,369</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Work-in-process</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">8,900</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">8,074</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Finished goods</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">96,955</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">108,248</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">162,644</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">167,691</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 10.3pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Goodwill balances did not change during the three months ended September&#160;30, 2016.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,040 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 144px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Accrued expenses and other current liabilities</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Employee related</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">19,043</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">21,712</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Commissions and rebates</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,143</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,722</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Insurance related</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,717</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,780</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Professional fees</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,546</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,573</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Income and other taxes</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,203</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,910</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Deferred consideration on acquisitions</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,250</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,250</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Other</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,257</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">11,756</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;44,159</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;45,703</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 13pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 166px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Accumulated other comprehensive income (loss)</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Derivative instruments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,689</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,655</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Foreign currency translation adjustment</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(42,797<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(41,904<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Unrecognized net pension gains (losses)</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(23,808<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(30,977<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on derivative instruments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(1,561<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(1,548<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for incomes taxes on long-term intercompany investments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">8,166</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">8,166</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 1.333pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on pension gains (losses)</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 23.25pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(914<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 23.25pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">1,823</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 23.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(58,225<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 23.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(61,785<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">5.&#160;&#160;&#160;&#160;&#160;Debt</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Revolving Credit Facility and Term B Loan</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We have a revolving credit facility (the &#8220;Revolver&#8221;), where we can borrow up to $200,000, subject to the terms of the agreement, and a term B loan (the &#8220;Term B Loan,&#8221; and together with the Revolver, the &#8220;Credit Facilities&#8221;). The Revolver has applicable margins equal to 2.50% or 2.75%, in the case of LIBOR loans and 1.50% or 1.75%, in the case of base rate loans; the margins are based on the First Lien Net Leverage Ratio. The Term B Loan has applicable margins equal to 3.00% with regards to LIBOR loans and 2.00% regarding base rate loans. The LIBOR rate on the Term B Loan is subject to a floor of 1.00%.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The Revolver requires, among other things, the maintenance of a maximum consolidated first lien net debt to consolidated EBITDA leverage ratio, calculated on a trailing four quarter basis, and contains an acceleration clause should an event of default (as defined in the agreement governing the Credit Facilities) occur. As of September&#160;30, 2016, we were in compliance with the covenants of the Credit Facilities.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">As of September&#160;30, 2016, we had $62,000 in borrowings under the Revolver and had outstanding letters of credit of&#8201; $14,242 leaving $123,758 available for borrowings and letters of credit under the Revolver. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The tenors of these letters of credit are all one year or less.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The weighted-average interest rates for the Revolver and Term B Loan were 3.26% and 4.00%, respectively, for the three months ended September&#160;30, 2016.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Long-Term Debt</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 102px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Term B loan due April&#160;2021</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">283,475</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">284,200</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Capitalized lease obligations</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">283,478</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">284,207</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Unamortized debt issuance costs and debt discount</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,877<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(3,035<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Less: current maturities</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,903<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,907<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">277,698</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">278,265</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 10.11pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">During the three months ended September&#160;30, 2016, we applied the provisions of ASU 2015-03,&#160;<font style="font-style: italic;">Interest&#8212;Imputation of Interest (Subtopic 835-30)</font>. Debt issuance costs of&#8201; $2,406 and $2,538 as of September&#160;30, 2016, and June&#160;30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.</div> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">6.&#160;&#160;&#160;&#160;&#160;Related Party Transactions</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Certain relatives of Jack C. Bendheim provided services to us as employees or consultants and received aggregate compensation and benefits of&#8201; $603 and $699 during the three months ended September&#160;30, 2016 and 2015, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.</div> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">7.&#160;&#160;&#160;&#160;&#160;Employee Benefit Plans</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The Company maintains a noncontributory defined benefit pension plan for all domestic nonunion employees employed on or prior to December&#160;31, 2013, who meet certain requirements of age, length of service and hours worked per year. Plan benefits are based upon years of service and average compensation, as defined.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">In July&#160;2016, we amended our domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September&#160;30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September&#160;30, 2016, we recorded a pension curtailment gain of&#8201; $6,822 in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities. We also modified the 401(k) retirement savings plan, effective October&#160;1, 2016, to include, for all domestic employees, a non-elective Company contribution of 3% of compensation and an additional discretionary contribution of up to 4% of compensation, depending on the employee&#8217;s age and years of service.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Separately, we recently offered a lump sum settlement option to certain pension plan participants. During the&#160;three months&#160;ending December&#160;31, 2016, we will recognize a partial settlement of the pension plan and a charge to the consolidated statement of operations. The settlement expense is expected to be approximately $1,700.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Net periodic pension expense was:</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 91px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="13"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Service cost &#8211; benefits earned during the period</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">561</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">719</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest cost on benefit obligation</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">543</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">689</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Expected return on plan assets</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(863<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(742<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of net actuarial loss and prior service costs</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 13.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">347</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">384</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net periodic pension expense</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 13.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">588</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">1,050</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="17">&#160;</td> </tr> </table> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">8.&#160;&#160;&#160;&#160;&#160;Commitments and Contingencies</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Environmental</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, &#8220;Environmental Laws&#8221;). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the time period during which such costs are likely to be incurred are difficult to predict.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based upon our experience to date, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The United States Environmental Protection Agency (the &#8220;EPA&#8221;) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (&#8220;Omega Chemical Site&#8221;), which is upgradient of a facility in Santa Fe Springs, California, operated by our subsidiary Phibro-Tech, Inc. (&#8220;Phibro-Tech&#8221;). The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (&#8220;PRPs&#8221;) due to groundwater contamination from Phibro-Tech&#8217;s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September&#160;2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that groundwater contamination at its site is due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, a nearby property owner has filed a complaint in the Superior Court of the State of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for alleged contamination of groundwater underneath its property, and a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling has filed a complaint under CERCLA, RCRA and the common law public nuisance doctrine in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA&#8217;s investigation and Phibro-Tech&#8217;s dispute with the prior owner&#8217;s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 5.02pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be $6,990 and $7,024 at September&#160;30, 2016, and June&#160;30, 2016, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries is liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Claims and Litigation</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 4.01pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">PAHC and its subsidiaries are party to a number of claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.</div> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">9.&#160;&#160;&#160;&#160;&#160;Derivatives</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 4.02pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We monitor our exposure to foreign currency exchange rates and use derivatives to manage certain of these risks. These derivatives generally have an expiration/maturity of two years or less and are intended to hedge cash flows related to the purchase of inventory. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). We record the portion of the changes in the value of the derivative, related to a hedged asset or liability (the effective portion), in accumulated other comprehensive income (loss). As the hedged item is sold, we recognize the gain or loss recorded in accumulated other comprehensive income (loss) to the consolidated statements of operations on the same line where the hedged item is charged when released/sold. We immediately recognize in the consolidated statements of operations in the same line as the hedged item, the portion of the changes in fair value of derivatives used as cash flow hedges that is not offset by changes in the expected cash flows related to a recognized asset or liability (the ineffective portion).</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We routinely assess whether the derivatives used to hedge transactions are effective. If we determine that a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see &#8220;&#8212;Fair Value Measurements.&#8221;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The following table details the Company&#8217;s outstanding derivatives that are designated and effective as cash flow hedges as of September&#160;30, 2016:</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 63px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; height: 14.25pt; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="padding-bottom: 0.333pt; line-height: 9pt; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">Instrument</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 80.51pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="text-align: center; padding-bottom: 0.333pt; line-height: 9pt; white-space: nowrap;">Hedge</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="text-align: center; padding-bottom: 0.333pt; line-height: 9pt;">Notional&#160;<br />Amount at&#160;<br />September&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Fair value as of</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; height: 0pt; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.083pt;" colspan="4"> <div style="text-align: center;">September&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.083pt;" colspan="4"> <div style="text-align: center;">June&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Options</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 80.51pt; padding-right: 0.5pt; padding-top: 2.75pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real calls&#160;</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="text-align: center;">R$97,500</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,815</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,027</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Options</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 80.51pt; padding-right: 0.5pt; padding-top: 3pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real puts&#160;</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 3pt;"> <div style="text-align: center;">R$97,500</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(126<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(372<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 16.18pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The fair values at September&#160;30, 2016, are unrealized and will fluctuate based on future exchange rates until the derivative contracts mature. Other comprehensive income (loss) for the three months ended September&#160;30, 2016, included $34 of net unrecognized gains. Accumulated other comprehensive income (loss) at September&#160;30, 2016, included $2,689 of net unrecognized gains on derivative instruments; we estimate that $167 of those gains will be recognized in earnings within the next twelve months. At June&#160;30, 2016, realized losses of&#8201; $1,528, related to matured contracts were recorded as a component of inventory. We recognized $1,135 of these losses in cost of goods sold during the three months ended September&#160;30, 2016, and anticipate we will recognize the remaining $393 of these losses in costs of goods sold during the three months ending December&#160;31, 2016. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold. We hedge forecasted transactions for periods not exceeding twenty-four months.</div> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">10.&#160;&#160;&#160;&#160;Fair Value Measurements</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Financial assets and liabilities are measured at fair value using the three-level valuation hierarchy for disclosure of fair value measurements. The determination of the applicable level within the hierarchy of a particular asset or liability depends on the inputs used in the valuation as of the measurement date, notably the extent to which the inputs are market-based (observable) or internally derived (unobservable). Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs are inputs based on a company&#8217;s own assumptions about market participant assumptions developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of inputs as follows:</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Level 1&#8212;Quoted prices in active markets for identical assets or liabilities.</div> <div style="text-align: left; line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 8.19pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Level 2&#8212;</div> <div style="text-align: left; line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 8.19pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Significant observable inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly through corroboration with observable market data.</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="text-align: left; line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 8.18pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Level 3&#8212;</div> <div style="text-align: left; line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 8.18pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Unobservable inputs for which there is little or no market data available, and that are significant to the overall fair value measurement, are employed that require the reporting entity to develop its own assumptions.</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">In assessing the fair value of financial instruments at September&#160;30, 2016, and June&#160;30, 2016, we used a variety of methods and assumptions that were based on estimates of market conditions and risks existing at the time.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 6pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Current Assets and Liabilities</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Letters of Credit</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The carrying values of these letters of credit are considered to be representative of their fair values because of the nature of the instruments. The tenors of these letters of credit are all one year or less.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Long Term Debt</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We record the Term B Loan and the Revolver at book value in our consolidated financial statements. We believe the carrying value of the Term B Loan is approximately equal to the fair value, which is based on quoted broker prices that are Level 2 inputs. We believe the carrying value of the Revolver is approximately equal to the fair value due to the variable nature of the instrument.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Deferred Consideration on Acquisitions</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We estimated the fair value of the deferred consideration on acquisitions using the income approach, based on the Company&#8217;s current sales forecast related to the acquired business.</div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 12pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Derivatives</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 61px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">September&#160;30, 2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">June&#160;30, 2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Derivatives asset</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,689</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,655</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">Deferred consideration on acquisitions</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(7,068<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(6,745<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 16.98pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The table below provides a summary of the changes in the fair value of Level 3 liabilities:</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 52px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;">Balance, June&#160;30, 2016</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">(6,745<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(393<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Payment</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">70</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Balance, September&#160;30, 2016</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(7,068<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="9">&#160;</td> </tr> </table> </div> <div> <div style="text-align: left; line-height: 11pt; widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: nowrap; orphans: 2; margin-bottom: 0pt; float: left; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">11.&#160;&#160;&#160;&#160;Business Segments</div> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;">&#160;</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace mineral products for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and such costs are referred to as Corporate. We do not allocate such items to the principal segments because they are not used to evaluate their operating results or financial position.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c)&#160;(income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 439px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;">Net sales</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; MFAs and other</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">83,419</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">85,521</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; Nutritional Specialties</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">26,304</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">22,370</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; Vaccines</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">14,778</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,243</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">124,501</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">120,134</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">51,592</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">54,469</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">11,894</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,517</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">187,987</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">187,120</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,898</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,876</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">542</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">608</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">218</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">194</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">5,658</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">4,678</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;">Adjusted EBITDA</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="6">&#160;</td> <td colspan="6">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">32,619</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">31,476</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,988</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,160</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">742</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">86</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">34,722</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;"> <div style="white-space: nowrap;">Reconciliation of income before income taxes to Adjusted EBITDA</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Income before income taxes</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">17,572</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">23,492</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Interest expense, net</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,907</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,819</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Depreciation and amortization&#8201;&#8211;&#8201;Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">5,658</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,678</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Depreciation and amortization&#8201;&#8211;&#8201;Corporate</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">660</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">751</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Corporate costs</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,524</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,015</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Acquisition-related accrued compensation</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">420</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">420</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Acquisition-related transaction costs</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,274</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Foreign currency (gains) losses, net</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">334</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(5,453<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Adjusted EBITDA&#8201;&#8211;&#8201;Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">34,722</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 116px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 18pt; padding-right: 18pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;">Identifiable assets</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">435,512</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">444,751</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59,687</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">57,939</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">20,988</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">21,557</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">516,187</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">524,247</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Corporate</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">81,897</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">83,588</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">598,084</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">607,835</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 13.48pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of&#8201; $4,040 and $4,076 as of September&#160;30, 2016, and June&#160;30, 2016, respectively. The Performance Products segment includes an investment in an equity method investee of&#8201; $428 and $504 as of September&#160;30, 2016, and June&#160;30, 2016, respectively. Corporate assets include cash and cash equivalents, debt issuance costs related to the Revolver, income tax related assets and certain other assets.</div> </div> <div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Net Income per Share and Weighted Average Shares</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares equivalents resulting from the assumed exercise of stock options. For the three months ended September&#160;30, 2016 and 2015, all common share equivalents were included in the calculation of diluted net income per share.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 121px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net income</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">12,177</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">18,753</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.25pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,408</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,092</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Dilutive effect of stock options</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">498</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">920</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">39,906</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">40,012</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;">Net income per share</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.48</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.47</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> </div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">New Accounting Standards</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Financial Accounting Standards Board (&#8220;FASB&#8221;) ASU 2016-15,&#160;<font style="font-style: italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font>, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December&#160;15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2016-02,&#160;<font style="font-style: italic;">Leases (Topic 842)</font>, supersedes the current lease accounting guidance and requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December&#160;15, 2018. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-12,&#160;<font style="font-style: italic;">Plan Accounting (Topics 960, 962 and 965)</font>, modifies certain disclosure requirements and asset valuation measurements. We applied the provisions of this guidance during the three months ended September&#160;30, 2016, and it had no material impact on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-11,&#160;<font style="font-style: italic;">Inventory (Topic 330)</font>, requires entities to measure inventory at the lower of cost and net realizable value (&#8220;NRV&#8221;). NRV is defined as &#8220;the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&#8221; The guidance is effective for annual periods beginning after December&#160;15, 2016, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-05,&#160;<font style="font-style: italic;">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Subtopic 350-40)</font>&#160;provides guidance regarding the treatment of cloud computing arrangements and if an arrangement includes a software license. We adopted this guidance during the three months ended September&#160;30, 2016, and it had no material impact on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2015-03,&#160;<font style="font-style: italic;">Interest&#8212;Imputation of Interest (Subtopic 835-30)</font>, requires debt issuance costs to be presented as a reduction of the related liability. These costs were previously included in other assets. Debt issuance costs associated with line-of-credit arrangements may continue to be recognized in other assets. We adopted this guidance during the three months ended September&#160;30, 2016, and applied the guidance retrospectively. Debt issuance costs of&#8201; $2,406 and $2,538 as of September&#160;30, 2016, and June&#160;30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2014-15,&#160;<font style="font-style: italic;">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40)</font>, requires management to assess an entity&#8217;s ability to continue as a going concern within one year after the issuance date of the financial statements, and to provide related footnote disclosures in certain circumstances. Management will need to consider relevant conditions that are known and reasonably knowable at the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. Under the new standard, the definition of substantial doubt incorporates a likelihood threshold of&#8201;&#8201;&#8221;probable&#8221; similar to the current use of that term in GAAP for loss contingencies. ASU 2014-15 will be effective for annual periods ending after December&#160;15, 2016, and for annual periods and interim periods thereafter. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">ASU 2014-09,&#160;<font style="font-style: italic;">Revenue from Contracts with Customers (Topic 606)</font>, establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2015-14,&#160;<font style="font-style: italic;">Deferral of the Effective Date</font>, amended ASU 2014-09, resulting in a one-year deferral of the effective date. ASU 2016-08,&#160;<font style="font-style: italic;">Principal versus Agent Considerations</font>; ASU 2016-10,&#160;<font style="font-style: italic;">Identifying Performance Obligations and Licensing</font>; and ASU 2016-12,&#160;<font style="font-style: italic;">Narrow-Scope Improvements and Practical Expedients</font>&#160;also amended ASU 2014-09<font style="font-style: italic;">.&#160;</font>The amendments are effective concurrent with the effective date for ASU 2014-09 for annual periods beginning after December&#160;15, 2017, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.</div> <div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Revisions of Previously Issued Financial Statements</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">During the fourth quarter of fiscal 2016, the Company determined that amortization expense related to product-related intangible assets should be recorded in cost of goods sold rather than in selling, general and administrative expense within the consolidated statement of operations. The Company has revised its financial statements for the three months ended September&#160;30, 2015, to correct the classification of amortization expense to increase cost of goods sold and reduce gross profit and selling, general and administrative expenses by $953. These revisions had no impact on the Company&#8217;s previously reported net income (loss) or cash flows. The Company evaluated the impact of the revisions on prior periods, assessing materiality quantitatively and qualitatively, and concluded the errors were not material to any previously issued financial statements.</div> </div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 121px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net income</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">12,177</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">18,753</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.25pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,408</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,092</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Dilutive effect of stock options</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">498</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">920</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Weighted average number of shares &#8211; diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">39,906</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">40,012</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;">Net income per share</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">basic</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.48</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">diluted</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.47</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 220px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;">Interest expense, net</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Term B loan</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,905</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,935</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Revolving credit facility</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">955</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">260</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">393</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">345</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of debt issuance costs and debt discount</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">253</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">242</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Other</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">81</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">86</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Interest expense</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">4,587</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,868</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest (income)</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(680<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(49<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,907</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,819</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 2.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Depreciation of property, plant and equipment</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,731</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,111</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of intangible assets</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,528</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,259</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of other assets</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 268pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">6,318</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">5,429</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 88px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Inventories</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="6">&#160;</td> <td colspan="6">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Raw materials</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">56,789</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">51,369</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Work-in-process</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">8,900</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">8,074</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Finished goods</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">96,955</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">108,248</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">162,644</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">167,691</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 144px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Accrued expenses and other current liabilities</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Employee related</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">19,043</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">21,712</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Commissions and rebates</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,143</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,722</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Insurance related</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,717</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,780</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Professional fees</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,546</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,573</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Income and other taxes</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,203</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,910</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Deferred consideration on acquisitions</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,250</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,250</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Other</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,257</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">11,756</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;44,159</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;45,703</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 13pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 166px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;">Accumulated other comprehensive income (loss)</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Derivative instruments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,689</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,655</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Foreign currency translation adjustment</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(42,797<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(41,904<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Unrecognized net pension gains (losses)</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(23,808<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(30,977<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on derivative instruments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(1,561<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(1,548<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for incomes taxes on long-term intercompany investments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">8,166</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="min-width: 23.25pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">8,166</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 1.333pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on pension gains (losses)</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 23.25pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(914<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 23.25pt; text-align: right; padding-bottom: 1.333pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">1,823</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 23.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(58,225<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 23.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(61,785<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.98pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <div style="line-height: 0pt; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; clear: both; font-size: 0pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; padding: 0pt;"><font size="3"></font><br />&#160;</div> </div> <div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 102px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Term B loan due April&#160;2021</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">283,475</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">284,200</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Capitalized lease obligations</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">283,478</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">284,207</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Unamortized debt issuance costs and debt discount</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,877<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(3,035<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Less: current maturities</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,903<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(2,907<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">277,698</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">278,265</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> </div> <div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 91px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="13"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Service cost &#8211; benefits earned during the period</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">561</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">719</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest cost on benefit obligation</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">543</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">689</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Expected return on plan assets</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 13.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(863<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(742<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of net actuarial loss and prior service costs</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 13.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">347</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">384</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 262pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net periodic pension expense</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 13.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">588</td> <td style="padding-bottom: 0pt; padding-left: 7.835pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">1,050</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="3">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="17">&#160;</td> </tr> </table> </div> <div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 63px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; height: 14.25pt; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="padding-bottom: 0.333pt; line-height: 9pt; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">Instrument</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 80.51pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="text-align: center; padding-bottom: 0.333pt; line-height: 9pt; white-space: nowrap;">Hedge</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 0pt;" rowspan="2"> <div style="text-align: center; padding-bottom: 0.333pt; line-height: 9pt;">Notional&#160;<br />Amount at&#160;<br />September&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;" rowspan="2">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Fair value as of</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; height: 0pt; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.083pt;" colspan="4"> <div style="text-align: center;">September&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.083pt;" colspan="4"> <div style="text-align: center;">June&#160;30,&#160;<br />2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Options</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 80.51pt; padding-right: 0.5pt; padding-top: 2.75pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real calls&#160;</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="text-align: center;">R$97,500</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,815</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,027</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 124.86pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Options</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 80.51pt; padding-right: 0.5pt; padding-top: 3pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real puts&#160;</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="text-align: center; padding-bottom: 1pt; padding-left: 0pt; width: 47.41pt; padding-right: 0pt; padding-top: 3pt;"> <div style="text-align: center;">R$97,500</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(126<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 9.85pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(372<font style="position: absolute;">)</font></td> <td style="padding-bottom: 0pt; padding-left: 0.045pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> </div> <div><br class="apple-interchange-newline" /> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 61px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">September&#160;30, 2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">June&#160;30, 2016</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Derivatives asset</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,689</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,655</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; white-space: normal; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">Deferred consideration on acquisitions</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(7,068<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">&#8199;&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(6,745<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> </table> </div> <div><br class="apple-interchange-newline" /> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 52px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;">Balance, June&#160;30, 2016</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">(6,745<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(393<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Payment</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">70</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Balance, September&#160;30, 2016</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(7,068<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="9">&#160;</td> </tr> </table> </div> <div><br class="apple-interchange-newline" /> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 2pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 439px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September&#160;30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2015</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;">Net sales</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; MFAs and other</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">83,419</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">85,521</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; Nutritional Specialties</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">26,304</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">22,370</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">&#160;&#160; Vaccines</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">14,778</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,243</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">124,501</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">120,134</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">51,592</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">54,469</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">11,894</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,517</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">187,987</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">187,120</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,898</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,876</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">542</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">608</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">218</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">194</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">5,658</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">4,678</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;">Adjusted EBITDA</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td colspan="6">&#160;</td> <td colspan="6">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">32,619</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">31,476</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,988</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,160</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">742</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">86</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">34,722</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 8.25pt;"> <div style="white-space: nowrap;">Reconciliation of income before income taxes to Adjusted EBITDA</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Income before income taxes</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">17,572</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">23,492</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Interest expense, net</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,907</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,819</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Depreciation and amortization&#8201;&#8211;&#8201;Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">5,658</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,678</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Depreciation and amortization&#8201;&#8211;&#8201;Corporate</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">660</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">751</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Corporate costs</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,524</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,015</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Acquisition-related accrued compensation</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">420</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">420</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Acquisition-related transaction costs</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,274</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">&#8212;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Foreign currency (gains) losses, net</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">334</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(5,453<font style="position: absolute;">)</font></td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 276.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Adjusted EBITDA&#8201;&#8211;&#8201;Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">34,722</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 0px; width: 40%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 116px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June&#160;30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 18pt; padding-right: 18pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;">Identifiable assets</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">435,512</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">444,751</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59,687</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">57,939</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">20,988</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">21,557</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">516,187</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">524,247</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Corporate</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">81,897</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">&#160;</td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">83,588</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total</div> </td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">598,084</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="width: 6pt; padding: 0pt;">&#160;</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">607,835</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;">&#160;</td> <td style="width: 0pt; padding: 0pt;">&#160;</td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14">&#160;</td> </tr> </table> </div> 920 498 953000 86000 81000 3868000 4587000 49000 680000 3819000 3819000 3907000 3907000 4111000 4731000 1259000 1528000 59000 59000 51369000 56789000 8074000 8900000 108248000 96955000 4040000 2538000 2406000 21712000 19043000 3722000 4143000 1780000 1717000 3573000 3546000 1910000 2203000 1250000 1250000 11756000 12257000 6745000 7068000 2655000 2689000 -41904000 -42797000 30977000 23808000 -1548000 -1561000 -8166000 -8166000 -1823000 914000 1274000 284207000 284200000 7000 283478000 283475000 3000 3035000 2877000 -2907000 -2903000 2.50% or 2.75% 1.50% or 1.75% 0.0300 0.0200 0.0100 123758000 699000 603000 719000 561000 689000 543000 384000 347000 742000 863000 1050000 588000 6822000 0.03 0.04 7024000 6990000 140 97500000 97500000 3027000 -372000 2815000 -126000 34000 -70000 86000 7015000 31476000 3160000 34722000 742000 7524000 32619000 3988000 37349000 <div> <div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 1pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">Dividends</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px;">We declared and paid quarterly cash dividends of&#8201; $0.10 per share, totaling $3,941, during the three months ended September&#160;30, 2016, to holders of our Class A common stock and Class B common stock.</div> </div> 1700000 2655000 2689000 0.10 3941000 2538000 200000000 62000000 0.0400 0.0326 0001069899pahc:AnimalHealthMember2016-09-30 0001069899pahc:AnimalHealthMember 2016-06-30 4076000 0001069899pahc:PerformanceProductsMember2016-09-30 428000 0001069899pahc:PerformanceProductsMember2016-06-30 504000 2406000 4040000 00010698992015-10-012015-12-31 62000000 4076000 iso4217:BRL 2689000 0001069899us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberpahc:OptionsMember2016-09-30 393000 0001069899us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberpahc:OptionsMember2016-07-012016-09-30 1135000 0001069899us-gaap:CashFlowHedgingMemberpahc:OptionsMember2016-09-30 1528000 167000 EX-101.SCH 7 pahc-20160930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Description of Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Statements of Operations-Additional Information link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Balance Sheets-Additional Information link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Employee Benefit Plans link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Derivatives link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Business Segments link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Statements of Operations-Additional Information (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Balance Sheets-Additional Information (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Employee Benefit Plans (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Derivatives (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Business Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details 1) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Statements of Operations-Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Balance Sheets-Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Balance Sheets-Additional Information (Details 1) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Balance Sheets-Additional Information (Detail Textuals 1) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Debt - Summary of long-term debt (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Debt (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Related Party Transactions (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Employee Benefit Plans - Net periodic pension expense (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Employee Benefit Plans (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Commitments and Contingencies (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Derivatives (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Derivatives (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Business Segments (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Business Segments (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 pahc-20160930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 pahc-20160930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 pahc-20160930_lab.xml XBRL LABEL FILE EX-101.PRE 11 pahc-20160930_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document and Entity Information - shares
3 Months Ended
Sep. 30, 2016
Nov. 02, 2016
Entity Registrant Name PHIBRO ANIMAL HEALTH CORP  
Entity Central Index Key 0001069899  
Trading Symbol pahc  
Current Fiscal Year End Date --06-30  
Entity Filer Category Accelerated Filer  
Document Type 10-Q  
Document Period End Date Sep. 30, 2016  
Amendment Flag false  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Class A common stock    
Entity Common Stock, Shares Outstanding   18,519,757
Class B common stock    
Entity Common Stock, Shares Outstanding   20,887,811
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]    
Net sales $ 187,987 $ 187,120
Cost of goods sold 126,988 127,913
Gross profit 60,999 59,207
Selling, general and administrative expenses 39,186 37,349
Operating income 21,813 21,858
Interest expense, net 3,907 3,819
Foreign currency (gains) losses, net 334 (5,453)
Income before income taxes 17,572 23,492
Provision for income taxes 5,395 4,739
Net income $ 12,177 $ 18,753
Net income per share    
basic (in dollars per share) $ 0.31 $ 0.48
diluted (in dollars per share) $ 0.31 $ 0.47
Weighted average common shares outstanding    
basic (in shares) 39,408 39,092
diluted (in shares) 39,906 40,012
Dividends per share (in dollars per share) $ 0.10 $ 0.10
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Statement of Comprehensive Income [Abstract]    
Net income $ 12,177 $ 18,753
Change in fair value of derivative instruments 34 (4,903)
Foreign currency translation adjustment (893) (21,729)
Unrecognized net pension gains (losses) 7,169 384
(Provision) benefit for income taxes (2,750) 3,686
Other comprehensive income (loss) 3,560 (22,562)
Comprehensive income (loss) $ 15,737 $ (3,809)
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
ASSETS    
Cash and cash equivalents $ 37,415 $ 33,605
Accounts receivable, net 119,607 123,790
Inventories, net 162,644 167,691
Other current assets 20,102 17,745
Total current assets 339,768 342,831
Property, plant and equipment, net 127,336 127,323
Intangibles, net 58,572 60,095
Goodwill 21,121 21,121
Other assets 51,287 56,465
Total assets 598,084 607,835
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current portion of long-term debt 2,903 2,907
Accounts payable 54,274 60,167
Accrued expenses and other current liabilities 44,159 45,703
Total current liabilities 101,336 108,777
Revolving credit facility 62,000 69,000
Long-term debt 277,698 278,265
Other liabilities 54,774 61,313
Total liabilities 495,808 517,355
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 18,519,757 shares issued and outstanding at September 30, 2016, and June 30, 2016; 30,000,000 Class B shares authorized, 20,887,811 shares issued and outstanding at September 30, 2016, and June 30, 2016 4 4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding
Paid-in capital 118,299 118,299
Retained earnings 42,198 33,962
Accumulated other comprehensive income (loss) (58,225) (61,785)
Total stockholders' equity 102,276 90,480
Total liabilities and stockholders' equity $ 598,084 $ 607,835
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares
Sep. 30, 2016
Jun. 30, 2016
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 16,000,000 16,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A common stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 18,519,757 18,519,757
Common stock, shares outstanding 18,519,757 18,519,757
Class B common stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 20,887,811 20,887,811
Common stock, shares outstanding 20,887,811 20,887,811
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
OPERATING ACTIVITIES    
Net income $ 12,177 $ 18,753
Adjustments to reconcile net income to net cash provided (used) by operating activities:    
Depreciation and amortization 6,318 5,429
Amortization of debt issuance costs and debt discount 253 242
Acquisition-related accrued compensation 420 420
Acquisition-related accrued interest 393 345
Deferred income taxes 1,706 38
Foreign currency (gains) losses, net 97 (5,434)
Other 87 53
Changes in operating assets and liabilities:    
Accounts receivable, net 3,906 (5,597)
Inventories, net 4,544 (5,469)
Other current assets (2,430) (1,570)
Other assets 346 (444)
Accounts payable (5,004) (3,010)
Accrued expenses and other liabilities (1,357) (6,150)
Net cash provided (used) by operating activities 21,456 (2,394)
INVESTING ACTIVITIES    
Capital expenditures (5,911) (8,094)
Other, net 25 246
Net cash provided (used) by investing activities (5,886) (7,848)
FINANCING ACTIVITIES    
Revolving credit facility borrowings 34,000 55,500
Revolving credit facility repayments (41,000) (38,000)
Payments of long-term debt, capital leases and other (729) (734)
Proceeds from common shares issued   693
Dividends paid (3,941) (3,910)
Net cash provided (used) by financing activities (11,670) 13,549
Effect of exchange rate changes on cash (90) (706)
Net increase (decrease) in cash and cash equivalents 3,810 2,601
Cash and cash equivalents at beginning of period 33,605 29,216
Cash and cash equivalents at end of period $ 37,415 $ 31,817
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Description of Business
3 Months Ended
Sep. 30, 2016
Description Of Business [Abstract]  
Description of Business
1.       Description of Business
 
Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (collectively, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.
The unaudited consolidated financial information for the three months ended September 30, 2016 and 2015, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 (the “Annual Report”), filed with the Securities and Exchange Commission on August 29, 2016 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of financial position, results of operations and cash flows for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2016, was derived from the audited consolidated financial statements, which include the accounts of Phibro and its consolidated subsidiaries, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.
The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity. Intercompany balances and transactions have been eliminated in the consolidated financial statements.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and New Accounting Standards
3 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies and New Accounting Standards
2.     Summary of Significant Accounting Policies and New Accounting Standards
 
Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2016, there have been no material changes to any of the significant accounting policies contained therein, except for the application of Accounting Standards Update (“ASU”) 2015-03, Interest—Imputation of Interest (Subtopic 835-30), during the three months ended September 30, 2016. Prior periods have been adjusted to reflect the retrospective application of this guidance. For further discussion, see “—New Accounting Standards.”
Revisions of Previously Issued Financial Statements
During the fourth quarter of fiscal 2016, the Company determined that amortization expense related to product-related intangible assets should be recorded in cost of goods sold rather than in selling, general and administrative expense within the consolidated statement of operations. The Company has revised its financial statements for the three months ended September 30, 2015, to correct the classification of amortization expense to increase cost of goods sold and reduce gross profit and selling, general and administrative expenses by $953. These revisions had no impact on the Company’s previously reported net income (loss) or cash flows. The Company evaluated the impact of the revisions on prior periods, assessing materiality quantitatively and qualitatively, and concluded the errors were not material to any previously issued financial statements.
Net Income per Share and Weighted Average Shares
Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.
Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares equivalents resulting from the assumed exercise of stock options. For the three months ended September 30, 2016 and 2015, all common share equivalents were included in the calculation of diluted net income per share.
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Net income
      $ 12,177         $ 18,753    
Weighted average number of shares – basic
        39,408           39,092    
Dilutive effect of stock options
        498           920    
Weighted average number of shares – diluted
        39,906           40,012    
Net income per share                          
basic
      $ 0.31         $ 0.48    
diluted
      $ 0.31         $ 0.47    
Dividends
We declared and paid quarterly cash dividends of  $0.10 per share, totaling $3,941, during the three months ended September 30, 2016, to holders of our Class A common stock and Class B common stock.
New Accounting Standards
Financial Accounting Standards Board (“FASB”) ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2016-02, Leases (Topic 842), supersedes the current lease accounting guidance and requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December 15, 2018. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-12, Plan Accounting (Topics 960, 962 and 965), modifies certain disclosure requirements and asset valuation measurements. We applied the provisions of this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
ASU 2015-11, Inventory (Topic 330), requires entities to measure inventory at the lower of cost and net realizable value (“NRV”). NRV is defined as “the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-05, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) provides guidance regarding the treatment of cloud computing arrangements and if an arrangement includes a software license. We adopted this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30), requires debt issuance costs to be presented as a reduction of the related liability. These costs were previously included in other assets. Debt issuance costs associated with line-of-credit arrangements may continue to be recognized in other assets. We adopted this guidance during the three months ended September 30, 2016, and applied the guidance retrospectively. Debt issuance costs of  $2,406 and $2,538 as of September 30, 2016, and June 30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.
ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), requires management to assess an entity’s ability to continue as a going concern within one year after the issuance date of the financial statements, and to provide related footnote disclosures in certain circumstances. Management will need to consider relevant conditions that are known and reasonably knowable at the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. Under the new standard, the definition of substantial doubt incorporates a likelihood threshold of  ”probable” similar to the current use of that term in GAAP for loss contingencies. ASU 2014-15 will be effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.
ASU 2014-09, Revenue from Contracts with Customers (Topic 606), establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2015-14, Deferral of the Effective Date, amended ASU 2014-09, resulting in a one-year deferral of the effective date. ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing; and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients also amended ASU 2014-09The amendments are effective concurrent with the effective date for ASU 2014-09 for annual periods beginning after December 15, 2017, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Statements of Operations-Additional Information
3 Months Ended
Sep. 30, 2016
Supplemental Income Statement Elements [Abstract]  
Statements of Operations-Additional Information
3.     Statements of Operations—Additional Information
 
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Interest expense, net                          
Term B loan
      $ 2,905         $ 2,935    
Revolving credit facility
        955           260    
Acquisition-related accrued interest
        393           345    
Amortization of debt issuance costs and debt discount
        253           242    
Other
        81           86    
Interest expense
        4,587           3,868    
Interest (income)
        (680)           (49)    
        $ 3,907         $ 3,819    
Depreciation and amortization                          
Depreciation of property, plant and equipment
      $ 4,731         $ 4,111    
Amortization of intangible assets
        1,528           1,259    
Amortization of other assets
        59           59    
        $ 6,318         $ 5,429    
 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets-Additional Information
3 Months Ended
Sep. 30, 2016
Balance Sheets Additional Information [Abstract]  
Balance Sheets-Additional Information
4.     Balance Sheets—Additional Information
 
As of
   
September 30,
2016
   
June 30,
2016
 
Inventories      
Raw materials
      $ 56,789         $ 51,369    
Work-in-process
        8,900           8,074    
Finished goods
        96,955           108,248    
        $ 162,644         $ 167,691    
 
Goodwill balances did not change during the three months ended September 30, 2016.
We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,040 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.
As of
   
September 30,
2016
   
June 30,
2016
 
Accrued expenses and other current liabilities                          
Employee related
      $ 19,043         $ 21,712    
Commissions and rebates
        4,143           3,722    
Insurance related
        1,717           1,780    
Professional fees
        3,546           3,573    
Income and other taxes
        2,203           1,910    
Deferred consideration on acquisitions
        1,250           1,250    
Other
        12,257           11,756    
        $  44,159         $  45,703    
 
As of
   
September 30,
2016
   
June 30,
2016
 
Accumulated other comprehensive income (loss)                          
Derivative instruments
      $ 2,689         $ 2,655    
Foreign currency translation adjustment
        (42,797)           (41,904)    
Unrecognized net pension gains (losses)
        (23,808)           (30,977)    
(Provision) benefit for income taxes on derivative instruments
        (1,561)           (1,548)    
(Provision) benefit for incomes taxes on long-term intercompany investments
        8,166           8,166    
(Provision) benefit for income taxes on pension gains (losses)
        (914)           1,823    
        $ (58,225)         $ (61,785)    
 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt
3 Months Ended
Sep. 30, 2016
Debt Disclosure [Abstract]  
Debt
5.     Debt
 
Revolving Credit Facility and Term B Loan
We have a revolving credit facility (the “Revolver”), where we can borrow up to $200,000, subject to the terms of the agreement, and a term B loan (the “Term B Loan,” and together with the Revolver, the “Credit Facilities”). The Revolver has applicable margins equal to 2.50% or 2.75%, in the case of LIBOR loans and 1.50% or 1.75%, in the case of base rate loans; the margins are based on the First Lien Net Leverage Ratio. The Term B Loan has applicable margins equal to 3.00% with regards to LIBOR loans and 2.00% regarding base rate loans. The LIBOR rate on the Term B Loan is subject to a floor of 1.00%.
The Revolver requires, among other things, the maintenance of a maximum consolidated first lien net debt to consolidated EBITDA leverage ratio, calculated on a trailing four quarter basis, and contains an acceleration clause should an event of default (as defined in the agreement governing the Credit Facilities) occur. As of September 30, 2016, we were in compliance with the covenants of the Credit Facilities.
As of September 30, 2016, we had $62,000 in borrowings under the Revolver and had outstanding letters of credit of  $14,242 leaving $123,758 available for borrowings and letters of credit under the Revolver. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The tenors of these letters of credit are all one year or less.
The weighted-average interest rates for the Revolver and Term B Loan were 3.26% and 4.00%, respectively, for the three months ended September 30, 2016.
Long-Term Debt
As of
   
September 30,
2016
   
June 30,
2016
 
Term B loan due April 2021
      $ 283,475         $ 284,200    
Capitalized lease obligations
        3           7    
          283,478           284,207    
Unamortized debt issuance costs and debt discount
        (2,877)           (3,035)    
Less: current maturities
        (2,903)           (2,907)    
        $ 277,698         $ 278,265    
 
During the three months ended September 30, 2016, we applied the provisions of ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30). Debt issuance costs of  $2,406 and $2,538 as of September 30, 2016, and June 30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions
3 Months Ended
Sep. 30, 2016
Related Party Transactions [Abstract]  
Related Party Transactions
6.     Related Party Transactions
 
Certain relatives of Jack C. Bendheim provided services to us as employees or consultants and received aggregate compensation and benefits of  $603 and $699 during the three months ended September 30, 2016 and 2015, respectively. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Employee Benefit Plans
3 Months Ended
Sep. 30, 2016
Compensation and Retirement Disclosure [Abstract]  
Employee Benefit Plans
7.     Employee Benefit Plans
 
The Company maintains a noncontributory defined benefit pension plan for all domestic nonunion employees employed on or prior to December 31, 2013, who meet certain requirements of age, length of service and hours worked per year. Plan benefits are based upon years of service and average compensation, as defined.
In July 2016, we amended our domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of  $6,822 in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities. We also modified the 401(k) retirement savings plan, effective October 1, 2016, to include, for all domestic employees, a non-elective Company contribution of 3% of compensation and an additional discretionary contribution of up to 4% of compensation, depending on the employee’s age and years of service.
Separately, we recently offered a lump sum settlement option to certain pension plan participants. During the three months ending December 31, 2016, we will recognize a partial settlement of the pension plan and a charge to the consolidated statement of operations. The settlement expense is expected to be approximately $1,700.
Net periodic pension expense was:
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
   
Service cost – benefits earned during the period
      $ 561         $ 719      
Interest cost on benefit obligation
        543           689      
Expected return on plan assets
        (863)           (742)      
Amortization of net actuarial loss and prior service costs
        347           384      
Net periodic pension expense
      $ 588         $ 1,050      
 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies
3 Months Ended
Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
8.     Commitments and Contingencies
 
Environmental
Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the time period during which such costs are likely to be incurred are difficult to predict.
While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.
The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based upon our experience to date, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.
The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of a facility in Santa Fe Springs, California, operated by our subsidiary Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that groundwater contamination at its site is due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, a nearby property owner has filed a complaint in the Superior Court of the State of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for alleged contamination of groundwater underneath its property, and a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling has filed a complaint under CERCLA, RCRA and the common law public nuisance doctrine in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.
Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be $6,990 and $7,024 at September 30, 2016, and June 30, 2016, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries is liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.
Claims and Litigation
PAHC and its subsidiaries are party to a number of claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivatives
3 Months Ended
Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives
9.     Derivatives
 
We monitor our exposure to foreign currency exchange rates and use derivatives to manage certain of these risks. These derivatives generally have an expiration/maturity of two years or less and are intended to hedge cash flows related to the purchase of inventory. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). We record the portion of the changes in the value of the derivative, related to a hedged asset or liability (the effective portion), in accumulated other comprehensive income (loss). As the hedged item is sold, we recognize the gain or loss recorded in accumulated other comprehensive income (loss) to the consolidated statements of operations on the same line where the hedged item is charged when released/sold. We immediately recognize in the consolidated statements of operations in the same line as the hedged item, the portion of the changes in fair value of derivatives used as cash flow hedges that is not offset by changes in the expected cash flows related to a recognized asset or liability (the ineffective portion).
We routinely assess whether the derivatives used to hedge transactions are effective. If we determine that a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.
We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “—Fair Value Measurements.”
The following table details the Company’s outstanding derivatives that are designated and effective as cash flow hedges as of September 30, 2016:
Instrument
   
Hedge
   
Notional 
Amount at 
September 30, 
2016
   
Fair value as of
 
 
September 30, 
2016
   
June 30, 
2016
 
Options
   
Brazilian Real calls 
   
R$97,500
      $ 2,815         $ 3,027    
Options
   
Brazilian Real puts 
   
R$97,500
      $ (126)         $ (372)    
The fair values at September 30, 2016, are unrealized and will fluctuate based on future exchange rates until the derivative contracts mature. Other comprehensive income (loss) for the three months ended September 30, 2016, included $34 of net unrecognized gains. Accumulated other comprehensive income (loss) at September 30, 2016, included $2,689 of net unrecognized gains on derivative instruments; we estimate that $167 of those gains will be recognized in earnings within the next twelve months. At June 30, 2016, realized losses of  $1,528, related to matured contracts were recorded as a component of inventory. We recognized $1,135 of these losses in cost of goods sold during the three months ended September 30, 2016, and anticipate we will recognize the remaining $393 of these losses in costs of goods sold during the three months ending December 31, 2016. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold. We hedge forecasted transactions for periods not exceeding twenty-four months.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements
3 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements
10.    Fair Value Measurements
 
Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Financial assets and liabilities are measured at fair value using the three-level valuation hierarchy for disclosure of fair value measurements. The determination of the applicable level within the hierarchy of a particular asset or liability depends on the inputs used in the valuation as of the measurement date, notably the extent to which the inputs are market-based (observable) or internally derived (unobservable). Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs are inputs based on a company’s own assumptions about market participant assumptions developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the reliability of inputs as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—
Significant observable inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly or indirectly through corroboration with observable market data.
 
Level 3—
Unobservable inputs for which there is little or no market data available, and that are significant to the overall fair value measurement, are employed that require the reporting entity to develop its own assumptions.
 
In assessing the fair value of financial instruments at September 30, 2016, and June 30, 2016, we used a variety of methods and assumptions that were based on estimates of market conditions and risks existing at the time.
Current Assets and Liabilities
We consider the carrying amounts of current assets and current liabilities to be representative of their fair value because of the current nature of these items.
Letters of Credit
We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The carrying values of these letters of credit are considered to be representative of their fair values because of the nature of the instruments. The tenors of these letters of credit are all one year or less.
Long Term Debt
We record the Term B Loan and the Revolver at book value in our consolidated financial statements. We believe the carrying value of the Term B Loan is approximately equal to the fair value, which is based on quoted broker prices that are Level 2 inputs. We believe the carrying value of the Revolver is approximately equal to the fair value due to the variable nature of the instrument.
Deferred Consideration on Acquisitions
We estimated the fair value of the deferred consideration on acquisitions using the income approach, based on the Company’s current sales forecast related to the acquired business.
Derivatives
We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates.
As of
   
September 30, 2016
   
June 30, 2016
 
     
Level 1
   
Level 2
   
Level 3
   
Level 1
   
Level 2
   
Level 3
 
Derivatives asset
      $  —         $ 2,689         $  —         $  —         $ 2,655         $  —    
Deferred consideration on acquisitions
      $  —         $  —         $ (7,068)         $  —         $  —         $ (6,745)    
The table below provides a summary of the changes in the fair value of Level 3 liabilities:
 
Balance, June 30, 2016
      $ (6,745)    
 
Acquisition-related accrued interest
        (393)    
 
Payment
        70    
 
Balance, September 30, 2016
      $ (7,068)    
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments
3 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Business Segments
11.    Business Segments
 
The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace mineral products for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.
We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and such costs are referred to as Corporate. We do not allocate such items to the principal segments because they are not used to evaluate their operating results or financial position.
We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.
The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Net sales                          
   MFAs and other
      $ 83,419         $ 85,521    
   Nutritional Specialties
        26,304           22,370    
   Vaccines
        14,778           12,243    
Animal Health
        124,501           120,134    
Mineral Nutrition
        51,592           54,469    
Performance Products
        11,894           12,517    
Total segments
      $ 187,987         $ 187,120    
Depreciation and amortization                          
Animal Health
      $ 4,898         $ 3,876    
Mineral Nutrition
        542           608    
Performance Products
        218           194    
Total segments
      $ 5,658         $ 4,678    
Adjusted EBITDA      
Animal Health
      $ 32,619         $ 31,476    
Mineral Nutrition
        3,988           3,160    
Performance Products
        742           86    
Total segments
      $ 37,349         $ 34,722    
Reconciliation of income before income taxes to Adjusted EBITDA
                         
Income before income taxes
      $ 17,572         $ 23,492    
Interest expense, net
        3,907           3,819    
Depreciation and amortization – Total segments
        5,658           4,678    
Depreciation and amortization – Corporate
        660           751    
Corporate costs
        7,524           7,015    
Acquisition-related accrued compensation
        420           420    
Acquisition-related transaction costs
        1,274              
Foreign currency (gains) losses, net
        334           (5,453)    
Adjusted EBITDA – Total segments
      $ 37,349         $ 34,722    
 
As of
   
September 30,
2016
   
June 30,
2016
 
Identifiable assets                          
Animal Health
      $ 435,512         $ 444,751    
Mineral Nutrition
        59,687           57,939    
Performance Products
        20,988           21,557    
Total segments
        516,187           524,247    
Corporate
        81,897           83,588    
Total
      $ 598,084         $ 607,835    
 
The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of  $4,040 and $4,076 as of September 30, 2016, and June 30, 2016, respectively. The Performance Products segment includes an investment in an equity method investee of  $428 and $504 as of September 30, 2016, and June 30, 2016, respectively. Corporate assets include cash and cash equivalents, debt issuance costs related to the Revolver, income tax related assets and certain other assets.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and New Accounting Standards (Policies)
3 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Revisions of previously issued financial statements
Revisions of Previously Issued Financial Statements
During the fourth quarter of fiscal 2016, the Company determined that amortization expense related to product-related intangible assets should be recorded in cost of goods sold rather than in selling, general and administrative expense within the consolidated statement of operations. The Company has revised its financial statements for the three months ended September 30, 2015, to correct the classification of amortization expense to increase cost of goods sold and reduce gross profit and selling, general and administrative expenses by $953. These revisions had no impact on the Company’s previously reported net income (loss) or cash flows. The Company evaluated the impact of the revisions on prior periods, assessing materiality quantitatively and qualitatively, and concluded the errors were not material to any previously issued financial statements.
Net Income per Share and Weighted Average Shares
Net Income per Share and Weighted Average Shares
Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.
Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares equivalents resulting from the assumed exercise of stock options. For the three months ended September 30, 2016 and 2015, all common share equivalents were included in the calculation of diluted net income per share.
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Net income
      $ 12,177         $ 18,753    
Weighted average number of shares – basic
        39,408           39,092    
Dilutive effect of stock options
        498           920    
Weighted average number of shares – diluted
        39,906           40,012    
Net income per share                          
basic
      $ 0.31         $ 0.48    
diluted
      $ 0.31         $ 0.47    
Dividends
Dividends
We declared and paid quarterly cash dividends of  $0.10 per share, totaling $3,941, during the three months ended September 30, 2016, to holders of our Class A common stock and Class B common stock.
New Accounting Standards
New Accounting Standards
Financial Accounting Standards Board (“FASB”) ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2016-02, Leases (Topic 842), supersedes the current lease accounting guidance and requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December 15, 2018. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-12, Plan Accounting (Topics 960, 962 and 965), modifies certain disclosure requirements and asset valuation measurements. We applied the provisions of this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
ASU 2015-11, Inventory (Topic 330), requires entities to measure inventory at the lower of cost and net realizable value (“NRV”). NRV is defined as “the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” The guidance is effective for annual periods beginning after December 15, 2016, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
ASU 2015-05, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) provides guidance regarding the treatment of cloud computing arrangements and if an arrangement includes a software license. We adopted this guidance during the three months ended September 30, 2016, and it had no material impact on our consolidated financial statements.
ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30), requires debt issuance costs to be presented as a reduction of the related liability. These costs were previously included in other assets. Debt issuance costs associated with line-of-credit arrangements may continue to be recognized in other assets. We adopted this guidance during the three months ended September 30, 2016, and applied the guidance retrospectively. Debt issuance costs of  $2,406 and $2,538 as of September 30, 2016, and June 30, 2016, respectively, have been presented as a reduction in long-term debt on our consolidated balance sheets.
ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), requires management to assess an entity’s ability to continue as a going concern within one year after the issuance date of the financial statements, and to provide related footnote disclosures in certain circumstances. Management will need to consider relevant conditions that are known and reasonably knowable at the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. Under the new standard, the definition of substantial doubt incorporates a likelihood threshold of  ”probable” similar to the current use of that term in GAAP for loss contingencies. ASU 2014-15 will be effective for annual periods ending after December 15, 2016, and for annual periods and interim periods thereafter. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.
ASU 2014-09, Revenue from Contracts with Customers (Topic 606), establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2015-14, Deferral of the Effective Date, amended ASU 2014-09, resulting in a one-year deferral of the effective date. ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing; and ASU 2016-12, Narrow-Scope Improvements and Practical Expedients also amended ASU 2014-09The amendments are effective concurrent with the effective date for ASU 2014-09 for annual periods beginning after December 15, 2017, and interim periods within those years. We are evaluating the impact of adoption of this guidance on our consolidated financial statements.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and New Accounting Standards (Tables)
3 Months Ended
Sep. 30, 2016
Accounting Policies [Abstract]  
Schedule of Net Income per Share and Weighted Average Shares
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Net income
      $ 12,177         $ 18,753    
Weighted average number of shares – basic
        39,408           39,092    
Dilutive effect of stock options
        498           920    
Weighted average number of shares – diluted
        39,906           40,012    
Net income per share                          
basic
      $ 0.31         $ 0.48    
diluted
      $ 0.31         $ 0.47    
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Statements of Operations-Additional Information (Tables)
3 Months Ended
Sep. 30, 2016
Supplemental Income Statement Elements [Abstract]  
Schedule of additional information of statements of operations
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Interest expense, net                          
Term B loan
      $ 2,905         $ 2,935    
Revolving credit facility
        955           260    
Acquisition-related accrued interest
        393           345    
Amortization of debt issuance costs and debt discount
        253           242    
Other
        81           86    
Interest expense
        4,587           3,868    
Interest (income)
        (680)           (49)    
        $ 3,907         $ 3,819    
Depreciation and amortization                          
Depreciation of property, plant and equipment
      $ 4,731         $ 4,111    
Amortization of intangible assets
        1,528           1,259    
Amortization of other assets
        59           59    
        $ 6,318         $ 5,429    
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets-Additional Information (Tables)
3 Months Ended
Sep. 30, 2016
Balance Sheets Additional Information [Abstract]  
Schedule of additional information of balance sheets
As of
   
September 30,
2016
   
June 30,
2016
 
Inventories      
Raw materials
      $ 56,789         $ 51,369    
Work-in-process
        8,900           8,074    
Finished goods
        96,955           108,248    
        $ 162,644         $ 167,691    
 
As of
   
September 30,
2016
   
June 30,
2016
 
Accrued expenses and other current liabilities                          
Employee related
      $ 19,043         $ 21,712    
Commissions and rebates
        4,143           3,722    
Insurance related
        1,717           1,780    
Professional fees
        3,546           3,573    
Income and other taxes
        2,203           1,910    
Deferred consideration on acquisitions
        1,250           1,250    
Other
        12,257           11,756    
        $  44,159         $  45,703    
 
As of
   
September 30,
2016
   
June 30,
2016
 
Accumulated other comprehensive income (loss)                          
Derivative instruments
      $ 2,689         $ 2,655    
Foreign currency translation adjustment
        (42,797)           (41,904)    
Unrecognized net pension gains (losses)
        (23,808)           (30,977)    
(Provision) benefit for income taxes on derivative instruments
        (1,561)           (1,548)    
(Provision) benefit for incomes taxes on long-term intercompany investments
        8,166           8,166    
(Provision) benefit for income taxes on pension gains (losses)
        (914)           1,823    
        $ (58,225)         $ (61,785)    
 

 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt (Tables)
3 Months Ended
Sep. 30, 2016
Debt Disclosure [Abstract]  
Schedule of long term debt
As of
   
September 30,
2016
   
June 30,
2016
 
Term B loan due April 2021
      $ 283,475         $ 284,200    
Capitalized lease obligations
        3           7    
          283,478           284,207    
Unamortized debt issuance costs and debt discount
        (2,877)           (3,035)    
Less: current maturities
        (2,903)           (2,907)    
        $ 277,698         $ 278,265    
 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Employee Benefit Plans (Tables)
3 Months Ended
Sep. 30, 2016
Compensation and Retirement Disclosure [Abstract]  
Schedule of net periodic pension expense
     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
   
Service cost – benefits earned during the period
      $ 561         $ 719      
Interest cost on benefit obligation
        543           689      
Expected return on plan assets
        (863)           (742)      
Amortization of net actuarial loss and prior service costs
        347           384      
Net periodic pension expense
      $ 588         $ 1,050      
 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivatives (Tables)
3 Months Ended
Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges
Instrument
   
Hedge
   
Notional 
Amount at 
September 30, 
2016
   
Fair value as of
 
 
September 30, 
2016
   
June 30, 
2016
 
Options
   
Brazilian Real calls 
   
R$97,500
      $ 2,815         $ 3,027    
Options
   
Brazilian Real puts 
   
R$97,500
      $ (126)         $ (372)    
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Tables)
3 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of fair value derivatives, assets and liabilities

As of
   
September 30, 2016
   
June 30, 2016
 
     
Level 1
   
Level 2
   
Level 3
   
Level 1
   
Level 2
   
Level 3
 
Derivatives asset
      $  —         $ 2,689         $  —         $  —         $ 2,655         $  —    
Deferred consideration on acquisitions
      $  —         $  —         $ (7,068)         $  —         $  —         $ (6,745)    
Schedule of changes in the fair value of Level 3 assets

 
Balance, June 30, 2016
      $ (6,745)    
 
Acquisition-related accrued interest
        (393)    
 
Payment
        70    
 
Balance, September 30, 2016
      $ (7,068)    
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments (Tables)
3 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Schedule of information regarding reportable segments

     
Three Months
 
For the Periods Ended September 30
   
2016
   
2015
 
Net sales                          
   MFAs and other
      $ 83,419         $ 85,521    
   Nutritional Specialties
        26,304           22,370    
   Vaccines
        14,778           12,243    
Animal Health
        124,501           120,134    
Mineral Nutrition
        51,592           54,469    
Performance Products
        11,894           12,517    
Total segments
      $ 187,987         $ 187,120    
Depreciation and amortization                          
Animal Health
      $ 4,898         $ 3,876    
Mineral Nutrition
        542           608    
Performance Products
        218           194    
Total segments
      $ 5,658         $ 4,678    
Adjusted EBITDA      
Animal Health
      $ 32,619         $ 31,476    
Mineral Nutrition
        3,988           3,160    
Performance Products
        742           86    
Total segments
      $ 37,349         $ 34,722    
Reconciliation of income before income taxes to Adjusted EBITDA
                         
Income before income taxes
      $ 17,572         $ 23,492    
Interest expense, net
        3,907           3,819    
Depreciation and amortization – Total segments
        5,658           4,678    
Depreciation and amortization – Corporate
        660           751    
Corporate costs
        7,524           7,015    
Acquisition-related accrued compensation
        420           420    
Acquisition-related transaction costs
        1,274              
Foreign currency (gains) losses, net
        334           (5,453)    
Adjusted EBITDA – Total segments
      $ 37,349         $ 34,722    
 
As of
   
September 30,
2016
   
June 30,
2016
 
Identifiable assets                          
Animal Health
      $ 435,512         $ 444,751    
Mineral Nutrition
        59,687           57,939    
Performance Products
        20,988           21,557    
Total segments
        516,187           524,247    
Corporate
        81,897           83,588    
Total
      $ 598,084         $ 607,835    
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and New Accounting Standards (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Accounting Policies [Abstract]    
Net income $ 12,177 $ 18,753
Weighted average number of shares - basic 39,408 39,092
Dilutive effect of stock options 498 920
Weighted average number of shares - diluted 39,906 40,012
Net income per share    
basic (in dollars per share) $ 0.31 $ 0.48
diluted (in dollars per share) $ 0.31 $ 0.47
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and New Accounting Standards (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Accounting Policies [Abstract]      
Cash dividends per share amount (in dollars per share) $ 0.10    
Cash dividends $ 3,941    
Debt issuance costs $ 2,406   $ 2,538
Revised amortization expense intangible assets   $ 953  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Statements of Operations-Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Interest expense, net    
Acquisition-related accrued interest $ 393 $ 345
Amortization of debt issuance costs and debt discount 253 242
Other 81 86
Interest expense 4,587 3,868
Interest (income) (680) (49)
Interest expense, net 3,907 3,819
Depreciation and amortization    
Depreciation of property, plant and equipment 4,731 4,111
Amortization of intangible assets 1,528 1,259
Amortization of other assets 59 59
Depreciation and amortization 6,318 5,429
Term B Loans    
Interest expense, net    
Acquisition-related accrued interest 2,905 2,935
Revolving credit facility    
Interest expense, net    
Acquisition-related accrued interest $ 955 $ 260
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets-Additional Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Inventories    
Raw materials $ 56,789 $ 51,369
Work-in-process 8,900 8,074
Finished goods 96,955 108,248
Inventory, net $ 162,644 $ 167,691
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets-Additional Information (Details 1) - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Accrued expenses and other current liabilities    
Employee related $ 19,043 $ 21,712
Commissions and rebates 4,143 3,722
Insurance related 1,717 1,780
Professional fees 3,546 3,573
Income and other taxes 2,203 1,910
Deferred consideration on acquisitions 1,250 1,250
Other 12,257 11,756
Accrued expenses and other current liabilities, total 44,159 45,703
Accumulated other comprehensive income (loss)    
Derivative instruments 2,689 2,655
Foreign currency translation adjustment (42,797) (41,904)
Unrecognized net pension gains (losses) (23,808) (30,977)
(Provision) benefit for income taxes on derivative instruments (1,561) (1,548)
(Provision) benefit for incomes taxes on long-term intercompany investments 8,166 8,166
(Provision) benefit for income taxes on pension gains (losses) (914) 1,823
Accumulated other comprehensive income (loss) $ (58,225) $ (61,785)
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Balance Sheets-Additional Information (Detail Textuals 1) - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Balance Sheets Additional Information [Abstract]    
Equity method investments $ 4,040 $ 4,076
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt - Summary of long-term debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Debt Instrument [Line Items]    
Long-term debt including current maturities $ 283,478 $ 284,207
Unamortized debt issuance costs and debt discount (2,877) (3,035)
Less: current maturities (2,903) (2,907)
Long-term debt 277,698 278,265
Term B loan due April 2021    
Debt Instrument [Line Items]    
Long-term debt including current maturities 283,475 284,200
Capitalized lease obligations    
Debt Instrument [Line Items]    
Long-term debt including current maturities $ 3 $ 7
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt (Detail Textuals) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Jun. 30, 2016
Debt Instrument [Line Items]    
Outstanding borrowings $ 62,000 $ 69,000
Debt issuance costs 2,406 $ 2,538
Revolving credit facility    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 200,000  
Weighted-average interest rates 3.26%  
Term B Loans    
Debt Instrument [Line Items]    
Weighted-average interest rates 4.00%  
Term B Loans | LIBOR    
Debt Instrument [Line Items]    
Applicable interest rates 3.00%  
Applicable floor rates 1.00%  
Term B Loans | Base Rate    
Debt Instrument [Line Items]    
Applicable interest rates 2.00%  
Term B Loans And Revolving Credit Facility    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 62,000  
Outstanding borrowings 14,242  
Aggregate available credit facilities $ 123,758  
Term B Loans And Revolving Credit Facility | LIBOR    
Debt Instrument [Line Items]    
Interest rate, description 2.50% or 2.75%  
Term B Loans And Revolving Credit Facility | Base Rate    
Debt Instrument [Line Items]    
Interest rate, description 1.50% or 1.75%  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Detail Textuals) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Relatives of Jack C. Bendheim | Compensation and benefit for services provided    
Related Party Transaction [Line Items]    
Aggregate compensation and benefits $ 603 $ 699
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
Employee Benefit Plans - Net periodic pension expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Compensation and Retirement Disclosure [Abstract]    
Service cost - benefits earned during the period $ 561 $ 719
Interest cost on benefit obligation 543 689
Expected return on plan assets (863) (742)
Amortization of net actuarial loss and prior service costs 347 384
Net periodic pension expense $ 588 $ 1,050
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Employee Benefit Plans (Detail Textuals) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Defined Benefit Plan Disclosure [Line Items]    
Settlement expense   $ 1,700
401(k) retirement savings plan    
Defined Benefit Plan Disclosure [Line Items]    
Contribution percentage 3.00%  
Maximum additional discretionary contribution percentage 4.00%  
Domestic noncontributory defined benefit pension plan    
Defined Benefit Plan Disclosure [Line Items]    
Pension curtailment gain $ 6,822  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies (Detail Textuals)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2012
PRPs
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Commitments And Contingencies [Line Items]      
Number of potentially responsible parties | PRPs 140    
Current and long-term liabilities      
Commitments And Contingencies [Line Items]      
Accrual for environmental loss contingencies payments | $   $ 6,990 $ 7,024
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivatives (Details) - Options - Cash flow hedges
BRL in Thousands, $ in Thousands
Sep. 30, 2016
USD ($)
Sep. 30, 2016
BRL
Jun. 30, 2016
USD ($)
Brazilian Real calls      
Derivative [Line Items]      
Notional amount | BRL   BRL 97,500  
Fair value | $ $ 2,815   $ 3,027
Brazilian Real puts      
Derivative [Line Items]      
Notional amount | BRL   BRL 97,500  
Fair value | $ $ (126)   $ (372)
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivatives (Detail Textuals)
$ in Thousands
3 Months Ended
Sep. 30, 2016
USD ($)
Derivative [Line Items]  
Unrecognized losses on derivative instruments recorded in earnings within the next twelve months $ 167
Options | Cash flow hedges  
Derivative [Line Items]  
Other comprehensive income (loss), unrealized gains (losses) on derivatives 34
Unrecognized losses on derivative instruments recorded in earnings within the next twelve months 1,528
Options | Cash flow hedges | Cost of goods sold  
Derivative [Line Items]  
Realized losses on hedging derivatives recognized in cost of goods sold 1,135
Unrecognized losses on derivative instruments recorded in earnings within the next twelve months 393
Options | Cash flow hedges | Other comprehensive income (loss)  
Derivative [Line Items]  
Unrecognized gains (losses) on derivative instruments $ 2,689
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Details) - Fair values - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivatives asset
Deferred consideration on acquisitions
Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivatives asset 2,689 2,655
Deferred consideration on acquisitions
Level 3    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivatives asset
Deferred consideration on acquisitions $ (7,068) $ (6,745)
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Details 1) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Business Combination Contingent Consideration Liability [Roll Forward]    
Acquisition-related accrued interest $ 393 $ 345
Fair values | Level 3    
Business Combination Contingent Consideration Liability [Roll Forward]    
Balance, June 30, 2016 6,745  
Acquisition-related accrued interest (393)  
Payment 70  
Balance, September 30, 2016 $ 7,068  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Segment Reporting Information [Line Items]      
Net sales $ 187,987 $ 187,120  
Depreciation and amortization 6,318 5,429  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 17,572 23,492  
Interest expense, net 3,907 3,819  
Depreciation and amortization 6,318 5,429  
Acquisition-related accrued compensation 420 420  
Foreign currency (gains) losses, net (334) 5,453  
Identifiable assets 598,084   $ 607,835
Operating Segments      
Segment Reporting Information [Line Items]      
Depreciation and amortization 5,658 4,678  
Adjusted EBITDA - Total segments 37,349 34,722  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 17,572 23,492  
Interest expense, net 3,907 3,819  
Depreciation and amortization 5,658 4,678  
Acquisition-related accrued compensation 420 420  
Acquisition-related transaction costs 1,274  
Adjusted EBITDA - Total segments 37,349 34,722  
Foreign currency (gains) losses, net (334) 5,453  
Identifiable assets 516,187   524,247
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 124,501 120,134  
Depreciation and amortization 4,898 3,876  
Adjusted EBITDA - Total segments 32,619 31,476  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 4,898 3,876  
Adjusted EBITDA - Total segments 32,619 31,476  
Identifiable assets 435,512   444,751
Operating Segments | Mineral Nutrition      
Segment Reporting Information [Line Items]      
Net sales 51,592 54,469  
Depreciation and amortization 542 608  
Adjusted EBITDA - Total segments 3,988 3,160  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 542 608  
Adjusted EBITDA - Total segments 3,988 3,160  
Identifiable assets 59,687   57,939
Operating Segments | Performance Products      
Segment Reporting Information [Line Items]      
Net sales 11,894 12,517  
Depreciation and amortization 218 194  
Adjusted EBITDA - Total segments 742 86  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 218 194  
Adjusted EBITDA - Total segments 742 86  
Identifiable assets 21,557   20,988
Operating Segments | MFAs and other | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 83,419 85,521  
Operating Segments | Nutritional specialties | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 26,304 22,370  
Operating Segments | Vaccines | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 14,778 12,243  
Corporate      
Segment Reporting Information [Line Items]      
Depreciation and amortization 660 751  
Adjusted EBITDA - Total segments 7,524 7,015  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 660 751  
Adjusted EBITDA - Total segments 7,524 $ 7,015  
Identifiable assets $ 81,897   $ 83,588
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments (Detail Textuals) - USD ($)
$ in Thousands
Sep. 30, 2016
Jun. 30, 2016
Segment Reporting Information [Line Items]    
Equity method investments $ 4,040 $ 4,076
Animal Health    
Segment Reporting Information [Line Items]    
Equity method investments 4,040 4,076
Performance Products    
Segment Reporting Information [Line Items]    
Equity method investments $ 428 $ 504
EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 57 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 80 177 1 false 32 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.pahc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.pahc.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 2 false false R3.htm 003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.pahc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 3 false false R4.htm 004 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.pahc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 005 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) Sheet http://www.pahc.com/role/ConsolidatedBalanceSheetsParentheticals CONSOLIDATED BALANCE SHEETS (Parentheticals) Statements 5 false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.pahc.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 007 - Disclosure - Description of Business Sheet http://www.pahc.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 008 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards Sheet http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards Summary of Significant Accounting Policies and New Accounting Standards Notes 8 false false R9.htm 009 - Disclosure - Statements of Operations-Additional Information Sheet http://www.pahc.com/role/StatementsOfOperationsAdditionalInformation Statements of Operations-Additional Information Notes 9 false false R10.htm 010 - Disclosure - Balance Sheets-Additional Information Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformation Balance Sheets-Additional Information Notes 10 false false R11.htm 011 - Disclosure - Debt Sheet http://www.pahc.com/role/Debt Debt Notes 11 false false R12.htm 012 - Disclosure - Related Party Transactions Sheet http://www.pahc.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 013 - Disclosure - Employee Benefit Plans Sheet http://www.pahc.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 13 false false R14.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.pahc.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 015 - Disclosure - Derivatives Sheet http://www.pahc.com/role/Derivatives Derivatives Notes 15 false false R16.htm 016 - Disclosure - Fair Value Measurements Sheet http://www.pahc.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 017 - Disclosure - Business Segments Sheet http://www.pahc.com/role/BusinessSegments Business Segments Notes 17 false false R18.htm 018 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies and New Accounting Standards (Policies) Policies http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 18 false false R19.htm 019 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) Sheet http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables Summary of Significant Accounting Policies and New Accounting Standards (Tables) Tables http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 19 false false R20.htm 020 - Disclosure - Statements of Operations-Additional Information (Tables) Sheet http://www.pahc.com/role/StatementsofOperationsAdditionalInformationTables Statements of Operations-Additional Information (Tables) Tables http://www.pahc.com/role/StatementsOfOperationsAdditionalInformation 20 false false R21.htm 021 - Disclosure - Balance Sheets-Additional Information (Tables) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables Balance Sheets-Additional Information (Tables) Tables http://www.pahc.com/role/BalanceSheetsAdditionalInformation 21 false false R22.htm 022 - Disclosure - Debt (Tables) Sheet http://www.pahc.com/role/DebtTables Debt (Tables) Tables http://www.pahc.com/role/Debt 22 false false R23.htm 023 - Disclosure - Employee Benefit Plans (Tables) Sheet http://www.pahc.com/role/EmployeeBenefitPlansTables Employee Benefit Plans (Tables) Tables http://www.pahc.com/role/EmployeeBenefitPlans 23 false false R24.htm 024 - Disclosure - Derivatives (Tables) Sheet http://www.pahc.com/role/DerivativesTables Derivatives (Tables) Tables http://www.pahc.com/role/Derivatives 24 false false R25.htm 025 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pahc.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pahc.com/role/FairValueMeasurements 25 false false R26.htm 026 - Disclosure - Business Segments (Tables) Sheet http://www.pahc.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.pahc.com/role/BusinessSegments 26 false false R27.htm 027 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesandNewAccountingStandardsDetails Summary of Significant Accounting Policies and New Accounting Standards (Details) Details http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 27 false false R28.htm 028 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details 1) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesandNewAccountingStandardsDetails3 Summary of Significant Accounting Policies and New Accounting Standards (Details 1) Details http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 28 false false R29.htm 029 - Disclosure - Statements of Operations-Additional Information (Details) Sheet http://www.pahc.com/role/StatementsOfOperationsAdditionalInformationDetails Statements of Operations-Additional Information (Details) Details http://www.pahc.com/role/StatementsofOperationsAdditionalInformationTables 29 false false R30.htm 030 - Disclosure - Balance Sheets-Additional Information (Details) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetails Balance Sheets-Additional Information (Details) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 30 false false R31.htm 031 - Disclosure - Balance Sheets-Additional Information (Details 1) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetail1 Balance Sheets-Additional Information (Details 1) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 31 false false R32.htm 032 - Disclosure - Balance Sheets-Additional Information (Detail Textuals 1) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetailTextuals Balance Sheets-Additional Information (Detail Textuals 1) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 32 false false R33.htm 033 - Disclosure - Debt - Summary of long-term debt (Details) Sheet http://www.pahc.com/role/DebtDetail Debt - Summary of long-term debt (Details) Details 33 false false R34.htm 034 - Disclosure - Debt (Detail Textuals) Sheet http://www.pahc.com/role/DebtDetails1 Debt (Detail Textuals) Details http://www.pahc.com/role/DebtTables 34 false false R35.htm 035 - Disclosure - Related Party Transactions (Detail Textuals) Sheet http://www.pahc.com/role/RelatedPartyTransactionsDetailTextuals Related Party Transactions (Detail Textuals) Details http://www.pahc.com/role/RelatedPartyTransactions 35 false false R36.htm 036 - Disclosure - Employee Benefit Plans - Net periodic pension expense (Details) Sheet http://www.pahc.com/role/EmployeeBenefitPlansNetPeriodicPensionExpenseDetails Employee Benefit Plans - Net periodic pension expense (Details) Details 36 false false R37.htm 037 - Disclosure - Employee Benefit Plans (Detail Textuals) Sheet http://www.pahc.com/role/Employeebenefitplansdetailtextuals Employee Benefit Plans (Detail Textuals) Details http://www.pahc.com/role/EmployeeBenefitPlansTables 37 false false R38.htm 038 - Disclosure - Commitments and Contingencies (Detail Textuals) Sheet http://www.pahc.com/role/CommitmentsAndContingenciesDetailTextuals Commitments and Contingencies (Detail Textuals) Details http://www.pahc.com/role/CommitmentsAndContingencies 38 false false R39.htm 039 - Disclosure - Derivatives (Details) Sheet http://www.pahc.com/role/DerivativesDetails Derivatives (Details) Details http://www.pahc.com/role/DerivativesTables 39 false false R40.htm 040 - Disclosure - Derivatives (Detail Textuals) Sheet http://www.pahc.com/role/DerivativesDetailTextuals Derivatives (Detail Textuals) Details http://www.pahc.com/role/DerivativesTables 40 false false R41.htm 041 - Disclosure - Fair Value Measurements (Details) Sheet http://www.pahc.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.pahc.com/role/FairValueMeasurementsTables 41 false false R42.htm 042 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.pahc.com/role/FairValueMeasurementsDetails2 Fair Value Measurements (Details 1) Details http://www.pahc.com/role/FairValueMeasurementsTables 42 false false R43.htm 043 - Disclosure - Business Segments (Details) Sheet http://www.pahc.com/role/BusinessSegmentsDetails Business Segments (Details) Details http://www.pahc.com/role/BusinessSegmentsTables 43 false false R44.htm 044 - Disclosure - Business Segments (Detail Textuals) Sheet http://www.pahc.com/role/Businesssegmentsdetailtextual Business Segments (Detail Textuals) Details http://www.pahc.com/role/BusinessSegmentsTables 44 false false All Reports Book All Reports pahc-20160930.xml pahc-20160930.xsd pahc-20160930_cal.xml pahc-20160930_def.xml pahc-20160930_lab.xml pahc-20160930_pre.xml true true ZIP 62 0001571049-16-019689-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001571049-16-019689-xbrl.zip M4$L#!!0 ( )V!:4EH$K.7):, $8P"P 1 <&%H8RTR,#$V,#DS,"YX M;6SLO?ESV\B2)_Y[1_3_@/7TF[4C(!K@3;N[-V3)?NT>'QI)_7HF]OL-10DH MBG@& 38.R7H;L7_[9E853H(W" )DS?2,*5R55957965]\N?_]7UJ*X_4\RW7 M^>6%WM)>*-0Q7--R'GYY\B2@IA+Z<%]Y M_Z^S_WIW_2EZ71FV-/Q?Y7_K^FNM^[JMZ7U%Z[WIZF_:NG+U^?]7SLZB3[TC M/GP&WF$?:+?TY!Z[F%;B>\@_1IM[JLS;A MYVU(?9,\J\H7]Y%.[ZFG:$-5X50,W\!_W1%0(1KZ?N_9UAO\_PJ,@.._F9&) M\X GMQ[NF%;^0?KC_FM^,'YW[]%.'/:N/1J/7[&[\J&\5/0@?U5__U^=/-\:$ M3LF9Y?@!<8P,+=82VO//6[[;;>N#96_P)Z(7'-=QPFGQ\V;@O0Z>9_0U/'0& M3U'/,N+W5K^4?8$-7% XJCT^JD'TJ.&&3N ]9Y_UJ=%ZBL.@]<;?@19-:Q>_ #7R\FWVR!D%K\S)OX]FT-Q MHZ#K< >9P2]\A]TI>.F[O81__^M32JC"P%OXZ.@UW'V!J@/%\(W/!.R:CA4F MEF^(9WBN39<+[^N9Y\ZH%UA 9TI-L \@];^\\*WIS(ZO33PZ_N4%*J*S2 FU MOOOFB]>1&KUPG8!^#Y0;:@2H#3/*S1 W+?.7%^+!NXO0#]SIG:;?W=#9'7RT M?:MI=_R_VZ]W'6W^^HODBZ"0K> Y^=LR\0JH9T]AXY'M?C3]%Q__X\6O&B@F MK3\:CD8_O\Z_C!]\7=P"C);EFLG?H)Z\X!)L$%Q"*L^T$4QV\G[Z?DRTF7NA MHZ4;C.Y&5Y(F7V?&E>>Y1C6C-A?G\#SX4\L:H)]\\*=SBA<81<<\QTX3&,K^.!Z-]1[M SJ M\V]4,_EB[N@#=B:Z8$*3WV>V95@!IT4Q+;C/W3^A>-^L/XHO?HW>V7(X?WY= M2%49Y'+Z4'N^67->EA#S>FXT3TZVX$7?M2V3C>+'@$Y]QO-?9[@H@/7 #1\; M,99W-P%0B1?>X6J!^GYTG[UU1;VQZTW1V;SR7#,T@H;(1O$H)'*P8#C*X/.E M(RHX?>&X2M[>@K:$OLW2NQ@Y*C2^#HXD&57+V4JSU8AP0?B&'9EECJ MW5)O^NZ3"RN#AG#E7!<$/^0[(CEA&2=\@92S(K%+/9NB'TSHX8%\VC1;9=0IR-PRX9-BIX4O75$ M[Q_$,'!NI;"M$+;L0$GQDN*U4RRE[I(@660UBWSX[Z4L\GOHX/5^PCKS3/]/Z M>^&=<] ,XV(N6< ]MU*MZB;QJIRQ_D49UUN M(-=",U6S@7P:S"GW@QN]'UQ?)I7;N\F];#\SI M;(@/LSP3:6G73FKF=_!J=.G5;.75Z-*K.0K^;TO^WXK_VY+_Z\/_E]#0(UB_ M1Y@A/_ 8J,FUY7\3D;6462Q\U/\[L9Q/+GA-S[]1\\%R'MAA5WQK8LV$&^%/ M/MCND[@O/G;E^E:\P8S&NAG\OVRX1) D,VAE,/EVXYYV=@HFH S"TG.8-)=, MIA2DJ@7I9N)Z#=F/DY*T4I)2LWE2HB1SU1H]XSPW\>SWT#XKF.^S&SH[RZO. ML>70"/7BRB:.G_AD?L%=Q@Z7[I2"5V=\<1VDPK/NP\#UGG./\]G MRKD%OZ_ M.9[91$UM,1Y"9VXW*A4DM_4W2&[CCV-:9-F);17QYC4-++X6N2%XX,WO:OI_ M'( )#\*"*SI_8KP6)>#.V3V1HUW3%,H=1C1ZH8K,]]6C*B&W).16O2&W&BQ; M,I^Y 4E9AX3<.C[>E@G0DDUDQG13=-]!(+"G1-91H*8V'E\:&R5B;VT3 8_' MS$C$7HG8*T6O/J(G$7LE8J\4K^JW8NLN"9)%JM[7!-=YZ>X/J&K/(O'8X3XJ3X\..\SS;A$,?^?.!H_V>"%U[D&2>>1,RTPZ* MFUUW5I5IXZ"@2,L=[+A!;6==HJ7+V99HZ<?UB:L#M#Y4I D=/ZQ M2E+%T/FU$269-'YR,[YZW_1T,[V/.I_[N%CRZ)*PCR/5NDHFT]IW7]S'>28K MO"XWV/8_V[I^IK6;,]MR@ZW&LQV?[^DM* "57*_OF8C>?JMD+1DD864;,DB[ M6(G_<7:F_.%8@7)#6_W!\+^OZ5_6 MKY\]VW]^LC[^7[S7[_;>&-UNU^CU>L;M_YG\^O.;M\/1^Y\_ZF][;S_HP]]^ M^TW_^?W;]_K;C^_?C/I_[_\V_/DWT0BG)L3F<7K\"?$HR*6X/N51\U^%P+&; M40^B>]'?^(V"+_YQ44?7;= ;Q5L;CN/5]=7\ M+/-#+7!GU<>0,]_;3*5GF/9GDUIOWC/1N:8/EA]X( 5?R)0J@MVOZ7B7?;G]3+KY>7_W\>E'+2&YR[P(H]HC]T3'I]_^@ MSR61E=8I"]N*"+GUB(D+^.?IO6N71 !.'&\Z\_6H20'6^,'R#6+_-R7>>W[Z MKZ36S[B-X 0L:BL[#Q\LFWH7E'3_KY;M[]M;3@<#'5]T_Y>N@8+VV*"3TE,IFMG_\G)2'\\W^ 5L_;E M2EFR&LVVGVDK(N0<[IAX]X--BB=UA_@"M^>=T?9#N> M:Z>8##XZ91+RGWH1&:EVD)!4>C!U0KI.VVLXP(F@H%.5DI*S#BJ%@=X&2P3L MD6]];Q15=4QY>Z+I"6 M2P=FV.NU]3H,S$%!")<.4;O=&52M&NL %K="C;2[G3('90WKNTJE5$_2U8=S 8KAR4"]C; MV="V^Z/A<%WZ_NZYO@^\,+:""L8.5636!TBUOSU9NPY97QN-1NN0=4-M&]CX M[Y39!]"RY^;4:7OIS*[#WQGIP_Z. MG8E53%0 Q:\B+-/6A[VLJ!70L3N9NPXPD)G36"O(9.E?U _X73'<7V@5*N*L M,\RY"XN(*8G@70?WK#/*Z;1U"/[@>M1ZQ5ZN=O+\L<&Y!VR5Z4Z'/4*7;.<$&@1 M1 '%_#7^'+Q,_???P6BYGFDYQ'MFW?CB.CA GLML7*0LJK!6X#.T>=DRZ WDL.U;$1YXE.%UX0Z] ]>^FC5G=]#)^Y.%I)1#[:YB MT.N,>IM2"ZYEI:L>?3C(>4H9"G8A;??@ASX8K$?:>^(YP*S^%?58C@D"!QA[ M&+U41F.*V/:+7[56=YC064A.&?1N.J1+Z.WH.]![:=DA9F]5.\*#Q10+@LJA MN:)1+J#Y3W!D)W#M_!$4]@/]$J(5^#J>RYO:"W_/YW1I&,_11NVD#QL1N,^> M;31'"WK6U8;[ZYF8W?42]\J>-5@@Z:MG;1&)^^U=&3,WTOJE]"Z5FWC)E*C^=NG-H@K7R7%__S]#8EOC9YC4NSH?1!XUGT8X!G%6_>*8,9S%8'/[DC+!6GWU9NZ#-G.&P?=^HS7XHC2 MN6.ROSB6Q+GYS] /V*9J3?@.7.;V:*V!W$\?:SVZ.X=?AZ/UA/IP8WL)ZTF' MFF)A>64C,%;MF+0S7%?6=^Q,749L9\8;Z/WUI+J2(^?]WT%/J[K77VCP=7QXO=%N]_KMM?N^!M'5]G]G#ZG77W_F-^Q]P5>B M+U1C$;2L?EM"3WED[QR@[ TZ@ZW()OX$/ '\Y_U?(?BS-DO$"RZ(YZ$_R]!, MEYSP2Y )YKHP=WT%3W7Z6C9&O19M)7=F_9*4*Q*INOJ!.[,1EL1R/3]JZ_W: M=F;3%#=]F#OYM7%GS@W##>&1:VI0>!ST&$B6.,-U0I=5>>.Z->\(RKP0!T+NK;&:X'*Y/H]J#3SD9.EM%4#NUE23S0WNEO M1?L'"[Y+/X$G:'YT N(\6*!D^2Q5-?) >"X%83E199%?TN#WAOD,E_7)QQ,2 M3Y9=#-Q2]CBW=3UWLC=J?G.2RM*P:Y&4TKJ8]U.A?NWUN_V%ABJA94=BRV)$ MO9T[[[J26'ZO(BD?##N] F.P-WIJ<1BWK>7/1AVHUXL+J*\X3-FK!_W5'"7N M=KN#7I%#U9#^;G60>##*)2S6J\LKJ&]WV]U!">27I85'0RVW=;1G>NJAY_1> MK])9*%O/Z<-1+>BO2,]U>CV]W=S^;J7G1OUAG:=XE7?7UU>2CP5P;D4=RBKC M$.W\B<0"0G:BLZSU1C[C:06=4?SQBCQC\+'*(>W#H\7!T"PQNY);EMGKM@?= MSXF)Z2B"ZI&'N=O7>:'.B#S3$NC8\F$4U6H%M[A1IL#0INY%:53G'%6 LX-=O MU5%4Y6S3KK#HJB93J UA2+%*A6U%6ELD<]6!%O@YEF/QO!7R1 M 2SMXLG4!^H8^QO#[[[UQK'L7UX$8,-?O"Z%F*V';04QXE@$RWE8#^.[1%\M MG\"TB)I2B"Z+\;8A^LJC8PK2;%8YV$MF?A=Z]L&)YZ8I(/6NB&5^=(3A28UN M-9ZM/FSG$+Q64U9F/TK+N=FQ']5(. UM+)N :=Y&17YQIS/J MY\$P5Q%69C?*4AEM?92'(-RD&ZF[Z^3=5C(U9WU],.SEUZR;D+FW'I8T:V>] M8;M=6@^9B$UCUD;07%%D[*G::1UA]F5Y3PANY!9VE*]W1[T-Z SY>N! M'W6@P2W8_%Y%5WE]V-_&UB9]2-F/*^)]]5A\WV0.173 MJSMQ2W+XRP\)=S% M4\)8E:G0FUO4FSIW?KY63IT[OWY Z@AGON3.'VKF.<+!>1A,7,_ZUX(C_M7) M^H+24!U-R\=7E_2ACEU=NPI6I_*>[EV,ZS.I>Q?:O4_J1]\/ZRJE2<&Z%>37 MK8=;E*C;=P\/)935S>&A9+&<.2P_^%?]1*Z.SQZVKV5.:>E]K;& UKVO%C26W:LMHPZ5]6I/7OH:@M7/^VC+"2NK"]M,2$5=*-456TW^ M"KKGK?*V-)=Q.T(7TNO[LN,[(OZ2SKSX#LL!P9^VU2@:IU/$>CD M7^QZ)44V&M?OBH[: M#4<-YX\*C^CEOK1\?A2K@C5' M_M3&NJ3MJ3L[GWS(U9W9ICN1=%RXTWMX@6],YH_N%PI>64PC;97IEFC M#V4SS:AWZ!Y]();'MK_>/<<_?[- G7K&Y/D3?:0VZV-\[Z,S"P.?W>@(GS[U MB<^4^*'''7SB6UP[O_<#Z') P?F)GHQ_H/=CN_C.>B5R-^#B2Q%[/UQ5QT[> M15]*4+FT[YPT/]#RHC, MHU17(0B]',>L0]<>^K'S''1&.>6T>TW2.I16TM>=HU/=SO[[&BM% M#C)1V41V5[)F(67[Z9+Z>F^-2=J Z(H'8./*ZGXM7-PTQ\YN15F86AUIN;E<2578/=C](KNN[]P 6R/"8 M0:GI?_#<*9-<]%7][)16(FXYV[XAB?OMWX MCNY8D^1*.U\"BLEP+<6Y1>?3G)+&=^G.W_N M8H,N7,-2D OOU_&A9H&%T7,(1RNH*KL+.^^VZZ5W(8NB>4-A#5B5]1KDXNF; MD+?';NTZ2?D*\]MV*RU@>,@&DT-A5E? M)4[1?W17%VRY305>11?QY<6JG'' MK(*K.J-;?K+"_S*&;&M!^>-8M-Q\%:QP>\[FU#K81*\471]!I>>+--]\M\H M[;<*>S[ S7P\:?)&<5R'OE7&0,X9^R)>\6 \WBI3XCU8SEG@SMXH&GZ%O6HY M8)0"O/)=O#8F4\M^?J/\S\":@F?ET"<%W +B_$]585=4Q8?1&@,5$RN@9_Z, M&*R5)X_,WBJN-P/9X+2)%N_=('"GHM&Q[9(@[AH- NJQ3X"@)*0:KNUZ;Y1_ MXVYQU!WK7]".WHD)?1)CF;RI:0[C\2S"/S+(.1A"OVDF]K[W=Y= V=@4S_^D&.3#%-H6_/$/ OP.8LF:Q=^X"VD^6'=Z39L M2CR:+S=#5Q+KW7(6?M5+X82LE.J>&DO>2S^&PW=;$P_$%'8="2=\__^TB=?>5 M0AQ3L0)?\<-[WS(MPM(M7L+8V)1%G>UG&/ )37\# 7R)\YSYC.4K1 %^H9YO MC2UJ*@^V>P_DFIA0B>6759AZ)QP3 P?'8\T"+WRC,#6H.H@"9!-3\= [81=X M=R>\N^QQ?HA*<:)35,I,G$R$$?;@_UQ3O.4KEF/8(4-'F+FA'7C0"?\)WE<5 M@P2!#?^:Q/*>V7?)7R$QX"&@JZ7<0E=%_UB?;-\%VI:2/DN.2F8I"L%/L!PV M>O",CS#BT+P'C9,0S(J+PZO"$V8(,V_AS0F=6@;\P";B/X!B8C_[0?PD]5O* M'XX-BE9Q,=3\9+&&3'@Z@)&'EK%)8>,5C[)]A-2S*EP;4\REHSXG$'KJ4>"G M0 G<]$P_437-2JD[;N@MNA7ZF3O8%]\"82:>0K_/@!*?^2",!FQ/\'<1([:D M3JJG3D(Q"1T"(A;PE%!Q>@7^&/,%)3"NY3"Y8*(Z%EP93#Q*E2FT/O$5"D-L M*N!9!BQ'.C%%'4U5T-ED3(%K 16%$7D'I@19G$N53Z94N<=\;(7X[$K2N!\= MR(R4 ;PFA#&GO_3!6Q^TJQ/"6]=<"N#['X!T1=?._B,F?6SY*([/%!F94?Y[ MZ- "HE_F]&7FVVFMJ<(W;?C.DP4J#E]*A06QY]%J36$%4)C<(&GGX0/H@:3A M]BAJ^ -\#N:QI6B:?M;I=W7M54OYR'OMSBQ'^&G LN2!#0[3[?[R<0,E"!K) M_">TR:\[%!2'3T!]XM 090RJ-'D/&T@^-W/Y,2/4.3XH61]ON\E*A&DZ6-&@ M=_WDQV-MP31[UA3U)JQN0+#P.;R1I@-QMYCIX)S+GO%P!#U4_ Y)-'I"3T0% MHQQU?*8A]DG'#>(N@KA'FA64-;:&1*0_PC@CM#E?\-8RX@!&D%D&?T)ID!$) MPL:BF(=4Y0ENFT#4(XH4:!G>^^4"E\R=BBK(F,13R%X6B3S8:D[G9KZ75L"J M8\0D'/[(QT-OGJ!EF>V$B#&L&EDIYH,QXV^P^"GPLC7\X MK$OL #6C[7P*W39(QJWY^_GY55IR^$!OI('\"7@"0"%.'V&MPTO_#!V62)Z( MX,JA98,&@T&9QO$H6+"\@LD(O+1A-;9AJV=[5PGBG(JA'::^GR84N0:=-!0H M8)[4F_ UL"P!5C&(O3:\;9E"7W+E_4_7PT<>729D3(-1'V4>5,83164-II4% M_%!GH1_HN;;B/E*NK7@+:!?@14/XND)-<>X.DA,6OC(A\)%[2H$T&]PXAZ1D M=^7P99@_%8N>"TEECD%X#^#'\X/E%^F#L>SHU=?Q%?<#^"41:QA)9R!4L\+UI2IF: KREQ^%R,2F'@4RSS M@-?\F?"C4KW@+ MS>-68=Z>RM?!GA=I7@-+%C"3%ZG;P@'FH9Z)I8RRPL('GN1X&&$2(-'9:A+.2ZJ+%U>#* M@( T:?71@U^ &SG. S*/PJM:(!?\R4B#Z3Q_!$%YH/R6M&,D1EIW8*S MR1#]<0L-K)G!2_&B4C,QL9?ME22/PV64]J=HUHF8=2=$W8TJQV#)U?R;H')2 ME0A2OCG78@[_7V:)$>*G3K\0+*'!L9I"F32[]0S,',""/39Z05W)MR>#[MN5N/^ M6)JH#$W,@N:WC*)A%NZ.N616"D0I8'@!0IAVEIQAL<$4G-/5_O96N463H*T_!H&[+CNCJAW1KTHCF=8\.%+)@%U>D1(Y-=BFDAF%=TAO M%S%/.QHW]'$E6YP@6W2+V**;8HO>GMEB+[:2=22?FI,DU M[6WG)>_JWL/263'=\-X&F9C"$EM0T!&S72!BI2M-I/:GTBAOZWN@NU"@%W9& M;ZOZ8%!_EFB,?/2E?!R5? S50:]3?Y:HD[\BG9(BIZ3 O]W.(VEOX9'\N7B+ M1.Q=Q$D#^EMVL,V0KLLVV:D-P9J5UM6/]9 M;0R+5V%J)(MOR.+:J%W_6:V3 R$#'DN=9CX6BW:[]KJYT-G<];B,9W;V1_Z!%IMQC[JC98Y08UGFQ*7T@.$@ M*:5[D-)16SM&EEDH0+7P!T_1Z:LPH+3-%M=F 2615"I#2HU8;P^:M]X>I-?; M(ZU?_UEM#(L?94BIT2S>U51-ER$E&5)J@'<1.\Y?"LZ3'(-ZK*\'L/B4P?[( M6UL[;D;<:OW8R'EM#)/7UP>03%[W>:V3%R!-?16F?BZ*D#D2J<=S+]-,FK)@ MBJ=V66[?X1=),9E:JZ/7?Q(;P]'U-?\GQ-'='?.D3LW6RQ5_0]P N3D@U:9T M!!K!T=(1J %'=W<\KM4<1^ U0Q7P-ZZI0:V9J(O%KER1YP3R M/$'NG_'*\[Z"D/KXO1@^/X:-GL=]-D13F9)$*1SK#'1U'CR9X1 #8::)521ESJ+B;UCFB.-V@Y*E]P%"&\]$GQ"CF5V#687)"BU_PEI'^&E@ M7"S% )?YE73AIOC]*<'Z:0S:DD"KO'H1:M=[+*W$ZL*AI?!<@U)@@1BVTJ=8 MMS3JJ>7XH<=Z $-F35E_H5_(#5:Z^!,O<\=*5.3Q-7WEGH*\.GB%TW,),YFU M&(AE"=PU:"GO"5JL= T$+,B(&.@@@28K/66[^"6?@5^RN>:8U"$H #Z[\:@S M:&'\%&6E04,;.)XRZ&@^;ZFW\Y46V+M@ONZ3+X0,WIKDRC4PAN%E8N%!SR7& MI*7\R=\78-J1]4S0M(GIS@H+/""R-IK)S0I>255;'U4;*TJMO86B_(08\[%> M'';;^;(D?H@E?JG)JP(J6(021=5FV/2IHBT)'S-P>E'D+:G[QDJ0&.Z# R,8 ME0; 1VV+W%LV+PV*0HW%DR(&1.Z'1P1P/_QEL36TVJH:+)8B*=+L_% MG-5D+;' WFULY2(9SM; 3E8]+G00JTW[TAI*/= [T[99^7^,"U#Y\1&Q]MN_ MNZ[Y9-F\&M)7K#.5NLE*](&K>/8'\-^-.PZ>D/62>GV=GG;6S2F3A+!X]1]S M8.)(,BL' AK$"WG;#4TFDF&0]S"Y;(S19TY=CE;R<%OQ(]J@MUC B8L)2@(S MO-+,2O':1+P.6^\R-L8LZH01+1[V87:+!T)FO!XV-YR$ESQ+E'Y2ARY:0SZG MBA[SBF;\:ZPP2;J,5[K6*2LZQQ>D+3!=\[3 /1>8&QM"2\53A-SQF8'6-LB* M\)0\BU!9&$5SXE5O07/[$M^T,YY22ZDP$D:DBCJ;VZMIJUV-UW^!G[W.$"=B M51U8?/KWT*%%]V!"8P+45*72A3,-0X;AMS.L2L@YI4@!92(!4O747/5TE\?T MM]I3RPQ^KR.WT HVU>/5/4CP'XY8];-E$+EW<9O 4=ZS8%VLW+'"XSE7K:C- M+B+-QH3T[RZJ*+@&7W)2ZKZM]>;RZ 5;2SD0* ML7ZIB)D8EF>$4RS[!8NVEO(YZ1QS-QW*RZ1&>R;X75C3\%T4'J+T1:%5F)=O MCOODB$!FO*C#BVQ%)Y:EF3ZU%!AV;)W7#7-#MH%CH28'3](*V&:&Y]ZS#[!V MV**3AV09A6"A0H??QK4P'J-$,W#/&#"]*;5J>%O 4]&&"(J9+W;[>'U9M@*V M(N/MSQ&-9S<]6(N2@'FZMO6-VM8$O'9F_WSR_H6J "@ M.RJ%+B+8H2\X @<%K0OT\>_GYU=LA8ME2Y,]+RQ&WE)2VBL>NJ7K8LI+P:VW M*"YXOVBMS JALR\R[\%TV<8>%G0%WWSQHACS(M#8DL2?C_#2I#_?;+T>LZ4V MVL*?OZ:/%-4JVXY%_>[!(H_+O'(1^H$[Q5P:$5+K:_V\6@=/'^3- L<+%0U( ML36S:5(N63B_$5-ZZ=:,;&M&U!K?*F6[J_:SB(CQ[Z(VP]+(R W6F%=G!,% MIN*AGY36PAA1W 0K7.@:: 1$76$J''1*C,F";W"3, 'O-+-W%;W\Q.ZPBM.\ MDK$/;_DLH$Z23( %GQ:F**(O5BZ],[V[Q2Q>TC'UL-BS^.[[6"U=0I]S4T:F M?!619IQ4/4E0@P25_1E3]F;NRXG"XSH_V7T<;K-UP6<6/O\($Q^"L\$R#"[2 M&0;9;(NWJ<00;9OUJ^ =[.E5:FZ^IE@'Y_T3B[# 4[G6\5Y"P3;;-5]@P>@^ MG=T8[HPJL'8&AR,5_[E"=L!#',I[T.FF-9=NDC1(;-\MFLQU"6EE:8];0.EC MGQ54>>E91Y]+&% FM?,\P60_1-!S2/&T5\_OP[]LP="9F^^>@_$$?7< M+^(OPA]8O]C_.K[B*UU^243R+ZEO>!:C[MPQDZV\*W@9?8];4/_O0']]^_7' M'WZ.&CJ/M[CC9*N/#N-GO)IX^_'+3-O ']=T_,N+"_[[KO/Y_9VFW_T>VG?( MTK>:=L?_N_UZU]'N8*&?O?[BUYSE7U')M%%^!%P"LWE/HI"5^S5]Q(AVSJ%]GL5).XG\)(RHI!ES?7=2VYI!Y MAN S&$W=81Q%PP:%Q$[?33*9"DR8K,)^XEI 5F&4%YJT.0I]$J5U9@5FR10%;R K,3<:2 M.9 =W0,R?9RUA#MICD]5S/4]!DB-7JM?4TB-0T!KZ@->.NTHT#6KF-K&\/E0 M\OFQ\GD54ULG;Z#6)O]XX>,6!VLP.>B=8KND8%.CZ7JSOOY!99!;FRC+/:%N MM=61UJO_1#:&J^OK#9P85W=VY.I3L_U-C02"$5>EJZ"%*+[E.+=D:=^L]G8YA;N@CU8NZNC"K(J,*1>@]3 MA)#\5WQ*L @MX)AV/"DEW0FK<_2[*>M*=D.[$L3)W=\=B]Z?F3IRB MS[ ZH;2R_/\MO J.>+BNEW \.=5;G-PZC.U:G$U=RD>BWFZI>#=)1=] \0Z7 MU*.CD>M?8NF@Z# MUHXY\Y+./(JU#J/R)R25CGP,RK2^VU@2)JH!4]L8/J_O3I;D\P9,;9U,OXPY M',8OV&(7*^,^N&.L/#F#H7I6E9F--2_1H\ RH#,L*"-S9!J0/M! U*FN.N@L M2RRNR40VAJOKZTJ<%E?K^HY+E;;V?1JL7PFG M,;KSF#V"YF03QB3K:J^]8RJA= U.Q#5H)'NW>W)?0087RDNBY6/1E"3:O(/A MXJGG37V+U4.PAU2X S52$WLG\^TJS;=;:B,:RS0G+J]N1.GK@ "_X-\_OP[]LP="9F_.X=S^_O-/WN]]"^PSK?MYIVQ_^[_7K7 MT>YNZ"Q[_<6O(N!3&/V9]U:RSITN^,E] K>GO8F?-R7> P@9XS$]%B_+,:'K M."O?2W$%76\V 6(8;:+%C(2,;9<$<==H$(!>P$\PUHA(7>9/=F)"L_G)3Z!C MDB\EW=G*D53@X_??+!A9'",_\-QO]"P6-0%:UVVEF';-7X+#%,9B/K\^;.OM MMPD/*RG>G0_KI5AE7N:VXHMY-N#SEI;C;7F"MY#FB76GW+ I\=A"83*O2PJ7 M#94RP&I=FYDUIK12*GLWZ1T42Z\@KZO][:TB+"Z,J@W=@N]$ORJ;T(@QAT.D M+3^]HCO<3G;S!J- R \RRR_$./[R0GM19"S3RMJ@B'&14]>C.BW%AVNOQ ]U MXJ/5[P]6+,1[&SI1ZV^OX'/I0]JKXVE+]ST%:7I$R+FON&.F&3+GNT\+ V63 M&5]OCA-'LEL\WP4RRAX$ORR@TWOJ)81W-!5?OO>4UWM@"-XUO5_$)/UH%-%3 ME$Q2&R;Y/71HQ?PQ*N*/487\L9= ==%2Y@CS%O9B.-=-K]G01*:#'1^=1^!Z MU[.HOZ=06BR!_5(?EGLD-;0ZD>;9+CF^8-V M=S]$;;(9W5<'PQW#O57,9&/8>BC9N@YLK:N=_LZ[&)6Q=2UR))KJ>YZ@:_"G MZWT[ X&;>:Y!?>D<-$J+;DI<#=3I4!UI.Y9OET["B3@)C6'O'W](,[@VZ-9_ M3NOD+IRB3U %&/W^O(8/EF/Y$VHJ#ZYK;G]RIKD!]I+ P?4D;^)_M]3 M1OZHKXYZRVK/-Y9Q3EQ6J[#)4E8KE55=&ZKM[K(4[L9RCL2(;Y K6,KIFDV3 M>HYK%7Q 3^KHS@X<3C.G^Z/WVVJ_N^-"6D:*ZN'!2!G9DXP,U/YH9\RWY@6; MFG/"9OF) [TM!G['HRA:JQ,S8WFG4;8_>="0U'2Q8B:^8 ME@E?"!0#NOU %3/T@!@EF%#X/X]290H-3GR%PCB;2G$*K((YAJWYL-B>^: _ MQP2IL:^>"^HZY7]2A3X2.R0!5=S04RSGD?H!'E_SX3>#'PZ>E2D-)JXI;E(8 M,9@)Q9K.B.7AHXHU5@S+,\*I'W"^@3&'%42 ;$("QB]C>%;!EBAB#>&5I"F8 MN&?EGHHO4K.EW$XBE$,%5D;4LY^1[XCR4U?5NEI$5NH+Q*.*$7H>_+;AAFE3 M7.=194(>*1ZS,^P06337KN5S[DY>%!2H( (^/.\ZK$:Y$<#O<8A#KR!&,PF0 M'(/X$SR ]N0C5/-K&!+3\F>N3VS>T0*F+_?@SK!8T=7SX([>[P=&R]W!'G)%3\PID**$Q#L.5YXXI"R406QE3&420^G3OJZQ>MU__ M&6T,>TMWH6[L/=@Q1G9J[H+T">KE$WQT#'=*4WF* ?DN'0.I.?>]::NV-;F[ M(!V#(V5O71WI,HX@XPC'Z3-9YP;1C@-V6GE"!?5G*I%-0>Z?@Q'BZUZO]/-;) M!6AJF. $O8,/K@>==T1U%>-989-I\P-)Q/QGR.L72G>A0:IUGZNM/>G8E]VV M.A@-\K';F.OYH.M=6:$Q@C%$?L;C10*71UIW4,(Q8DY M+-(KJ9=7\H?C4<-]<&"H3!CT0,%J<.B1/!#+\?GN!A7[&](KD0IX7PJXW5&' MVE!Z)=(KD4(1"T5'4T>#@[CJQ^B5M&48I2R'!0N#+]P,7.VT%";59E@I2GE: MDJT4Y?Z>\?'*)-3J,1^]O/+<1PL]FE?*/77HV I@-+PH>X-!R"$3_&YY"/P=_S$X;%= M;)MZ4[@%_V!N*W&>X8]'RC>BI/,CE7MERGVHZOV=T?>E%R.]F!-@]!-S1V1L M)C,U^6-,?"PV@]#36YU.I_G>3.+,[+AIM7I,]W!T\$"-U,.2[@O]:QEG[\'" M;(8"MLF.PH;]V'0M/=++3W9H*N^=N+17X$Y(:3^HM.OJL+T,):>I;+10IJKS M6S491MLTC";A_>IF (\6KVRQ"O[QAYV(WPRQ[&5OJ+;;/;FU=_1!,2E9NY&^ MH5SUL0CV0>2J@3&XIH$&1I&;GU^'_MD#(;,W-^%L9E/^A?8=00[>:=L?_N_UZU]'N;N@L>_W%KR*ZM3C4E?&'LNZC+GAH1T#$ M6!(S>(@E.)MIH$/18D8HQK9+@KAK"Y 0EWFL\SB''$"H6I1#G+M>*\6H:_Y" MQIH/,J;F?UYXMIKL^;GEDY$6R/TC6N;GT; I\=CZ8C*O% Z/7;E:::XU:UO( MJ 7ZR3)R,MK>@Y!N/W=UQ!K%N;BFCZ[]",TI%QXUK4#Y (W;5O#,RO[>8KK" M.^632YP-)K!=BI+MS\U?]Y#"5]<)_),J$_)(%:)X\50:?"K'T52^#"94$3#. M[;8F)CT"HH1+^MM7*@P5]:CR1!6#. A#Z[E/2CA3 E?YJ:UI*HP"C&IX_T]J M!'@1OXGI+(@RROX@#QYESH+*>(>PN\ ]8+*<.1)2G*6FR&!O!NX#9?AO3U8P M89^."%:5W&>R3&M1/]VEEG*;>A>&R5<(.#26P="1.:_Y"OTK)#9VJ-WJ:7\# MWF N[]]4Q7)8:P;Q*7;QT\=W7Z]99WQ&I1X]KA<^?H__>B2@_)6W[&;4)H&! MQ@=,W$O#&Q\LSP^43Q9UE"\4?E @F#P \7A:G?^6]-PRHJ\8B"883:.&0_; MR,-XKM$$7PV9(O/,^W(:1NBU%(:MK!0C^BJX7E%1D3ZA M0H4V,-?/MMCPQ2K-@)9@1(-8?X 8594H) M87"]C%UC/(TON&'@!_ 'KNC M#GI#A3R"]###@*D;J8:QE?FOSI/34L"K<.]1P@J>9PSM.*#S4> 80QO48P^# M+4$Q=CWN/H* AA[7&O=L&K#VL\I27AWVT"ST#+!EE),6@;XZP+A&@*8L]1JW M1J"%7"\2&9#S>>K0M!(;7G6H\@SK);30-O6E--55FG!:.174/"/"+K 4:0KF M!!T/G_'QG+RD_1"F:3NM=O]O[%87O0\5V-&?(9L^4OM9C3\23$#;*V#J@@FX M3# UYC)9WH1OY,JU0K[YA/GTC >*HT+EUD 9%,_)4SU+H&AM60*E'BD"L@3* M4C24_%:2+(%RU-4M9 D4R22R!,JJ!#H$>SA,"IT\^K&I]2S'I M^+H94N5\YEEVPC!MK:VOS:F-22JJHMAJQ9!)ZZ8,;5D9M%RPI#2Q[6%'[0YV M!)"6U7,S:4Z2N^O#W5VUK6GUGU"9A%^O$Z+S7MYJ1V)1TN;^ 4DOR(Q%(1&/ MU*9L]SJ)NI_@2FAU(S4Q:OLZY+5UZO-FT(^;'>XZ6"7TN%.;'.AJ#,^C;&4:K(;K5F2&3%T8&HSIL#QLR_=#EHAIN'[ LRW9==/R M#7##HG@PG9W981@, MU/Y(;J0U*Z8E9:1:&1FJ[?Z.)PN:&.%J&FCHGC$T=*VESZ-M2AR- CR$R]"S M!&[19@@7#*V&H8G!<_CZ+*H!Q'!5SF_^P,=Z9UI'S7))>M51 &K!J/HH@#PB MX!J]_?;C=!8&'*T)/A\]H+R\">]ASBU#&79Z9QTMNUYI,92'_#YF#A"GK7:U M/MO$T>1+ M(%X)Q+M4-ZB#D5CMGDAPK-H9]8L86 WD#>P0 MLV>_$U#A%RWE'9AVF)8I-]AHY6%8'BV#,K3/T$?K1*-2A\%,S8PP/"@ :40152$&9FSO 9405PSM;VM0ZWM/W12#&W]3TX#BEX M%UECVU(^>ZG^(=PIF$_P4L)@XGH(:0L=?'0#M*'$XZ."9M8/T+JY3XCM>/^L MO/OP4;EP6ZKRZ=,%6OI4L67ED4XLD-@(?3%NB_/>6D9Y XN;-M07J2$^=\SW M8H;>\8&^ M_ EY9:6NH";3#8PE)'[*4(_E(8@TDK+:VTM-)E0EBB5B?.,\=* MYM#$.,@,S=2Z#QG<:00['%76C:KHSD D&3PE I>:+HQ= ,M@>#MT\'9BP\4O MAI(,C\\\"S$M75@;&WD#JS,#VT%8=U>9PD(S!=+*\)[1"C+#21ZH"E/@/ 03 M_%/X$!R2%HRJCP/Z#=J<48\AJK:8"DD<@P3,/)P!7?B(G_]0A.N9=B]4)4%B MENBL-67MCXX"?L9S&E4HBAA-N7>'?E>:9]?G>&!<:EM3RV&.IZA9 P]#K$/ M&?[)N*66 P\C:K"JT/&8^XRK0ST<0)A1S1Q &"7PA3D(.,%4,A .>RK PED8 M+$5K2]DMO :>-D;AL2I"]-ETBUA&>\[!5H?M-A(7P2)/9QZ=X,N/-*K'S40+ MWQS[P&=(7R86A<3:%KGG52!P:*/&8^&%#]FAR4>!-Q2]@ CDB --;!\4B&M: MXR@^V-7TE]]>05.!4".*SQ"H?394Z4GY:@1N9E#T:$Q@[D73ZKSFBQ6>RI7H M&;7%!R,M&S.9B")V_L8@H/.+%T2'!W.*?Q.;'79 HN$/;_X3O-1%=^Y#*C Q M_(%&.:J $-$7!S4';WU4HZS-O/Z3JJVFJ@UDEB"\-,9VN8C"6-G/*$W48Z)J MA].9XH=3!:6+%T)3W!EC&"QL(.QI1J?!)X&#K1FNL=-*(Q&!M/9(K@H&6VC( M14$!"\0$=[:!X+G?K2D;4.4G71UH6AU8_Y#0V0T!7,;9 MP:HS,.T6Z'DCYIUHMI^(_V9^*LL%V!X6SUP] ;9'^FG@:Q?$@Y)YJD&&VX'1 MM;? $UF)_-#/)%5(V)^-?N7.P M[5F6:M%B"C'XI9;8) EVU3FJ-77"=BC"^4R.DB'X/XBJ*U?,N?"5]XO7R_,) MZJ>%/%AZ9N V$.R+=5/)C"*@UXM8FUWD>8 2FO\TV:);Q!;=%%OTZL@6\OWGLC&,/6SUCPUL91O&'K3:A^?L@3ZJ_V0VUOF0 M'L8>/8PM %+B8Q7,OTAV?%/@_M*/:("ZW1K;ZF#>1$QQK[L,,K\FT]D8WCY" M5V)[WCZ80Q&3W!]*;T*&,J2C\?9]E ;B4>BDH\0I)[Y/@_7WL!JCAZ6/42R[$= M@FE.7$ZK,/0G):<;^(S[$M1A]QBY1F;W'*MON8;GN!I9=J\)/LM.U,BPF(3@ M7$SYP?RV3"+0<$>$6ADBJX?+='SB<3!W*=T?7=5Z6OV9XJ#^3O5@MH.=P&SG M(;XVP>K*87Q-+08TYL-K"-P%Y%+'L*C$XY0H7\N/8@^W0/E*\1N+2F8X;M[; ME&!?P8)E2B/!OC877@'1G!7>]AZD]_A@0]X[CY;G.BAKQ-Y@DB2V2X63]#7T M4C F8J,&+R"L$4,L\\/[?U(C8"!4WP,!JS2FX(<26^5X**H"QIG8[&V8(^B4 MH]CD*<).?0AM_GE50!E9[)B.ZU/EP7VDGH-_SUS;9A!#;Y& @!K1=A+#$4I8 MZ2V[$/K0*$P8>6!P*ZIHR4:T*WQI0OY%/'")?2QY2'$C"N? MB!]0_ZU"+$^A4\MG0.YOE0>/4F<"KP)U#!JPH&M*32O>'T,?AC P+]9;? =Z$HYQS\R#;\,'8[PEWC&?>C4I6"EZ8TPY_8#Q^:#OT(G<>S_&]L5&UB37W0&T"T0,C%1[ 9'"T8 MKLQ8(=H:7 "?%;II,0"M_$S%^=_0UH1@\OR60!ADT$ "YBS=VQ!\$SL"+S*@*40R!+KH M%'&%.+'4;"G_ '.!&<#)0:E^(0O4)?Q63.A1E<08:CA+B*/&VV-H;(@Q!T-W!:+O M,*2F@N[@##"4M7OV+>04AL<&$N4(A<'FG_$%G:%@NR"PLP>/F(S!0,8$8AM2 MRL >Z7<0-]9YC]N!-.CCPO'C:)*)J%.\$G$/!646]0(1VW OW,Z*/6=OL#G, MWC!>QG^!-^"#L-:R?,;%U$,D:X1]8WS,5C\@?H2C\2W3,VST6LI'!W7+,SP< M\Q]3G\#S4XYB[2_K9J0,&'$\1AL=LP3+"!0)LGR!;FE;WQ#4*LC.$-XQK?$8 M69@)Y0PA#(V@#JA7TBDH< K^G%@V8\9[:EOTD7+]Y^9KL:3 M B0@)*[]*+2$]6@Q@30\AJ5I*QR&/)&ON!&0G',S@D-$VP;=Q^%$A\*'R8=V M&(HZ.!062)P7^4K4>0"/)-))H%9"%)6,I*H9,05J7T/K4]>QP(S@PW0,Y 1, M/\&:!V;5SVL.WW<-BZD -KH3T%_PJI&>&^$V,5(9-J5)&0@\0ME9Z+DA(!E\ M&SHA0/#9G#TSP2Z>,C:PS.-B5&;NYY$PV?A#D]0&FIA#"1IXRMIA5L<:/Q?H M654TP6&!U^"BM\K$?8)6/,9.!G& 7R+=PM\1)AAA\-&+9'";.#@1,*K)FW31 MS0T\%@<(4@YK5)0F;1<%YBH(%2X-N6T"3L%KZ2ZIBH!SB2QGTAVI]FJJ]F[W M[8P6ND9\+1+S+X@W$A!A6.(E9DC3ZC5RC%)R5^0&<>/,2&DI[Q+@:>;%?T=S M3E&Z@#"3+>+R"A][%+'['!?S)F+OJ4C'YTE$/?N-N:K9@1"C-0L]K%F5N.V% M=B,:%*9C2#(JQ 1%X"="SKL);CX0B_>CQ%XU\C6S )XJC#_X7&/;Y=Z=;8$L M@UP7%;B0TEH7:?T#S":"9&$0PL_QRU4213C'^.ZS\A(9.KU*O3I/+TMQ394R MU6*MC&=T6(!B+!1Z;C6/D-(6-ZW"2 -!//^$QPN8*&%A%ECU>>PN=WG@4U^G M]($H%Q,ZQ>P0Y0*FQ^7\J-R$P)IC^(AR@U]_F2([]Q;>3W=#%:XY](:O?"R! M5DNBY0_SUFY@U(GR@2HW,S1\P#@7Q+:@DXY%5"$8?)6;\72>E:N)=>^Y9[<4 MU^\?':.5(2YU-[ODQ^F" 6GJRSA6;FH(^,.#J_) EXQG/ M,9!%P0&T$35["E]]L",W;2%_+.(&G%>V@"N @&MK>INOY'!(T4UFF.-9:&&] MJRDX NFU?'[,\1/SXZW&^O\Y[4MSU\WBU?P6S<,X60AG'&QL*=WMF1TB+CO3 MUIS/%HQ!9'Q95]'M]UGTA"]X6;LT6NVF>\?6RH[)8S<__K!DSJ&GB"+$I!B$ M1O!(Y%:33$2&C0NXF&=H,?.C^=KU-E8#*1%-XJYLVHE8@""T.YA#\--]'G4@ M(I4>JS=YD:N?)H7UA'&C#\: (4]CXUR"G)S@H;/#(UT\#"5*9"EH>Z8.3+=! MXCG$84I"&PE@/@N#TC&-IR(3$-IZYK,3BAUZM!Y<^))OQ M_LOWG:V&TH/(RW%Z):I)P*P $GD!2CA&+&?F#O](-+9"L#*"'_!H3\03(/PI MC91?.&XOD2\+%3,: HW11;[\%X !5L/,60J )_'1^=1>XF<5BX M#F<1:XDJAB E=KJ+*&0E'#! Z?N1(?>H\6S8^%?QD/,@V,7[ZXM/YZIR?7%] M'FM(U.4NV]( )Q6$Q5!@8>\S+]AT#5PXTFC&LA[))0OE@SO*YR_2@Q?0#P]( MC6_7="XSE1\"]XEXX \17ZR'DI6!7TC/RHV0'13#91C#\T?!ZV3E)NQBQG;/ M$[/(RIN6/PL#FO0CI28R#\;ZA(6'F!:*@KA%L0B<3)/B[A+C[#@R\02<#29Z MC ^H*8625CR";PH\(PR)1]%<6UAKIJ:6QIQBUV&9/2VBJB,HD8\$\ L,-;2R:%<>!P.L219)FH:;#K@7WR. M8H>4/>A0B_$_\\$=I-")-]0S^AP:Q4Z*A50V3H96B)>XX@&S*>YJ1LX":$R% M[20DTT*OKF,+?)U &BXT&-[9[B]F-FD M<)CBXST6+_/R?:Q_T?BHBE# P(O6HV6&+&[%_&3NUD9UO<4.PP%W%PISZS?( MD4]GUU\"]8^L'OI'L!%>&'WC-VKB-NXY^B-LTF6NOTX"I$&=A\.6D\PTV^Q%,\$EESS&XV$_%D MV9 LFSK9A8O,.>8T\/J6N7? !&$.>!1U(NS0ML4MWNLI]M?B6P73 M1P4>$$\(#7A98-QP 9M$TW:2[2'P>VQ!%7K0#>[)8!C!P76D2&[RH;\8$T^3 MAWL XJ-\\Q.&Q2!\QP#Y4NQ-N?$6"IL,$7R+'(J$&AX3B%/3T,<@EAGY#V*M MG2*9).5'38[QF%[ /BLOXV]S(E^QKO#RQV(!Z:4#I:E5.B?6#F._)^FVFB6! M?;FX^20A"M?>HK%7*BOR;!CA5"2:+ZFI_!*AG7@R-T\89VV!W+'L9!\,55S1 MF5=A9?%>QEL>AX6*BSUOVNCRTJPYYRN*FOAD2IF#H?!%?@'1/)'?Q > [2JB9@?.9 M\&75BF"M6$NG%*A(?(UF'59U8Y1ZDV+P$AF<\1Y)?0Q,#"[XHG+(3DH-L:\S MK8'1.IY!*ZZB@L!U(T^H357YB22$=X M7/D^&S2;5HQLC5THP+@V/PDH$ M>9L%U"(=1>?L4%;\@DF@TR02P; M&>J!>/P44OP]'-Q,D&'&LE;H"JN:(JQ/K[6YKF,:7654QVP.Y8V@M[6)$ MM3GDG%:G@T"%V4D=+8+LJ:*H<1)VGL?/WC?P;W[\]@Z,6$J#JP=\!9L-M5:O M:$ZVY;)URL1OPWFX![$^OM_!YZ5YC- =M+KU800.]>AR5S@[(/>>HKS&V^=L M9Q <[07WB[V8!0_'%;&/CKT.QU(; *^EL,:T]?EIH;;XD*R\F$=;_LP6X*7M M#EY;Z&:-#N9F:?5VL6HJ%'JKWQ]L#^VH#3M9@5B_F/R+^FJ]IFNZ T_J7)IH MI?.Y%UTG@;H/6[MN@_7E=D#=7UFJ;--+U:T8Q87+IU9OLV$L$(V%(_O.(_^R M\%R];6A<:N16FY-+%M=:CW:C^;C>%LK:4=6^W$QK)V1]7:R^I5U60ZZ^3L M2H]VOQ[M%G4+I3N[]ACNX,O.PD"ZLCNRL/1CFV_LX]FMO:5/ZB/K;19[2N\/ M5U$?6;J]1^WV-E$2.H.#5 IOCI>/?47PUB MX=%T-C1#)\4CL6,[1"#S@"KW#$T$,<$$PD3V?!%'K<\FD',H(6($K" #O-12 MOJX\Y!'!)043!,V9PA'PR]VT:087G>_ZD]P<\SYR5RV#OL^FXI^GS&(C= M05@A#3\"UV='P($OE.")VH_1^$&O@R48)6+21>:[.XX24S7]+9"B]MK#S DC M/I=F:G:?J$>3[\0>807IIY"@:[8.0$%AX'7"\^M<4AO-F9B^(S* M0 /P4A#(;$[P?#;&0XF"XPI6)W-'W'_9[4?*X_*U,Y/367X(0HOQ0I-9G0\EGZW$$[1 M,H1;]!2!<<4'LA$TGMH(&)<<3F4GM-%LLBD#_XXDYU5;2K9!!'OQOM'@C'NW MTT3.!?9HC/\5'VW$8_1H\Q"R?SK+5(K"+RF\;!/X&6B=.<5X[MYR6$_8FT[! M25J@+,:587?GP?[11Q<4FKES:9RDV >!A>0CM=D]CK$WL:A'/&/RS(RX&9M) M7AXI_LPT?=",@7='W<[ =Y+9S+8,=ER(-Y1R/I.6V/G[5!&K@M/#)ITQM&9Q M5MMR,&[,3YVF3KQ'%5"BYM.SQ&L8@#<"U#RGP0R! 3C>6>K#; #3\_W2O<=J M2]B35QP7"'K+BK]P=PL?"9W40[" B?](?U7\W(P/HO.K9[E7FH M@&CLWCVL:XK!)^.CE.DZ:9SG$A8"";U'M0%+)Z0*IL<53C;C.S_;&+C,:2B' MJ..^.(OG%YQYJ]P('!*\KB'GV7!V/C&UHJ>.P_YGR 8F37P.70$6PMQON2+ M$PXC:B0:- L>N?SD]2HGOAR.&+;T4;/\^,9Q33O%-<<[X_-JH**5V^&F]P9F MBI4FP#A'WL"I(I@')MA1_LHIBVP!2J%IK4?AQWC#':(*F!?YG$"$) MQG^!87+#!T10]CSW/BKIPH"34]]/F?(-D"#D4K(A2\G*=,J"\_72BI1D13JU MLR+[F/$3M")%BZ,$'3O@2."(QQT$-@/7=MS,^BL%G\_!YH4-\5/6*2I2\TVMG^9#SBR7=Y#R)"7]* M0AI2>]13>_R95-T6D+*>Q^IL"QA\MD\?%7Y)9C:ZE*EX(B!H9T ?XO"SJ!>/ MA(-"2FFE>VJ0T$]@\<6W,A6R, -ZFDC$$)9R*/2Q06. +;3Q9 0FC0J<1&5X^1U(^)\J1C_FNN'*%^-YUV% M6!TH>8UOGL2:1B3^)5E,B!D>(08+K5439G_DPL,=HMURB[IO511-9VE++(\FZYWRB>7),4@K^FC M:S]BBD0 JV?W6X)RBYE\&93;9,&3 !OGZO+DE4^D$=(M8\Y%IEXU_0O5V!S* MNJ%!T4CK 7JP I?ZJJ61< MTC'UT.9="/,GTELGK":W)W+4LQ-,4A.< M2IL26?],!Q!CHF8S2XH FZ/UE4_ 58ESIO.X\:PY5L],E&&3.J&F7+55W2HI M^!4+?KK"1%[P%YR0N$_*($>9=U/7Q.PQ+O[SF_.I72&^9 F>9WPI51CV3:KL M^C-7E$EW/58W/:[&Q%B"%T_D!Z8*], I [#K$H"]'@ BC<=;[XQ:V@9XZYNA MA^2/ Y<,G'X>@]QB(_%)8HGJ>0#\XGX)^,5+-@/EQ#9Y8HLW<LA)01Z- 3X.G M3MQ(5Q? 2=)4:[#_7%Z4YL$;PJK2PM?B$\?.9O6P\'UUT.W5V,+O M&%ZJO@#AJ!H8UB/$U6580.R(ZSVUW2=EYKF/EHD9/HH?3J$CSS%T&2LLZ$VU3^,LK6H4ZDS]Z0S5VSJ;: Q M.YMKS!3^U5D$940,PPM923;P.ZC?M&3LYJTW.]L2=[!%9TSQR\ZH4XGF_/&' M!NM.Z8IFIB9_FHB/12FGB39I9&?LF?VJYBORC'!3:VO?M4>US)-OAVVD3/Z8 M/\.WG178^J3?9E9@(_(WL!.;D+^!G1AH=9OO$AN1WG9SO&V19EF.5M_NM&,< MI2@#+NIH?.X%"JT#\FFZX;U-*U?(ZV8/;T;YP71QNCNUSP0I30EG-&Z7#WWV MST)=-%\_+:4J"XA+CN>/=MK0BF3^Y]>A?_9 R.P-%K#_!VZ&7,95W/U;X)UW MMFM\^_7''WZ.'KRA#^@O7D=EY)+GX\=9*0GXXYJ.?WEQP7_?=3Z_O]/TN]]# M^PXUSZVFW?'_;K_>=;0[4%+9ZR]^%8JN4.NM*H^X.<9QX<;<'C;E]E@-<_G. M"T@@9Y.9\( MR#XJJXT3%:'@LXJ%)JP76,40BK%C$PL0/F;J%T5QY8A"57'"P&.>!I87F5$$ MV Z>DQ[@JX_$,+!=3L1G^.G!PU^B%[<8(*RA1-$38U]:.%R\P2OJ(9^S4DU7 MT:-KM)FJY9AI %A4-@3CXN*8X429(; (XHT;$SK%A1BO M$Q?] 2--[&<_B)\L!!:70ET'H<:R%9C% KR/!3:^$"7(@!5Y=1\_B N+,F;U*/0G2,K;@R[PK/N0I]+P M>A; M=$'V:L,^%Y\R4/JQ3DO>)KXR@5,GXMH]ZP:C^FRS\==9>^R:H11L8R9 M!SK%FJ$2B!J)2HW![>>80E8G%=Z)AY.7*'-G[& 9J#4815!9/M812Q#[H]6, M%)"&"8A@V(0G(LDX-_\)2@]^OW_W\?;RG',9'6-UB-PMY$91XN6>8JV6Z*^ M?(=!G]FAK[PDK^(M3H5^GU''!Q4,QDU57MZ_@@_//+1,L;B1*:ZK_L4NP"/& MJ\2O>LF__DJ!]1;H>YA/7OO7M'S@0BS;-U;Q#UQ^60[NK0K>9=7_7IJOA*44 M5$3U\,15_G&5%9R@,^+Q@E6\7#@?F+GJ74G-+C::J<827P"'!99I21P4/A8#S>L6IHJBLV&#HA'Y( M;!7EZ"RF"L?'8Y=@P($8:$?*;$UE]I;5.#*PJ"WW)VW+L+@GF)%9(HK:^P2K M+"%#N#X*JV^ B6&Y!?QVD@CJ R]:8_!RL$1N00O"_305$ EJ%6GU$\X![79& MIY$$6A!2DCCVF^!T;IRQV1[T6[W16@'SW0+^QPP'6P3.NF&RP0;YEZGB%UKQ MWM1&8+&W$X_"$APX<;(^9L-A$6-EP8M]UUW:0"ULMTN:WYPJN?32!U[L#1?1 MEFOZRGL'?8O"'=GYW:_30KLN?4.U7"SKDAE%G (N9)Z8>^(M>LD6DBTR;-'; M,UO4(CNIJ?FL!S*E*S+\MS2E7Z)MF%/(#CK<0:9-R6MW]T7?!D>:JIH6R5^2 MOYJ4#293RCTXO33:0QU=6_.\[R;::T]'UH8= MM:O+J@J2G4IBIY[::^NG8P:;NO:3%E)8R"^IY+L;D7QGT::A,3=8M^W3X]^3 MDFOWU8[6E393\E7)?-56.TN/AAZ9\3Q%"[DZM%WE9F0Y-O0?(CO]!+=]]KA3 M<9J'\S=1PWLZG:]WU<%@6+=)ES(B9:1&,M)6V]U.W29=[A,WR!,ZU$[QNJY. MYM21C ?L>=TV7_"M"4NW--5ZNZOVM&IBGY*]3I"]-%7O5!-UJH6YE#:Q9O'S MN7.WTBC*8.;"%4)/5WNCMK2&DJ]*YJNNVNU7D[!0"S,H5XU+E_Q[ ++=IPTM M0JG8.FPN,6UE2+!&(4%='8Z6K4_J!6PK943*R"'"YCU]4+=)E^#/=?-RRD!N MWG-X_-8-4E!5IQ<*.!6$YL-IS4STTU-231 M^ //0UZ\F]%QN0R1[Q24G#RD6N=#JI*_)'\=O2&LM;4[Q2UJF;,ESZ%H66JW-("2F];GIHXZ'/1/Q]PU==UWBI90)FO)I)I-DFIDII9DJI*9JJ]5 MXVG5PC:>H@%L^%GF4G.QY/%,F6=R\%VI!$E"E^>7I8!( 5F !Q20*2 5"X@PV5+]WK)1RT\GU-T;V3^0^V7:G*7NXX_UQ MH^F:J5'3K8\G)D^"2KO-7(\$5%I5 MJ?X6@VE6=)9$,M4),=6@IY^.195FLV9F,S9\,(:^7%1*3;5,4ZF]]C+$1FD M)5MMQ5::WCL=$R@7EB6%X(47DKREN9A();2'U MV_*@645E:2532:8Z3I,I[6(#["*;-6*P^*M<2TK]M2+[56T/Y%I2LE7);!7O M[K1/Z""(7%%FIJ;AJ$\?7 _&!VQHZ'G4,9Z5EP_$!_N -C#JQN P&2G2, _4X/A/H'!;6_B80BK MQV:O'_.,Y9A@O9#:[[&=[6I_>ZL(1@3Z;3#N\)WHUXZ^"B?&]683H)EUP:9! M "WA$VS@HF=B5TKO(W%Y]R9CQ;OYN= [^$ZA9_,$/4M:T^+GMG)V%/C\_3<+ MY@!'TP\\]QL]BYGU.W '\A?7F@OBO@P+;@&Q;/+.4=R5"<_J:HH+NJ;=3*\,/J)S:8TMYKP2WZFV^MU>:F@V4"-[WHB7H(P-F-K&\/E \OFQ\GD54ULG7Z#6 M!K^V:9UKFOR3*E!=$R,B42I7IJUW>FI/7Q:7KLE4-H:OZ^L/G!1?=[OJ\H/\ M-9G*.MG_IL8"3LXU:'HI[YK8%)G'OSY^W4CM#YLOL?2^JLL8@G06CI;!VUVUW97> M@@PB; B(,9\ANCL@QKZ?$ M9;4*8RQEM5I9[:B]I1'+QC*./&?2(!>P%*B/+0Z;;!0;DB&A$A6ZQ%4H39FG M^],;#55MN RVK"9LT1@9.:#3(V5D+S+2UP;JL+.LI$=-V.+4 4Q2=CGK6+7% MP.^&:*)W6MUAS(T1JDD*%F3_>"7+G+*ZH)$P_V="EMJ[ /X<]!7"")@*,6X"PH>:U?9TW-'[L4] M&,49-0+KD=JB'T69107=<;;N07O(Z>]IW7*I3XJI\7/5$;6*0?P)^P[[@60^ M$AMW057%I/= ON^'K+\,.%^)(?5=-LO7]-&U8?6@XO?<*54"\CU^1K3$/@X+ M# (CX<)+GKC1*G"JQ5\_OP[]LP="9F]N^.!>TQF63'4>+BW?L%T?./P6>/:= M[1K??OWQAY^CQ]\3SX&G?)BHFPGQZ!4L_XSG^%'HA(.\?DW'O[RXX+_O.I_? MWVGZW>^A?8T.)B![_<6O0D&MH:WTC;65!:L-R\AIJSE- ME0B^5%21HOI" ^4CY\(9,!F;?\9\?S+2@"'/@5/) ^6W"K;Y]VQTYF&TI,$I MF,=WQ+<,A!*/= K.IL]FT_)!3=E&R/7+_;,",V:A^Y%^'"ZC:GJ*9IV(67=" M5*.H4^&QJ>OP;X*2#0,_ #[!SYBAA__@^UZDU M ^8SG *9]#OU#,M'+P+8$,V;.\,C4'Y+^>!Z[-%@XH&7 9\.)O!9X")SF4/! MM"7\Z*G,I4L3E:'IB>+(<@<"G1G65#3,6&0'"#*7S$J!*)4+6#COVM<9L+"M MGP9@(8_N9C1E,E$U2(I"BB9R' Y"W3_I^9]B\_264OFVF%H*922VRT75:.3EBZ5W8H3-/( MK[EB#I:OO%_LTC"&DYB6Y>T'; -IN5@WEV:!N8711GM"34Z4FR1;>( M+;HIMNCMF2UDXLF1)I[LU9A^B=?.QY=_TFGIFV?I+V%3_+G MXDT2L7L1933H.KJDWLWDF=[3S,P$'*IZZK'6M?.[5B'^#''^K- MYO7U B2;UWU>Z^0'2&-?A;&?BR,L0&F3B29-63)M7$+U,,NDF$RMU=FQ>*H, M C3"_)\01W=WS)0Z-5LOU_P-<0/D]H!4F](1: 1'2T>@!AR]:XV>YC@">8#1 M>:C!%=B!:9C!+_3IW## 'T!@IBO/=>"G05GQ./[67G$'HX'Y?^U]:6_;R++H MYS? _ <^XQP@ ] .-TE49B: [23G>&X2&[;G#-XG@Z9:%F\H4L/%B<^O?]7- M1:1,+91(JDD6,(LL<:FNO:JKJ[#5X/%:#7X7E@P@W-%F8(8WP9:"G-+KD^48 MCDD[KA513;APX7_"FZ3.1)%^_71^=Y'^*?_ZBW!^]Z= I?%4'HAYE9/M5E @ M7>S]\*J J0=:U7))&ZU^LH'PPIM[=V&9@J)*O[P3+FW#]ZTI./5)#[7+N&LJ MN^.6F,1:Q/U4V3\!1:$];#=1JW3S%? MO2IIT,HXT#!9/36P9S"+N[OYV16P5K%3NH*H+2[M$SOK0BLR M?0I?1]\X/BS7BY:2WC\W)B1NP&? 6WT0/M^G+>T>@1?8I12/@"N(XX %TN9Z M/K"ZG:[4BT(ITBUG"<$#ALM0N@+SP2D%=J M6F)X/@ E\]UJ:,<]X*[1F0!&R'X1C,7"3H@#[X$' :8 52)M"FR[]$E1UV5& M:Y\1"X)3$E$WQ3IK@$H?!4CVK7EH \<3-_23=L:9NUG7YBS%Z+V!"["G3Z X MA!?# D'(DM["$<-8$4(7\$##G)T)?T7WDV?##@V&"PJ7-0>99V@U)E')_NO7 MTN]"CQ&55@^RKHW35'I3+BQJ'HRJE@=5FRI*2=E#47XFAD]2O:AKRB\KRLT/ M01A Q=!FX521A9Y'1=6F]PG&4KDO^1BDW*/-*[VH,S?MO!F\4-;VB.D^.8#! M;*-JVS(>+1OX&:ZF0@V^[RQA0,K]<(F[8,H&_K(C:-U(13X:-GNC/R,D6'DO M>*V4WX&%_P8= 2MFLD.O@;\I1-$7D[2[-6W\^016*7D->[D'//L4\W^MBDA' M$481'IS*^XCP#4A!ULV*9-D7QD-)A/\HC.O'P\&J9,_="7@D@/G$%5D*0R)( MD66G]S.)%6+>!(:;@XB$7B(:?RV-5K#%S&7:]Y;KE1LUW[<"869, +O 9T!S MRN")B* 4=$4*Y#VDX,IY!M2ZWDMBRU3P\5A\Y]2I4_2N4=)#!EE6?SD(6QJ CSCV6(IF-P A=Q<)+!8KT& WUS@ M:?I\:J"BV@5W>FI2(QOD)7=NO,09LC!)XJ3!;L'KZI+:K ^>T4:9[!%-1!4M M=F4LEB)J4C2< CX.5+W*T5@B:!;P(QX)<=83&%!&LV[ R-X\8I BO9-+ *#& MX5SC:/NE\I<#R"@+_NG$T2ISWXU'EZ:W'>$C2S*E2FGTJR^<1RJ!BN-E(IJ, MR_[E4AF#[^!)3D9-*=+@E9G/J"D@G1&;9#HU#T39S^2W&<#M6!8.-,^+)<''.3'!*-G$MR_?2YX(M'V?\HM4;S@4:TM_#-<;\[ M<0(N#4;HERP2B<.IW)K.!$ [?7LTE<<-V<:#1541>$!6P)+PGOO('L#>PX*E M*)7(( 05&SK1SS2&HT>4J!Y[9.R;W4S9AMXSX*DDD4^%U(]WJ43V#8OBXD%_E,"V]8W8U@R\3:; _9EK3_+*M> C!%S)6K,QF&^! @&XX\E_ M2>8U]&..H$BAZA'6^*_S\QL6F0&E_>5>C6E1VF;$+T7=QGB.1(.6=@OF"NXO MBO&H_2/LBIWSZ"C09FG=AGZ@3LG7KJM,92&JVH=/%20-PL\!ZIH0(JMA1WO0$2> M)?/>$J;TLF\S\V\SD[=%6WQL5]!^B3,YT7.I-@-.MB@W6--H]MDB,]DTJ[5H M;B-]!1L+YIK4"$1016# LXAASM8\(S(),W"O;1L2E*X$N5R^!4UO:Q[61*P(].9]A^3-72!UCS"LF,>>0&9QDG M,ZV-CGVEROZ4*?O)RI.7"B_2^#[8Q?9G?&\U4" MOV8*&J1]XJZ8=^A*LT-QKS.L0^G^F64&X*J5M]/?EA#LL\WP%2(>]_OIG>DN MB Q'S@E4DL7VC8OEM$S%T!.5NI0$O>0*6//3:& MRLM2G?IZ-]K=N9[> MI-'U%2U)F:1U/VD!CH\3@?MCTU/.H,RZY TA8@YA616V9 ]TS_@DY8=E*FH* M6@94YM^AX071CM@4@DJ@8A0%9(;/@]FE(0G;ZXJBPSFMB/AOY#Q0;]_QES%J M%+;2E,]I\I659N^3&A$(H4*(H>*,FA>G[]B6' #RY%*UZM,H"ZSNC(5Q;!I\ MLITF"F"9"74$6()L K!!E.E%U1\)0)FRNYPRS=7@Q54H;-KK?6;),X/NP0'? M4\@ X"(-G/J5I;)Z8$I8" YFRPS6E!$6(ICZFH[IL1*= DQ%@3K@G0A/'@T8 M@0I3*]KB+($VGU8=_F,\4).LJY=*?[QWL-PRR/!(+E.2R6C.?G V9AK.X5C67'R<,>]#V1QG#SY3C_@ M8%:A[@U'@ .9>6=KJUA IIZG MD8-8:-*6@*E]X]DZ/G#PYY_0 >@=3^/L88SY.^D(X/8 JDUT!5K!T>@(<,#1 M?9P]O&QWN&?;H[3KX?+^\TDR7.[*88TXZ1_7TV7SI>OI==HLK"5-E$8I<[:@ MB9*B2-A$B8L(E2S[4$-E'")DK8+0>;*"%;8!.EGJ2" MCV1':R@M3\<)QDVG1=H>N@L9L<'9D-.,V#%J8^11=/JY$^4Q39"V-7RN(Y]W ME<^;("U/W@#7)K^[N[_KDS5T^N&%8+N&T[T]8'[]@\9VS,HHRYHVS11Q+ WX M)V1KN)I?;Z!G7*T>R-5]L_UMS03TT"VX)<^N_6S10=L>F5B!,#5,-H\;G80V MJ=,Z0ZN:].IX@+X"^@H=96YEN*F%#2?TY,EE0+^ +[_@W/P[M'Q6N9?.&S5, MTPM)/*B9^ &Z"*A%:]6BZOC OO#H(J"+P"US:YA5P*Q"1[V'[*!M=RI,R&/ M!CH;CAE-V?;9<&CV_<3R3: JNA.H<6L.R@X=,X/N!+H3W#*W=F"WNKZY$WWT M&;87E/(\Y> ZF!%O9R^A.S75>YS<.H[MZE.3]#(JOZ8^Z?JF0_>M99J>RVD3 M9ACEM%DYW=0JN[5,@X=16N3X<3[I8/7@"J:"6A M']+A_7@!$VL_DJJ@/#VQJB*FA[GL([4X-I0[$FVC^P2^8)FI/Q(_A9ZWAYYNA MSHH1LWT/%FY4V_5.,!X!Z# @T;61W.0:%72,V7HNWYA>ZIY\:V,^Q1NS4IB5 M.C K)<7:X7"GLJ,A]Q']-15D;.*&CS9I7*%GX]M-)TG+07X\79Z/U\<2)J7: ME91""6E60G1YS#]3\.1X<.U=M+T!FY)RY@>R\(AI177/M,#9R!1"=T&9\KN- MA0VJ6D#:UO YOSM9R.+HT&E>Z$JTPI7H%U?+\H%KN--J*U M3--S.<6Z6)335C#-6A'BPA_LH].'5:RMR/-@C5[=FC>[GJ&HRI@J:E>J""6D M20D9B)K2PVQ3SI70HF*A_)^%1C9W&P,FXP,4 +<<&RUKI2!]&QC +_3OW]XN MC)GY[LZ7B^(Q[[V[^EC M[H'!+FS7_/;^YY]^V^UI%X9-F^3>S0@)5AX":W(HR]Z2Z>\GE]'G!_7+QP=) M?O@CM!_H_/%[27J(_KF_?E"EASNRR']_\CY.!V6P3-^2H;?['3P>I8R+-S>\ M)Y OQEZC5+(L9P)8H03YD;*H)OWS5R$65R"1#=X5/"?Y=*"S& 'C>HL9P,R6 M8),@@#?1*QAO)-3B1DVBJWR2J]I]"S_ X+6[Y,2J_;R]D4 MX/&/WRP@ 46F'WCN-W*:BN,/X/$(C[^?2"=%DE8T&#TG1F.>_'A]9S?^6.7B M9\/A:(L7/RBI@7?/S=+K*AQ<'X,F)X"<^X([9>JOOB'UW!^P+D/QW6B\M$): M,;T+9)1="&H;;,HC\9: JY)(;W[TA+[GD7\FN+P5 *' ME5Z,"59.BO)V9+I]YJ<:WR%< )5L&78G"_#DSE8H[5B\K&CU %5F)VLHCO0# M*Y)?'0. M6J5%RP+'@3K5Q;%TX-1I=!)ZXB2TDKVED<8_17ER%OKH$331Q[H^G^&3Y5C^ MC$R$)]>=[%]TW][T^GZ-1W_^Z0B&K$_EO&7T?TWEO..A.!YL&IE=44OJYAFG M;])Z!*N,LMJHK,J2+BK:IOK/UG(.-IAND3-826E^V:*>;D7!1_2D.E=X?#S- MG%V//%3$H79@*(V9(CX\&)21FF1D) ['!S>,:E^ZJ3WE^774KNLIX[6@=EW6 M-"Q>YR/MB<7K6+Q^Y)>4H?AN-,;B=622^I@$B]RP<6Y:7HA MF23#[GW6USMJMF6&G@=" M0T'BW;"NHK>>]<$JD]XQ3*A+C$7]F MOQHYO2VH/[%$;]'&^L-T70@2/V$9 )CO[IZU1G_RZ"7TZEB&/ M14E3^:=D:]BZRX7$[6%K119'LL(_)7ER =J:*^BA=W#ISN>6[]/64RR?X)%' M[2F)B0-4FLUD M$"#2&O%/T=:P-_H$O+&W?N!!^[[Y!)A(:(V[<..Y4\(2"88M3 FF$%"?UJ)/ M?_XI&V4-M"'_-&T-@Z/#P &#Y]A[=&".K&\. WH%?'D%5X[ISDFF4C$P?J!K M@)JS[DU;49%P=P$=@XZRMRR.9YY^BK6%O]"&ZQMY]\R'ZZ"BTNR_J-56+26<7HNJ]@,M7NR*HNCP:;=S=8R#C:ZV.@ _OP3 M7RX@=D-M16H'.SW6K9JSZXE(HLOC\:^:)LH#'+/7KDP12LNQI&4@C@[=FVUC MXJG?'5)E->7!-K1('0ZQ12H?&5!LD;HQP4FOPQ:IO>E^B2U2D4FP12IFCK!% M:G&<<6Z:X3QDIY63SJCN?.&1&7%\ZYD(5E2._,9V??^7+H3*@[.Q7G,@U**V MD>J9TIFVD0U0MC5O9""+7P ^\< Y^="=+ MBSE5H,UUDBRA-6L[E#34#]XFZKA3\/-/?!D/Y.H=N'KC>&T^Z,B3$]#6-$$/ M_8-/K@>+=^+Y*N:+P(AI1P>2C,G_AGY /09T&%JD6NN,MVK2L6\T11R-1ZNY MVX4;G85[)QB/OFN' 8DN_^5ULI5G1FB-4'38WVBE4,CB6-*.(10]CH[CJ7?1*%$RC5'A*9_]#.H4EM3E&2@J>-M0J)96_IQ&V4KO!&LC19C 3W+MI[>9WCEG:M &> _R- M+ Z&,OH_Z/^@?*R3#^TH\4'/7"'T=[KA[_S\4X''XR]='MNE;R?>''Z"_]': M5L-Y@3^>2;01A>X/JO?&U+LNRL.#N^^C'X-^3 \8O6<.">9FR]47.[25]WHN[0VX$RCM1Y5V6=2535URVLI&:V6J.;]5PD1:V40:MO?C MS0!VME]9"15<7[^R-P-=5)0!;NUU/B6&] MAF&O%H*O&P9&2:?LNNIO"[CJOIDV,3SFI,U>X_;X#0"+>"\5. #T]Q,U_3(G M7&F/J#S]\]FX^*_?WBZ,F?GNSIR126B3Z^DYO#-@T[^O'$I6=D;N>GIAV(9C MDKL9(8%_3_GE'J"^L%WSV_N??_HM]$^?#&.1>NYTJOI-#"ZX%LR M_?WD,OK\H'[Y^"#)#W^$]@-M,G4O20_1/_?7#ZKT<$<6^>]/WL=\FI&;2OM< MCE(5VX8VEY*";2[Y" .QS>7&$R^K#@.VN>QT!\.-;2ZQSR5R";MP79]+;'2) M'2PXRZ#6T.IR=^-Y3PL&+P3;-1QA$A+A?.%9]I)A%$F1=^;3UJ2..CA,=]?$ M$!=S1K/ *KHJ:J,#FP3AA)1<,@NYFQ_NUD1%PE&ZN-':Z5&ZE\;""@ VVG/" M)H9/!/>1X<1RG=V/'70G$&KMI-2J"GEP;&?AHLH4[;2&9WHNICA=MW-B6OL0 M;!RLBUFC(QY@[4,4W/$<3^GS<>3/6UE1%<$)9 MGCP -/.\-1(UYBZ@AN9T)N0Q$"S?#VFY%J#4#WS!<.+O)Y9O@N/6R4;GG5.N M^[=//)IFS?04%?7C=$]$EZ/;+D>KI4(5)?5(5?/]\E P1[$QP;1/XXKC;5E] M)CZL+YK=$@ASB@L0&++_;E7/3YWC;E7GTN#@;XTEM7++TEIVZ[F$XT97-R6\ M^HBJM>RAX M/'RX?1FNMC6&6#8-V/V\?W%W@*\DN(AZBE[2':I\0X%VM C04[EI08N L=R/ M#@&1WYD3D"6=./#2C]P?8(^*R*VU:T.E 0/O J9D,7S(;NS.NMR4&.SG2U8W5U>_1MD-6SXQ?PQY-; M^:9E:QA;/QMVK6!T'\8>'6O^?!;8D3SFGYBM=3[0PZC1P]BCR/.*>NT$7 OF M7[A..G-LV9X$_8@6J-N]Z_./YDVD$ ^T34T_."%G:WB[@Z[$_KQ]-(RJC?5;[XX\%,0,(^CT"KHG#YH':AB,8OD^Z.,4<#39/!ON-/JS^S ,G M7- :D4 [SY6=?S/2E&/(!+H'F&PHN7'56)W!'H[->=10@^4=!'<*E D$PPQ" MNGQ;H$/.65>-A6>Y'J51NC6"/53W;+37A%'MTYFU$NY972U4M=J[,QZ#:7HN MITT8^E[):0F?L2Y!U;4N<@V6RG35M]S!<]Q^U+36:IFOX"]&U2^6"1\%10QQ-F MS9]N'=5VNG7C>=5U [ ]Z]D(K&?2WC'8K3KC.E3[<<:5D_-K:=BBQ0JYPP?: M9$4[TXN&"J]1T(#'[Y%.4HKCAE?VX4Q5:3A>,-K\6.?@EEKK]2Y1W>GM5?S5 M'OY7\L+M"-_"9KIT-BBBR;YTK+QC!FM_7C((OOC@]1-DY]CH>2Y4(+S(>M;0[/ZW5 M%I\,RQ.>#3LD@N$+[K1ZRA9$!8>G: O=K/'1W"R);Q>+4Z&0SX;#T?X)#$E7 M\P*Q^_GC$WZU7MLUW9&)^D?HD./1LQ9=A]M1QSU752*^W&\[ZGI1;KXSGZGU M+5A<&S[E>UAM1V.!:*S%[(5G_->R@5&$6V+8 G"@[:\LKCT(WR5.V$*$W4.7 MG4F05;ZW_QB/Q($DM0RQ.^P'C,_TCI51M_;DM2+J\H'M2!N@9FLX6SJ3NG9" MH+6LK8J2R +HQ_;?F.? M4I=[2[\\!2@K+/?4]"E ='L[[?:V41+4T5'.P[;'2RXWY6%345NV$([N^OV' M;OI=O%P8-AU&?C&\T1. MP4^GOO])E*7'LKF>C(;@I&R.WRW!=QD;SMA7VV_UT33YHJ*T A5VS5DZ\RB?0P5O[+, MN<+8>2^EVBD/G\DSL049=7U;2:<@Z=I*.A5)UU;2H<)L+>E08;:6=#4H3"Y* M)[!.N&2&;5M5Q>Z!RWYUPLO\OA_U<.[>_K1\I@\[MBVW3S6:S$,U6H1,71Z/ MDX^*K+2 OGPP^]Z:OE6,RD79I")NGI]0 2F0IYKCJ3$'@^M*Z[X#2//S3WQQ M&2=JO 6*IO9OIHIU^4%,T<[$!W/D]36+*7 M8\"DP\&&!&-267@:H2M7KR>GO/*!3(GG$=K-T?&M"?'B@1:.8)A_AU94!MOV ML* MBET\6\K+V=*!TH^SI5@7=U"^M0*M5L&I(%55SL:U'5^-=: H''A^K>>NQ'HJ M[DZTZAV)LHN9$1_2 T^<1+BHY75/F)0=W8JE7,=\8 M+^E8L'W.+*W%:I4GP8[[DBKYX_69MH8'N9:S :7 +V$EJAWFFJYIM&F,*R?Z M@">+T4>ST(BOO7UB?0FMOM_IOS1'447SI,YXW+V9K'TL79Q=#O>5$94IX<;' M8X_KVN"I9K.F>(KV'7FBON8M6;B@_YVG*X<:(W;GQ4O\(P_[/?5M^"QKLUNP MX:.IXW[L^$0V'-NX[=W&K?3VC#(:G@W&Y3+]_#8J.5(WE%VF(G [2/9^YA$B M? %.G.U^9 '[/7*M* Y.=950"_L%1:N^:,5]AS^YGA#,B' #Y',GOO 1C/RD M. ![[>SVJ]E3Y?%3M:V<*F:4N BVD'E2[DDC;DK^X \>O M;5M?$;&FR4*&_.DGX_60O2115IO).G%A M+M$FO)PJ&C75G!Z_=P/#!@RSYB<]K)?K2T.FXVG-7/93 M'XEC?9/FQ'0"\N;Q>%-6>E2WU]:41.L//.O1["H&QP>R\&BY.ANE2X]X&7/: MG.R_1IJ9[[B2PT.J/!]21?Y"_NJ\(>3:VO5QBQIKMO!\ZL8$G";JXTVEW6@ MD9MVYR95U$?#_IB[ML9]?;2$6*R%135EBFJP4@N9JF*F&DK->%IQMB_;.R/!5I8!+.! MBETK@AF(PP$FUI$S^>-,31QN[.;#>2*B8,9;:_,0M11@U9=TSY9;G4_^-_0# M,A$^7ES=?SBO2<>D,U^&E5Z,_N#Q_4&LBNA;RKY%^]B*.,0F\,A.5;&3+&I] MJHM @\>9P8F=YG5D:AJF$)' MUN20-35QI#1SOH<+>]S63$2GVM.\LM)%B&-7WA+3=4S+CEO9N%/!L0U:\6J8IA<2VOEK3CKBMC6Y4=4R M X"P"Q0*2,\$Y,U U 8J70.U@KT3C$< .PQ(=/4O;.7T2H80SE@% M^T?QYBBUH'_4:I\)+)'&IC['UH-4YZQG E8+PKM MC]3.:M(_?Q5B1@3X;3#N\)SDTX&^2@2,ZRUF #-;@DV" -Y$KV"(2ZY)72EY M2(%;=6]R5EQ;I86LTGL*/9OOL++EVZ3TNKV<'0$>__C- AI0;/J!YWXCIRFS M_@ .B!#Y^XET4L2'6<$U"3V[O.)(CGGR(_6=WA?(*+OP MCBP",G\DWA)P51+IS8^>(+RM@2/BD&58Q"7#!(T0FPR12[CADC]"AS3-('H1 M@^@-,@@7>9:V[E5QVA=T1[N9C0RNJ'-I32WFO!J^3^(\"<_AYRI:I-=HT&S*V +2MH;/1\CG7>7S)DC+DR_ M<'GMJQS1Y/?JP'5G!@1 M[%*YM6Q='8@#>5->FA-2MH:O^?4'>L77FB9N/LC/"2EYLO]MS07TSC5H^RAO M3FP*UO'OWK]N+ [U30U@.2%I:_B[RVY"&_E[)([5395#G)"4)W?(*# MAI.W1FVB6\"5VE0D<:QO:D#*"4E;P]_H%O#%W[(X&!SH]O;-+< L0DL\AE:? MS>#$L* NW3W$DH>BC#D$=!8ZR^"*)BH:>@N81"C9$.-UA>CA#3'J-]."$+?K>P"0QMK^]#?W3)\-8O+LS9V02VN1Z>A?MT]R2!1VC MZ#Q=.:S<@U9_7KS$/]X#EUW8KOGM_<\__98\XLHQ/4)_->Q+=SYWG;N9 :[+ M>1!XUF/((+AW+PW;OE[0A_GGSN0OPP/_+?!A80[EW%LR_?WD,OK\H'[Y^"#) M#W^$]H,BR8-[27J(_KF_?E"EASNRR']_(H2.%3W"9V\^$2;$I&=;?-KPX_U8 MD9;K/0#8YM8\7+/FX&#/SW2UYMGPR.<_,V/SX@XY#(5?P7.?) M@H>W)2'+$S @@(,@OO0ZF!&O A60N7_^P_(?KI,7Q?Z _X6UWFG'L@_E.W4L%8LR=^NHEGR'+CLW MJ+L!12;+>?.5??\!$ MG7F1^ZXAGTC.N]W!K?OQB@-RQX%NB'Z^DM M\8GW3(JA/@==-:7P_1$ZA7"_^GX+W+(Z7+5!VP"KL!JW0=%=&#$:.*=7RR',N?DS-5#FO9LI\3PR@673(UN7=$ ? M.&G1D*%@G:=9-6-\8;LOA-Q&4Q,_6\:C M95N!1?S+Z/IFZ""/9"7/0MO@JG 1%1$"PDA-W7\1Y]$;22+%H#S,'P5L7B(WFT M)[S@;$P)HX%A?R+-JA=U,"IDCC4P505]14A7!]IP3^COC1_$OS%>Z!Y*HWP] MEO-\70#(07!693L522T#9^(N@4)Y!.M*8TL*FN4\P84TJV5-6)+)=1)=_](H MVI5!'NW[P]O$JJM22O6LFJ4,CN0/R?)HD)?Y-= <#'!E-% &H[( [T&GBK#_ M\,FPO/\8=D@N7M*/_[;@;9XY>_E,GHG-(J'TMRMG$08^^T&-0J+L([X0 ^Q? M%% 9OA5%41_] ! 4D.MI>F7ZX8/EF[9+[]DEOAJ.M,&A#-Y^O,L-X/V';[US M+/OWDP ,[,G;]B--Z1C2=E97[9+PD;12+,";A#>"]ZY)>"-(.[*$0RP2SD.6 MWF 6'Y"W\,B, +:>2;0%^]D%G$87P7>7,P,0ZE\Y7TGP+\-RZ*^?/'=^:?BS M3[;[_=]D C]_G$Z)&; T*+CDS>2@ABNIV4:6QADNJXJKABL;0;SB,AYN?QG/ MMK^GQW9L)N/1I-=YE#%MC@M/-9I&W =W999R5$Q5Q&.GFC(:O\I&<8"I#V0* M=F1R01SX$-S0G^')L''@FL2#W?V/#J1OE+E<:CO9"V[ZJX06!5JDW5 M);UI!$85#;N])_H$-]YX[K-%7Q*_\MKY0#SKF:G7*P?>%V[?.ZQ,K >W MSJ4<%U55Z35Y,)2;0]6&&S^[SM/I/?'FK*0.+EL8SLMG%WBS&9[1Y>%PB8B] M *USF571N\IE'LXML6*B/I=/+VVHQN-4UA6U2JY_O8XC(JFJ\A%9JQ]%J^'P MN?EW"/=%X; /-HE]X9')1XB-@\A[,LSDYZJXY< :X1W"_$K7M7NH7V7MLZRL M%*KMN;8L>JB2H3J&GOP [^326%B!87\FAD^N']G!?WH&"[C*#ND1P#BM_X7V M V!Y_F9B=5U35LJ^#X6;0QP\7 +%K."38;)D$^,3"M8%T_F[, C#D]1Y/%$X M@AB.^Y<%89A: \UNZ=AV8JRJ$$=7M9'>=1Q4(5V IT'G\52U=*FU88P^8QGC M_.D8T1D ,J$);C>$P!KB:RN"GO/@AGB6"X'1I$&_8E_F68KB(O1(5A:UD_?2&97$W3&667H;,;;".-M0 MHQR &I9O*;KGD^VZ7O;&#O"0G&:8=EKQ-M:Y)7/#YWZG>L%8P&_5 M%4\**Q&T+Y:OG/9H J!?U@I*^< M(SL$]'P/ A#B5/[HO9$-::2QC[9E2;L VLA2#SXKI:VF%JI?*FTI8X(>O"5! MZ#G7#GMJ4\TX1IJR98'KP:MQ60>W*AAND[K=EA5O:<9=?YIH1B.M'#[*0W 0 M; >K,EW?$;37Z+X,O<"P[/5E+Q&HIP#J:0&H!3T'7K_#7]8=KU9'T5^9(_/! MG8.JM4QZ@!W>S#I"NMY+83$5O6LGOT97M@E1=OD%B+I,0(G?&A_T]KX8@3FC M[G_V=^*9U(F;LA^/B-FQP^S\ZSY;G.E&7559I MG9QL,"UVX)5QNER(QD__;Z/"?)TEOS!LFI^_FQ$2?'9-8QF51$E?"$B2)''F M@.!N&[/*J]KHBA^5^OH91%'KC!O"#9=@V!*[^@IZ" M>;0)#0'7[3!>AG[@SBE*XJ4K:U"B%)FQF]N;7+/@JZ^?P,AJ24IJ)[#RNB4I M?F3.PE5_BRM[,CNCA9?ZR0&'BQ=ZK &HPB)M>M?, M6L3;KS2!*: R; M&>BOG.AD2^3:G@?I&:VJ:F6X0&\AKQ9NEBNK\5P9G"&V-S!ST6:N.EIUC'E M=\MTQZ[,K>CR:B4(8KM&YI:5U3YI)=&]VFNCH.+Z3\> MY<,Z/H0>_#?:8KP@4]HT[BN\;>+'B]J9.; M/[]=#:I;U6'@="0MCPYL1=#RJ 0[$$DF'PV/[F_Z$<*3##CKEI3M$PVA2S:_ M>HQF[UMZ6P+?L+DQ$(#=>.XD-'>KM-(8 M9W(#8)HOT7_O23P8LII=]_?Q$.G"B=+YD>!R/#+4_>Z_$Y1UT\&S(\#I:0G+ M_%6()U.S,:)R.D/5'=:XBX (]__&8!ZB@2_,!SOY'3=%SJCVB.:4)Y__7@ M[K7T44K3)X$H2Y_A*_IHR[FI2*"$0'\1J@%LPR,3P7 FPL*P)L+?H>'!JNP7 MP33\F3!)B"BXTVB.K ["]ZOP#^E,E@10,P*;* JXHR/: 73A'ZHXUF11F+#$ MD!#,"/SK$2+, =J9+\##X'T@Q0'32(S@DGQZ2C;[4II6\UI$-C,.OE)YX;T&-6F MLH=K,SA]'2W(IQ^(F?]^6\OW5_M;92#A97<[_( MUN/I<6%FDT<;#SC-&+4"VGJ:<=VB.$1&5><\ATI5B*%=#_YB@1:9G#^#)GPB M1SH?O/6@K[;:@V,#W'PL<5<*KSD%N3W$U@RBSI/XF\]EV8>9D&P>/?V[??OW\]^ M/'KVF>L]O07&4]_2G]_2"T_HH]^^>C;]EMYAO8MQ*UB3>N8\OH_?0UB?N.0O MJL #:VK1X-N?;D/K^]O/H?P+,DR=)PK(_'O[U=O3EYG!\!$?TY M@9?]6$ \;,4[ <+$FD?G.7X_2:BU<1TG[Z/TX:O51!"\>L'[!+(4CK=%BUZP M"I,4!8X?&' MQ>^I-#Y5I71]\2_)W\E];W,4 Q+^GUUH"(8,:;@##:FC.'*GJ%#%I6GI!!JV'0-NC./1ETL#*!8]]YUEQ-@%Z9^[P'^BN;U5MB7OAZ M!5!ZFZ-F\=Y!@$!(O. ##2\H9*>R="K)J2"FOZ5@3C*7*J>JO'Q%],MV:CPLH=X\RF6^MWQ74^31._@M MH4_R4_(WO3^G&K?4P;?ZH,##^E[UF9.PZR[:*\V[!9UQUI<%_'OYPQ%HJ2'* M'^EEW=?9$/(ZD+D[$7EU;C8@[^1]'/-6/2U>$TOAZNIM_ MUSD1W5QZ)J^TRM^ M+VSF:B<4$ETWB_B4[P'*WG@ZER=!K%=599$'HYJ0D;, MC?2_\.?_!U!+ P04 " "=@6E)+W6!"T , H=P $0 '!A:&,M,C Q M-C Y,S N>'-D[5UM<^(X$OZ^5?L?='R:JUJ'D,S,35(SLY47LI,Z E1@Y^;; MEK %Z-;(G"0G87_]M60;;-PV!I(;,KZJU(RQ^D7]M-3NEH7X^.O3S" MB$^-UM%Q@S#A!AX7DT^-WXD_9?3]K@.)/D:R2*MH_='QT?'!"Z'(5,>7?Q"NL$#FXV8),W01R=LW&-/3UI\9_0NK;+C8(&"G4N>';),A29H@> M3X\".0&2XU;SVUUG8/N7B/2Y^#-#_322?D)_VC3-(ZI80FY:/;UD2!._:T:- M2U*_1.ZW#@A."^4EQ%PH386[ZD2NT[&)K;.SLZ9M34@%FU#-O$+A9TT9^*P9 MDR538*'9MR(:'-#*6&4%_'%K0BCQSC. PV&_&V6G#VY4YS>M"#RN7A@2N,L M49MA.LTR"7?)N98@83T:@0@:8:@N+GCW0^YV(=]#KW%Y?#-O7 M9#"$_^[:W>& ]&Y(K]^^OQC> L'_\;\*9F#>E G%']@M)"HSU@G4!F<4,>&> M.:WNF:O>7?^^_:7='=Q^;9/;+GQNDS>=WF#P]WJZZI+Z)M,83!G3B%.RS3C\ M;\O@O[SH7'2OVF3PI=T>UG0Z9$#L4TA5])1I#IW8A/@:,8[_N^KXDS=9B34= M])E00]7TQ@\>-T6D)1GNA/=;Q*"+P1=RT^G]JT;3X9HI5_*YT= ;7X:*"Y8\ M _ F'.5_F(R'*]C>^:;3 :R/KT82BH4=5.U M<&$KCN7).I8Q/[$"2%I"?1!NS^9^L&#LD@GHF^[#%(W115MP9$_7D4UX2X&\KE5^J'[(Y1@X,=21&$>!,.YOMU, TSL=PD MS5X?8),J;L F*4QS=W$X*G2C[Q) MR&JT7Q9

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end